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ABSTRACT 
This thesis addresses the trend analysis of Post-traumatic Stress Disorder 
(PTSD) prevalence across the different branches of armed services in the U.S 
military between FY2001 and FY2006, as well as the effects of deployment 
characteristics on the probability of being diagnosed with PTSD among the active 
duty service personnel in the different branches.   On top of these, this study will 
also highlight the patterns of the comorbidity and treatment costs of PTSD across 
the different branches of armed services.    
The data used in the thesis are provided by TRICARE, the Department of 
Defense’s (DoD) health care system and Defense Manpower Data Center 
(DMDC), to obtain the demographics, deployment characteristics (deployment 
location, deployment frequencies, deployment duration) and the inpatient and 
outpatient medical information and services rendered by physicians for all active 
duty service personnel whom were diagnosed with PTSD between FY2001 and 
FY2006. 
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I. INTRODUCTION  
A. PURPOSE 
The recent ongoing military operations in Iraq and Afghanistan represent 
the most sustained ground combat operations involving American forces since 
the Vietnam era. Since October 2001, approximately 1.64 million U.S. troops1 
have been deployed as part of Operation Enduring Freedom (OEF; Afghanistan) 
and Operation Iraqi Freedom (OIF; Iraq).  The large magnitude of the 
involvement of military personnel who have gone through high intensity guerilla 
warfare and the chronic threat of improvised explosive devices (IED) and 
roadside bombs has resulted in increased incidences of both traumatic physical 
injuries and mental problems.   
Post-Traumatic Stress Disorder (PTSD) has been a leading health 
problem among the military personnel and veterans who have served in prior 
wars, with heavy combat typically being cited as a leading cause of PTSD.   With 
the ongoing Global War on Terrorism (GWOT), the rate of PTSD has risen 
steadily.   Based on several studies on the risks associated with the U.S. military, 
the current estimated risks of PTSD among U.S. Army and Marine Corps 
personnel from service in OEF and OIF ranged from 10 to 18% (Hoge et al. 
2004; Hoge et al. 2006; Vasterling et al. 2006; Hoge et al. 2007; Seal et al. 2007; 
Martin 2007). There are few existing statistics available for the Navy and the Air 
Force. 
In this study, the term PTSD is used to refer to “combat-related” PTSD 
that occurs in people who have been exposed to “war-zone trauma.”2 This study 
                                            
1 Terri Tanielian, Lisa H. Jaycox, David M. Adamson, and Karen N. Metscher.   Invisible 
Wounds of War—Psychological and Cognitive Injuries, Their Consequences and Services to 
Assist Recovery.  
2 This includes not only traditional combat experiences (e.g., firing a weapon at someone, 
being fired upon) but also a variety of other events which occur with increased frequency in war 
zones (e.g., exposure to death and dying, atrocities). 
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will identify the prevalence of PTSD rates across the different branches of the 
armed services after their participation in OEF and OIF (between FY2001 and 
FY2006) and evaluate how deployment characteristics (such as deployment 
intensity and length) and other risk factors affect PTSD prevalence across the 
armed services. In addition, this study will provide an in-depth look at the PTSD 
population among the active duty population, analyzing the comorbidity 
distribution, the different clinical diagnoses, and the patterns of treatment costs 
across the different branches of the armed services. 
B. RESEARCH QUESTIONS 
While past studies have provided important information on PTSD in the 
GWOT era, they have several shortcomings. This study will attempt to provide 
military officials and policy makers with better information to address the issue of 
PTSD in the current environment by examining the following research issues:  
• What is the prevalence of PTSD across different branches of the armed 
services and how is this affected by different demographic characteristics? 
• How do risk factors including deployment intensity (such as deployment 
location and tour length) affect the prevalence of PTSD, and does 
deployment effects differ across the branches? 
• What are the comorbidity risks and treatment costs of PTSD, and are 
there different patterns to comorbidity distribution and treatment across 
the different branches? 
For the first two research questions, all service members who were on 
active duty between FY2001 and FY2006 will be analyzed.  The final research 
question will focus only on the PTSD population, i.e., service members who have 
been diagnosed with PTSD at any time during the study period.  Separate 
analyses will be conducted for each branch of armed services (Army, Navy, 
Marines, and Air Force) and their results will be compared.  For each branch, the 
enlisted personnel and officers will be analyzed separately. 
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C. STUDY OVERVIEW AND SIGNIFICANCE 
The main empirical strategy for this thesis will be a combination of 
descriptive statistics and multivariate analytical methods to derive the trend 
analysis of the prevalence of PTSD, the probability of being diagnosed with 
PTSD given deployment intensity and other potential risk factors, as well as the 
comorbidity distribution and total treatment costs of PTSD across the different 
branches. There will be four main sections to the body of this thesis. The first 
section will be a review of the current literature on PTSD, especially focused on 
the effect of active duty personnel’s continued exposure to combat conditions as 
well as the current data that have been gathered on OIF and OEF. This review 
will also include past studies on the prevailing treatment for the active duty 
personnel who have been diagnosed with PTSD.  
The second section of the thesis will focus on the assessment of the 
trends of PTSD across the different branches of services from FY2001 to 
FY2006 (OIF and OEF periods) using data from the Defense Enrollment 
Eligibility Reporting System (DEERS) provided by TRICARE.  
In the third section of the study, the actual deployment data from Defense 
Manpower Data Center’s (DMDC) Contingency Tracking System (CTS), which 
has recorded deployment information since the start of the GWOT, will be 
merged with TRICARE data to determine the effects of deployment intensity and 
other risk factors for PTSD.   
The final section of the study will be directed towards the assessment of 
comorbidity distribution and patterns of the treatment costs of PTSD across the 
different branches among the active duty population who have been diagnosed 
with PTSD during the study period.   This portion of the study will use the clinical 
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data in TRICARE inpatient and outpatient claim systems to derive the treatment 
cost patterns and clinical characteristics across the different branches.3 
The rising trend in mental health illnesses, especially PTSD, since the 
start of the GWOT requires the DoD to be well-equipped to manage a new 
generation of military service members succumbing to PTSD.   Results from the 
first research question would aid the planners of the U.S military in their 
understanding of the risk factors for PTSD amongst their active duty personnel.   
As such, they could better focus their attention on preventive measures for those 
potentially at a higher risk.   Military planners could make use of the information 
from the deployment analysis in the structuring of the optimal tour length and tour 
rotation for their service personnel to minimize the risks of developing PTSD.  
The level of combat readiness of the fighting force would be compromised if 
potential or current PTSD cases were left untreated or inadequately treated and 
this could lead to prohibitive social cost.  A recent comprehensive study by 
RAND on mental health outcomes of returning service members from combat 
zones highlighted that there is a fundamental gap in our understanding of the 
mental health needs of these returning service members, with PTSD being one 
of the three major conditions to focus on.4  Thus, this study will provide valuable 





                                            
3 This includes the Standard Inpatient Data Record (SIDR), Standard Ambulatory Data 
Record (SADR), TRICARE Encounter Data – Institutional (TEDI) and TRICARE Encounter Data – 
Non-Institutional (TEDN). 
4 Terri Tanielian & Lisa H. Jaycox. (2008).   Invisible Wounds of War—Psychological & 
Cognitive Injuries, Their Consequences, & Services to Assist Recovery. RAND Corporation. 
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D. ORGANIZATION OF STUDY 
The rest of the thesis is organized as follows: Chapter I offers a brief 
summary of the increased occurrences of PTSD as the fight for the GWOT 
continues. Chapter II provides background on the prevailing research on PTSD 
and its treatment costs.  This literature review chapter offers an analysis of past 
studies on PTSD, in particular, cases of active duty personnel being deployed in 
combat regions. The chapter also summarizes the clinical diagnosis and 
treatment costs. Chapter III describes the data sources and the sampling 
restrictions.  Chapter IV lays out the empirical methodology – a combination of 
descriptive statistics and multivariate analysis models.  Chapter V presents the 
summary statistics and trend analysis of the prevalence of PTSD across different 
branches of the armed services and different demographic characteristics. 
Chapter VI focuses on the detailed probit analysis on the effects of deployment 
intensity on PTSD.  Chapter VII provides the in-depth analysis and findings 
derived from the analysis of the TRICARE inpatient and outpatient claim data on 
the PTSD population across the different branches of services.  In addition, this 
chapter analyzes whether the clinical characteristics differ across the branches. 
Chapter VIII comprises conclusions and recommendations and study limitations.    
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II. LITERATURE REVIEW 
A. INTRODUCTION 
Recent research suggests that the wars in Iraq and Afghanistan pose 
substantial mental health challenges to U.S. military service members, mental 
health systems, and the public at large. OEF and OIF are protracted 
engagements with surprise attack settings where it is difficult to distinguish 
enemies from civilians. Chronic combat-related PTSD leads to a host of long-
term family and workplace problems and is often comorbid with other psychiatric 
and physical disorders.5  With the rising trends of PTSD among the active duty 
personnel in the U.S military, timely detection and intervention with personnel 
suffering from PTSD should be a high priority. 
This chapter provides an overview of the prevailing studies on PTSD 
symptoms and its treatment costs.  Section B begins by defining the clinical 
definition and symptoms of PTSD.  In Section C, literature is reviewed that 
examines the prevalence and risk factors of PTSD. The way this study advances 
the literature in this area is discussed in Section D.  The existing knowledge of 
the treatment cost of PTSD is discussed in Section E, and Section F concludes 
the study. 
B. DEFINITION OF PTSD, SYMPTOMS AND TREATMENT 
Post-Traumatic Stress Disorder (PTSD) is a psychological disorder that 
develops following exposure to trauma. Trauma can result from experiencing or 
witnessing traumatic or life-threatening events such as terrorist attacks, violent 
crime and abuse, military combat, natural disasters, serious accidents, or violent 
                                            
5 Christopher Erbes (2007). Post-Traumatic Stress Disorder and Service Utilization in a 
Sample of Service Members from Iraq and Afghanistan. Military Medicine, 172(4),359. 
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personal assaults.6 The characteristic features are persistent re-experiencing of 
the event, avoidance of stimuli associated with the trauma, and symptoms of 
increased arousal. For the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) classification, the person must also have experienced intense fear, 
helplessness, or horror when the event occurred. These symptoms must persist 
for at least one month, and they must cause clinically significant distress and 
affect the individual’s ability to function socially, occupationally, or domestically.7  
The characteristic symptoms of PTSD (adapted from DSM IV8) are summarized 
as follows: 
Table 2.1. Symptoms of PTSD as classified by DSM IV9 
Re-experiencing phenomena (at least one required) 
• Recurrent and intrusive distressing recollections 
• Recurrent distressing dreams 
• Acting or feeling as if the events are recurring 
• Intense psychological distress to cues 
• Physiological reactivity to cues 
Avoidance and numbing (at least three required) 
• Avoidance of thoughts, feelings, and conversations 
• Avoidance of reminders 
                                            
6 Javier Iribarren, Paolo Prolo, Negoita Neagos, and Francesco Chiapelli (2005). Post-
Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium.  eCAM 2005; 
2(4), 503-512. 
7 Jonathan I Bisson (2007). Clinical Review: Post-traumatic stress disorder. British Medical 
Journal 2007; 334: 789-793. http://www.bmj.com/cgi/content/extract/334/7597/789  accessed on 
20 Aug 08.  
8 American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental 
Disorders DSM-IV (Text Revision). 
9 Ibid. 
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• Psychogenic amnesia 
• Greatly reduced interest in related activities 
• Detachment or estrangement feelings 
• Restricted range of affect 
• Sense of a foreshortened future 
 
Increased arousal (at least two required) 
• Difficulty sleeping 
• Irritability or outbursts of anger 
• Difficulty concentrating 
• Hypervigilance 
• Exaggerated startled response 
 
An important component of the epidemiology of PTSD is its patterns of 
comorbidities—that is, do people who have PTSD also have co-occurring other 
disorders?10    Based on current literature, the usual comorbidities that 
accompany PTSD are major depression, substance abuse, and other anxiety 
disorders.   According to a study conducted by Grieger et al. (2006)11 on a 
military cohort of hospitalized soldiers who were diagnosed with PTSD between 
March 2003 and September 2004, about 6.3% of the sample was found to have 
                                            
10 William E. Schlenger et al. (1999). Combat-Related Posttraumatic Stress Disorder: 
Prevalence, Risk Factors and Co-morbidity. In Philip A. Saigh & J. Douglas Bremner (Eds.), Post-
traumatic Stress Disorder: A Comprehensive Text (pp. 69-91). MA: Allyn & Bacon. 
11T.A., Grieger, S.J, Cozza, R.J, Ursano, C. Cozza, P.E., Martinez, C.C., Engel, & H.J Wain, 
(2006). Posttraumatic stress disorder and depression in battle-injured soldiers. American Journal 
of Psychiatry, 163, pp. 1777-1783.  
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depression and PTSD up to seven months after injury. This phenomenon was 
also evident in the RAND (2008) study, which established that approximately 
two-thirds of the survey respondents who had been diagnosed with PTSD also 
had major depression.12   
Based on the information from the National PTSD Center of the 
Department of Veterans Affairs, there are different treatments available for 
PTSD.13   One of the treatment methods is Cognitive Behavioral Therapy (CBT), 
which is a type of counselling to help PTSD patients understand and change the 
way they think about their trauma and its aftermath.  There is also a similar kind 
of therapy called eye movement desensitization and reprocessing (EMDR) that is 
used for treatment of PTSD via influencing a change in how a person reacts to 
memories of trauma.   Group therapy is yet another type of treatment for PTSD.  
In group therapy, all PTSD patients are encouraged to share their experiences 
with a group of people who also have been through a trauma and who have 
PTSD.   This treatment can help PTSD patients better cope with their symptoms, 
memories, and other parts of their lives.  Besides therapy, medications have also 
been shown to be effective in the treatment of PTSD.  For instance, one type of 
anti-depressant drug that is known as a selective serotonin reuptake inhibitor 
(SSRI) has proven to be effective for PTSD, as SSRI raises the level of serotonin 
in the brain which affects one’s emotions. 
 
 
                                            
12 Benjamin R. Karney, Rajeev Ramchand, Karen Chan Osilla, Leah Barnes Caldarone,and 
Rachel M. Burns (2008). Predicting the Immediate and Long-Term Consequences of Post-
Traumatic Stress Disorder, Depression, and Traumatic Brain Injury in Veterans of Operation 
Enduring Freedom and Operation Iraqi Freedom. In Terri Tanielian & Lisa H. Jaycox. (Eds.), 
Invisible Wounds of War- Psychological & Cognitive Injuries, Their Consequences, & Services to 
Assist Recovery (pp. 119-166). RAND Corporation. 
13 National Center for PTSD (Department of Veterans’ Affairs).  Treatment of PTSD.  
http://www.ncptsd.va.gov/ncmain/ncdocs/fact_shts/fs_treatmentforptsd.html accessed on 31 Aug 
08. 
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C. PAST RESEARCH ON PTSD  
The epidemiology of combat-related PTSD is the study of the occurrence 
of PTSD in human populations and includes the prevalence of PTSD (i.e., what 
proportion of a specified population has the disorder in a given time period), how 
PTSD relates to other disorders (i.e., comorbidities), and what risk factors 
contribute to the increased probability of having the disorder.14 Previous research 
conducted after other military conflicts (Korean War – 1951, Vietnam War – 
1970s) has shown that deployment and exposure to combat result in increased 
risk of PTSD and increased use of health care services.15  
Given the increased tempo of the fight in the GWOT, recent research 
studies have provided specific evidence of the prevalence of PTSD among the 
troops deployed or deploying to Iraq and Afghanistan.   These studies can be 
grouped according to the methodology adopted in research, sampling 
restrictions, and the time frame of the research. The RAND paper (2008) 
identified 22 independent studies that have provided specific evidence of the 
prevalence of PTSD among troops deployed or deploying to Afghanistan and/or 
Iraq16 and provided a concise description of these studies via the screening tools 
and criteria. 
The prevailing studies have adopted similar screening tools and criteria for 
the assessment of PTSD incidence amongst deploying active duty personnel.   
                                            
14 William E. Schlenger et al. (1999). Combat-Related Posttraumatic Stress Disorder: 
Prevalence, Risk Factors and Co-morbidity. In Philip A. Saigh & J. Douglas Bremner (Eds.), Post-
traumatic Stress Disorder: A Comprehensive Text (pp. 69-91). MA: Allyn & Bacon. 
15 C.Hoge, J. Auchterlonie, & C. Milliken, (2006). Military mental health problems: Use of 
mental health services, and attrition from military services after returning from deployment to Iraq 
or Afghanistan. Journal of the American Medical Association, 295(9), 1023-1032. 
16 Rajeev Ramchand, Benjamin R. Karney, Karen  Chan Osilla, Rachel M. Burns and Leah 
Barnes Caldarone (2008). Prevalence of PTSD, Depression, and TBI among Returning Service 
members. In Terri Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & 
Cognitive Injuries, Their Consequences, & Services to Assist Recovery (pp. 35-84). RAND 
Corporation.  
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Most of the prevailing studies, for instance, Hoge et al. (2004)17, Vasterling et al. 
(2006)18 and Grieger (2006)19 adopted the survey research approach for the 
analysis of PTSD prevalence among Army active duty personnel. These studies 
gathered survey responses from convenience samples of Army soldiers who 
were deployed in either Iraq or Afghanistan from 2003 to 2005.  To assess 
PTSD-related conditions, the studies used as the main screening tool the PTSD 
Checklist (PCL), which contains 17 questions corresponding to the three clusters 
of DSM-IV symptoms (American Psychiatric Association, 2000).  These 
symptoms are re-experiencing the event; avoiding stimuli related to the event; 
and hyperarousal, which is defined as increased arousal, such as difficulty falling 
or staying asleep. The respondents were to rate the degree they were affected 
by these symptoms over the past 30 days, and the PCL-DSM-5020 was the 
common metric for evaluating PTSD occurrences amongst the soldiers. 
Another commonality amongst the current literature is the selection of data 
samples used for the analysis of the prevalence of PTSD.  Predominantly, the 
data are comprised of convenience samples of Army soldiers who were deployed 
and/or recently returned from Iraq and/or Afghanistan from 2003 to 2005.   This is 
hardly surprising, given that through the current operational profile and mission, 
the Army soldiers formed a significant portion of the overall deployed troops in 
Iraq and Afghanistan and thus had a greater probability of being exposed to 
PTSD.   
                                            
17C.W., Hoge C.A. Castro, S. C. Messer, D.McGurk, D.I. Cotting, and R.L. Koffman (2004).  
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care.  New 
England Journal of Medicine,  351(1),13-22. 
18J. J., Vasterling, S.P. Procter, P.Amoroso, R.Kane, T. Heeren, R. F. White (2006). 
Neuropsychological Outcomes of Army personnel deployment to the Iraq War. Journal of the 
American Medical Association, 296(5), 519-529. 
19T.A., Grieger, S.J, Cozza, R.J., Ursano, C., Hoge, P.E., Martinez, C.C., Engel, & H.J. 
Wain, (2006). Posttraumatic stress disorder and depression in battle-injured soldiers. American 
Journal of Psychiatry, 163, 1777-1783. 
 20 PCL-DSM-50 refers to PCL-DSM + total score of at least 50 (range: 17–85) on PTSD 
Checklist. 
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In order to understand and interpret post-deployment mental health and 
cognitive conditions, several studies conducted surveys across the time span 
from pre-deployment to in-theater and post-deployment periods for the estimation 
of prevalence of PTSD amongst military personnel.  Hoge et al. (2004) assessed 
2,530 Army soldiers one week before their deployment and reported that nine 
percent screened positive for PTSD using the symptom cluster method and 11 
percent screened positive for depression regardless of functional impairment.21   
Vasterling et al. (2006) found that approximately 75 days prior to deployment; the 
mean score on the PCL was 29, which is significantly lower than the cutoff value 
recommended to classify individuals as having PTSD. This study did not present 
the percentage who met criteria for probable PTSD or depression.22   Other 
studies (Hoge et al., 2006; Hoge et al., 2007) that focused on post-deployment 
PTSD occurrences amongst returning soldiers from Iraq and Afghanistan 
summarized the presence of a high prevalence of PTSD (12 to 13%) during the 
first three to four months after their return home,23 with the post-deployment 
prevalence among Army soldiers being a high of 18%.24   Given the sensitivity of 
the outcome (being diagnosed with PTSD), it is evident that the surveys gathered 
from returning military personnel and/or deployed personnel remained the only 
research approach toward the evaluation of PTSD prevalence in the GWOT. 
In sum, the existing research generally has attempted to compare and 
contrast the mental and cognitive conditions during pre- and post-deployments in 
order to derive the impact of deployment intensity in Iraq and/or Afghanistan on 
                                            
21C.W., Hoge, C.A. Castro, S.C. Messer, D.McGurk, D.I. Cotting, and R.L. Koffman (2004). 
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care. New 
England Journal of Medicine, 351(1),13-22. 
22 J. J., Vasterling, S.P. Procter, P.Amoroso, R.Kane, T. Heeren, R. F. White (2006). 
Neuropsychological outcomes of Army personnel deployment to the Iraq War.  Journal of the 
American Medical Association, 296(5), 519-529.  
23C. W., Hoge, A. Terhakopian, C. A. Castro, S. C. Messer, and C. C. Engel. (2007). 
Association of posttraumatic stress disorder with somatic symptoms, health care visits, and 
absenteeism among Iraq war veterans. American Journal of Psychiatry, 164 (1), 150–153.  
24C.W, Hoge, C.A. Castro, S.C. Messer, D.McGurk, D.I. Cotting, and R.L. Koffman (2004). 
(2004).Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care. New 
England Journal of Medicine, 351(1), 13-22. 
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the incidence of PTSD amongst deployed active personnel. The target samples 
have been the large numbers of Army and Marine Corps military personnel who 
were deployed in Iraq and/or Afghanistan between the years of 2003 and 2005.   
Most of the studies have established the fact that deployment intensity increased 
the probability of PTSD amongst active duty personnel who were deployed in 
Iraq and/or Afghanistan. 
D. SHORTCOMINGS IN PREVAILING STUDIES 
While most of the prevailing studies were able to draw conclusions that 
the prevalence of PTSD increased over time and the increased incidence of 
combat exposure by military personnel raised the probability of having PTSD, 
there are limitations in these studies. One of the main shortcomings of the 
literature is the weak generalizability (i.e., the prevalence estimates were only 
specific to the respective samples examined in the various studies).25   Since the 
samples that were used in the various studies were not entirely the same, it is 
difficult to compare the results broadly as there may be unobserved 
characteristics within each distinct group that may have caused a shift in the 
PTSD prevalence estimates.   As Army soldiers make up the largest portion of 
the troops in Iraq and Afghanistan, they are the most frequently studied with 
respect to PTSD (Hoge et al., 2007; Grieger et al., 2006; Vasterling et al., 2006).   
In order for the studies to encompass and measure the differences in outcomes 
across all relevant groups, including the deployed personnel from the U.S. Navy 
and Air Force, the data samples should be randomized and include deployed 
personnel from these other two services. 
Given that the common methodology of assessment of PTSD has been 
through surveys, there is a tendency for the responses to be “inaccurate” 
                                            
 25 Rajeev Ramchand, Benjamin R. Karney, Karen Chan Osilla, Rachel M. Burns and Leah 
Barnes Caldarone (2008). Prevalence of PTSD, Depression, and TBI among Returning Service 
members. In Terri Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & 
Cognitive Injuries, Their Consequences, & Services to Assist Recovery (pp. 35-84). RAND 
Corporation.    
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predictors for PTSD prevalence in view of respondents’ unwillingness to divulge 
personal information.    Since most of the existing literature has adopted the 
survey research method in consolidating data information, the extent of validity 
and relevance of these responses from the selected interviewees remains 
questionable. On top of this, most studies were conducted under the ambit of the 
DoD, which may have lead to the possibility of respondents under-reporting their 
problems in order to avoid jeopardizing their careers or over-reporting in order to 
maintain their disability or medical benefits.  
Another area of limitations of current studies lies in the screening tools 
used to measure the mental and cognitive conditions of PTSD amongst returning 
soldiers from deployment. Screening tools (PCL-DSM IV) are typically short and 
simple to administer, but they are not tantamount to diagnostic procedures.26 
Moreover, such screening tools are not validated and thus could potentially miss 
a significant number of those personnel with mental and cognitive conditions. 
This could produce results that underestimate the actual prevalence of these 
conditions.27 
E. TRENDS OF PTSD TREATMENT COSTS 
 In view of the rising trends of active duty personnel suffering from PTSD,  
the main outcomes which are of concern include treatment costs, the costs of 
lives lost to suicide, and costs related to lost productivity (including reduced 
employment and lower earnings). Prior studies have projected costs associated 
with the wars in Afghanistan and Iraq, with medical care as one of the 
components, and these costs associated with mental and cognitive conditions 
stemming from the conflicts in Iraq and Afghanistan are substantial. On a per 
case basis, two-year post-deployment costs associated with PTSD are 
                                            
 26 Rajeev Ramchand, Benjamin R. Karney, Karen Chan Osilla, Rachel M. Burns and Leah 
Barnes Caldarone (2008). Prevalence of PTSD, Depression, and TBI among Returning Service 
members. In Terri Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & 
Cognitive Injuries, Their Consequences, & Services to Assist Recovery (pp. 35-84). RAND 
Corporation.  
 27 Ibid., p. 56. 
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approximately $5,904 and $10,298 respectively and two-year post-deployment 
costs associated with comorbid PTSD and major depression are $12,427 to 
$16,884 (at 2007 price levels).28 In the 2007 Congressional Budget Office (CBO) 
testimony before the House of Representatives Committee on Veterans’ Affairs, 
the CBO developed projections of the Department of Veterans Affairs (VA)’s 
costs to treat all veterans of OIF and OEF who are eligible for VA care. The 
projections showed that the costs of medical care for veterans of OIF and OEF 
will grow at the same rate as national health expenditures, and will rise to the 
range of $7 billion to $9 billion by 2017.29 
 Besides the economic perspective to the analysis of costs of PTSD, there 
exists the societal perspective as well as the government perspective.   The 
RAND paper (2008) focused on the societal impact—loss in future productivity 
from PTSD-related disability—and attempted to illustrate and predict the 
increasing costs of PTSD via a micro simulation model that captures uncertainty 
that exists in event probabilities and outcomes.30   This study provided 
comparisons between analyzing the costs from treatment expenditures, lost 
productivity, and costs associated with suicide.  The increasing trends in the 
treatment costs of PTSD are in tandem with the rising trends of PTSD 
occurrences amongst the returning active duty personnel as OIF and OEF 
continue.    
The prevailing research has focused on the different aspects of costs 
related to PTSD and the projections of future costs of PTSD among returning 
active duty personnel from deployments in Iraq and Afghanistan.   As the 
                                            
28 Christine Eibner, Jeanne S. Ringel, Beau Kilmer, Rosalie Liccardo Pacula and Claudia 
DiazTerri (2008). The Cost of Post-Deployment Mental Health and Cognitive Conditions.  In Terri 
Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & Cognitive Injuries, 
Their Consequences, & Services to Assist Recovery (pp. 169-241). RAND Corporation. 
29 Congressional Budget Office (2007). Projecting the Costs to Care for Veterans of U.S. 
Military Operations in Iraq and Afghanistan.  Washington D.C. 
30 Christine Eibner, Jeanne S. Ringel, Beau Kilmer, Rosalie Liccardo Pacula, and Claudia 
DiazTerri.  The Cost of Post-Deployment Mental Health and Cognitive Conditions.  In Terri 
Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & Cognitive Injuries, 
Their Consequences, & Services to Assist Recovery (pp. 169-241). RAND Corporation.. 
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operational tempo in the two regions remains high, the increasing costs for 
treatment and other forms of follow-on medical care for military veterans will be 
of utmost concern to the DoD.   Current literature may not have the details of the 
different treatments of PTSD across the different branches of services in the U.S. 
military.   This area of research may enhance the overall understanding of the 
different clinical approaches toward the treatment of PTSD within the different 
services and may assist the DoD in the budgetary planning of medical provisions 
to victims of PTSD. 
F. SUMMARY 
The prevailing studies in this literature review provide significant advances 
in the understanding of PTSD among military personnel upon the completion of 
their combat tours in Iraq and Afghanistan. The sustained duration of OIF and 
OEF seem to have exacerbated the toll on the deployed soldiers of the U.S. 
military as the statistics for PTSD continue to climb. In view of the shortcomings 
of the existing studies on PTSD, this thesis will be analyzing the prevalence of 
PTSD (taking into account the demographic characteristics) across the different 
branches of services in the U.S. military from FY2001 to FY2006, by using the 
medical information from the TRICARE database.  This study will also be 
evaluating the impact of deployment intensity (deployment tour lengths and 
location) on the probability of PTSD among deployed active duty personnel.  To 
facilitate a more comprehensive understanding of the treatment methods of 
PTSD across the different branches of services, the potential differences in the 
treatment costs and patterns for PTSD amongst the diagnosed personnel will be 
identified in this study based on the clinical data gathered from TRICARE.  The 
specific data samples and the data sources will be discussed in conjunction with 
the basic assumptions in the next chapter, followed by the methodology to be 
used in the analysis.  
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III. DATA SOURCES AND SAMPLES 
A. INTRODUCTION 
This chapter provides an overview of the data and their sources.  We also 
discuss the sampling criteria and present the summary statistics based on 
demographics and frequency distributions of the variables. 
B. DATA SOURCES 
The data for this thesis came from both TRICARE and DMDC (Defense 
Manpower Data Center).  There were a total of 6 data sets pertaining to all active 
duty service personnel in the U.S military to be used for the purpose of this 
thesis, with five data sets from TRICARE and one data set from DMDC between 
FY2001 to FY2006.   
The primary mission of TRICARE, the Department of Defense’s (DoD) 
health care system, is to provide care for eligible active duty personnel, retirees, 
and dependents. These beneficiaries, currently numbering more than 8.7 million, 
can receive their care through military hospitals and clinics called military 
treatment facilities (MTFs) or through TRICARE’s civilian provider network. The 
civilian provider network is developed by managed care support contractors and 
is designed to complement the availability of care offered by MTFs. 
From TRICARE, the data comprised of the main Defense Enrollment 
Eligibility Reporting System (DEERS) data which provided the basic 
demographic information as well as the identification of the PTSD diagnosis of 
the active duty service personnel.   The data files of the Standard Inpatient Data 
Record (SIDR) and the TRICARE Encounter Data – Institutional (TEDI) captured 
all treatment patterns among the PTSD population for those who were admitted 
under the inpatient setting while the Standard Ambulatory Data Record (SADR) 
and TRICARE Encounter Data – Non-Institutional (TEDN) were the data files 
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which captured the treatment patterns among the PTSD population for those who 
were admitted to outpatient setting.   From DMDC’s Contingency Tracking 
System (CTS), the data file contained information capturing the deployment 
characteristics of all active duty service personnel from the U.S. military between 
the FY2001 to FY2006. 
1. DEERS Data Set 
Eligibility for TRICARE is determined by the DEERS, a database of 
uniformed services active duty service members (sponsors), family members, 
and others worldwide who are entitled under the law to TRICARE benefits.  
Active duty and retired service members are automatically registered in DEERS.  
The DEERS data contained service-related eligibility and demographic data used 
to determine eligibility for military benefits, including health care, commissary, 
and exchange privileges for all service members, retirees, and their family 
members.   
The DEERS data set from TRICARE consisted of the general information 
of the enrolment across the different branches of the U.S armed services, i.e. 
one record per active duty or guard/reserve on active duty per month, for each 
month the member was eligible between FY2001 and FY2006.   The EDIPN 
(Electronic Data Interchange Person Numbers -personnel unique identifier) in the 
DEERS data set served as the key link across all the other data files which would 
be used in the study.   The entire data set comprised of 3,369,789 unique EDIPN 
observations of active duty service personnel from all four services (Army, 
Marine Corp, Navy and Air Force) and their respective demographic information 
(gender, race, age, military rank/paygrade, service status etc).  The detailed 
composition for the key variables of the DEERS data set from TRICARE, 








Population Non-PTSD (%) 
Sample     
Number of observations 36,355 1.1 3,333,434 99.0 
     
Sex     
Female 9,477 26.1 533,682 16.0 
Male 26,877 73.9 2,799,751 84.0 
     
Marital Status     
Single 15,614 43.0 1,819,054 54.6 
Married 20,740 57.1 1,514,379 45.4 
     
Service Branch     
Army 22,263 61.2 1,538,046 46.1 
Air Force 4,195 11.5 712,688 21.4 
Marine Corps 4,526 12.5 409,012 12.3 
Navy 5,369 14.8 673,687 20.2 
     
Rank Status     
Officer and Warrant Officer 2,148 5.9 420,346 12.6 
Enlisted Personnel 3,4206 94.1 2,913,087 87.4 
     
Race     
White 24,732 68.0 2,274,402 68.2 
Black 6,165 17.0 591,351 17.7 
Hispanic 2,254 6.2 178,005 5.3 
Asian 930 2.6 120,003 3.6 
Others 2,272 6.3 170,005 5.1 
Table 3.1. Descriptive Statistics of DEERS Data Set Variables 
Within this data set, a total of 36,355 active duty service personnel (based 
on EDIPN) were identified with PTSD diagnosis between FY2001 and FY2006. 
Given the identification of the PTSD observations among the military personnel in 
this data set provided the platform for the cumulative trend analysis of the PTSD 
incidence rate across the different branches of the armed services in the U.S 
military.   The study would be utilising the DEERS data set to analyze and 
identify the trends of PTSD incidence across the different branches of armed 
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services in the next chapter. The DEERS data set with the unique EDIPN 
information of the active duty service personnel would be the fundamental clinical 
data file used to merge all the subsequent inpatient and outpatient records via 
the data sets (SADR, SIDR, TEDI and TEDN) for the purpose of the analysis.    
2. Inpatient Records of PTSD Population  
A TRICARE beneficiary can utilize the health care services in military 
treatment facilities31 (MTFs) of the Army, Navy, and Air Force, or from civilian 
health care professionals.    The medical records from these two healthcare 
settings could be further separated into inpatient and outpatient records of the 
TRICARE beneficiaries.   As defined in the TRICARE Operations Manual32, the 
inpatient care refers to care provided to a patient who has been admitted to a 
hospital or other authorized institution for bed occupancy for purposes of 
receiving necessary medical care, with the reasonable expectation that the 
patient will remain in the institution at least 24 hours, and with the registration 
and assignment of an inpatient number or designation.    Under the DoD’s 
Military Health System (MHS), the SIDR database captures the records of active 
duty service personnel (enrolled under TRICARE) who sought inpatient care from 
MTFs, while the TEDI database captures the detailed information of each 
treatment encounter created by the formal acceptance of a hospital or other 
authorized institutional provider of a TRICARE beneficiary for the purpose of 
inpatient care for at least 24 hours with a registration and assignment of an 
inpatient number or designation.  
                                            
31 MTFs refer to military hospitals or clinics. 
32 TRICARE OPERATIONS MANUAL 6010.51-M, AUGUST 1, 2002, Appendix A, p. 21. 
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a. Standard Inpatient Data Record (SIDR)  
The SIDR data is one of the direct care data (inpatient claims) 
records33 maintained by TRICARE for the tracking of all inpatient admissions per 
MTF disposition.    The SIDR data are extracted from the Composite Health Care 
System (CHCS)34 database.  The SIDR data file from TRICARE for the purpose 
of this study contained a total of 373,250 observations (denoted by EDIPNs of 
active duty service personnel), one record per discharge from a MTF between 
FY2001 and FY2006 for all active duty military personnel enrolled under 
TRICARE.    
The SIDR data (a monthly updated data base) included details of 
the ICD-9 CM (International Classification of Diseases, 9th Edition, Clinical 
Modification) diagnosis codes (denoted by “dx 1-20” in the data set with dx1 
being the principle diagnosis), procedural codes (denoted by “proc 1-20” in the 
data set), source of admission, admission and discharge dates, full cost of 
treatment, on top of the personal information of the marital status, beneficiary 
category and the rank/paygrade of all active duty service personnel.    
The SIDR data set also provided the important information on 
active duty service personnel whom have sought treatment at MTF after being 
diagnosed with PTSD (denoted by ICD-9 CM diagnosis code as “30981”) during 
FY2001 to FY2006.   According to the SIDR data, the total number of PTSD 
treatment encounters at MTFs was 19,879 during these six years.   These 
records included not only the diagnosis of PTSD (diagnosis code “30981”) but 
also related co-morbidity influences of alcohol abuse, substance abuse, hyper-
tension etc.   With the increased tempo of GWOT post 9/11 incident, the SIDR 
data set showed an increasing trend of the number of PTSD related inpatient 
                                            
33 The other direct care records in TRICARE are the Standard Ambulatory Data Record 
(SADR - one record per MTF ambulatory encounter or inpatient professional service) and 
Lab/Rad Ancillary (one record per lab test or per radiology exam). 
34 Composite Health Care System (CHCS) database used by military training facilities. 
CHCS stores patient data including demographics, medical procedures, tests and pharmaceutical 
information. 
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treatments received at MTFs by active duty service personnel.35   The details of 
this are as shown in Table 3.2 below.    
FY Frequency Percent Cumulative 
2001 2,078 10.5 10.5 
2002 2,265 11.4 21.9 
2003 2,776 14.0 35.8 
2004 4,130 20.8 56.6 
2005 4,671 23.5 80.1 
2006 3,959 19.9 100.0 
Total 19,879 100.0 100.0 
Table 3.2. Details of Frequency of PTSD Treatment at the MTFs 
 
For FY2001 to FY2005, there seemed to be an increasing trend (about 56%36) in 
the number of inpatient admissions to MTFs pertaining to PTSD related 
diagnosis. 
b. TRICARE Encounter Data – Institutional (TEDI) 
TRICARE Encounter Data (TED) Records provide detailed 
information for each treatment encounter and are required for TRICARE 
Management Activity (TMA) healthcare and financial reporting.   Institutional TED 
(TEDI) records usually reflect a treatment encounter created by the formal 
acceptance of a hospital or other authorized institutional provider of a TRICARE 
beneficiary for the purpose of occupying a bed with the reasonable expectation 
that the patient will remain on inpatient status at least 24 hours with a registration 
and assignment of an inpatient number or designation.  This include the various 
diagnosis and procedural codes of each treatment encounter, the cost of 
treatment, the amount allowable for claims through TRICARE plans, the start and 
end date of care at the civilian hospitals/medical institutions, source of 
admissions and detailed personal information of the TRICARE enrollees.   To 
                                            
35 The numbers here reflected both new cases of PTSD diagnosis as well as repeated 
observations of the same active duty personnel (identified by EDIPN) whom were given inpatient 
care at MTFs during FY2001 and FY2006. 
36 Taking the difference between the number of inpatient admissions in FY2005 and FY2001 
and divided by 4,671 occurrences in FY2005, the increase from 2001 to 2005 is about 56%. 
 25
qualify for claim, any request for payment for services rendered related to care 
and treatment of a disease or injury which is received from a beneficiary, a 
beneficiary’s representative, or a network or non-network provider by a contractor 
on any TRICARE-approved claim form or approved electronic medium.  
Under the TEDI data set provided by TRICARE, there are a total of 
184,057 EDIPN observations of claim put forth by active duty service personnel 
between FY2001 and FY2006.   There are a total of 10,662 cases of PTSD 
related claims advocated by the active duty service personnel within this span of 
6 years.   The summary of the number of TEDI claims are as shown in Table 3.3. 
FY Frequency Percent Cumulative 
2001 1,043 9.8 9.8 
2002 1,160 10.9 20.7 
2003 1,410 13.2 33.9 
2004 1,867 17.5 51.4 
2005 2,472 23.2 74.6 
2006 2,710 25.4 100.0 
Total 10,662 100.0 100.0 
Table 3.3. Number of Institutional TRICARE Claims (TEDI) for PTSD 
Diagnosed Personnel between FY2001 and FY2006 
There seemed to be an increase in the number of institutional TRICARE claims 
for PTSD related treatments between FY2001 and FY2006 from 1,043 to 2,710 
(about 62%).      
3. OUTPATIENT MEDICAL RECORDS OF PTSD POPULATION 
Under TRICARE, all eligible active duty service personnel are also entitled 
to receive professional/specialized medical services or outpatient care from 
MTFs or civilian hospitals and institutions.     Outpatient observation stays are 
those services furnished by a hospital on a hospital’s premises, including the use 
of a bed and periodic monitoring by a hospital’s nursing or other staff, which are 
reasonable and necessary to evaluate an outpatient’s condition or determine the 
need for a possible admission to the hospital as an inpatient.  Such services are 
provided when ordered by a physician or another individual authorized by State 
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licensure law and hospital staff bylaws to admit patients to the hospital or to order 
outpatient tests.   The Ambulatory Data System (ADS) contains records of 
ambulatory care encounters (SADR) at the MTFs, which are recorded and 
scanned into the system by each clinic within an MTF.  This system operates 
completely separately from the CHCS system (which captures the inpatient 
admission records at MTFs).   
a. Standard Ambulatory Data Record (SADR) 
In 1997, the U.S. Department of Defense (DoD) instituted the 
SADR to record demographic and diagnostic data on all military outpatient visits, 
including (ICD-9) codes for each visit.37    The SADR is yet another direct care 
data files which records per ambulatory encounter, telephone consultation or 
inpatient rounds visit provided by a MTF for enrolees of TRICARE.   This data set 
basically captures the professional services via outpatient treatments rendered 
by MTFs.   Each record represents the most recent version of hospital record for 
a patient discharged from an MTF and includes the various diagnosis and 
procedural codes of each ambulatory encounter, the cost of treatment and 
detailed personal information.  
In the given SADR data set, there are a total of 83,647,524 counts 
of EDIPNs of active duty service personnel being given outpatient medical 
services at MTFs.   Out of these, there are a total of 2,699,602 observations/ 
records of active duty service personnel being rendered PTSD related outpatient 
and professional services by MTFs.   Based on the SADR records, the 
breakdown of the number of professional services /outpatient treatments related 




Frequency Percent Cumulative 
                                            
37 Paul D. Rockswold, MD, MPH, MHS Medical Informatics Overview 2008 (16 Mar 08). 
http://www-nehc.med.navy.mil/presentations08/disease%20mangement/Medical%20informatics/080316-
NMCPHC-%20Rockswold%20-MHS%20Medical%20Informatics%202008.ppt. (assessed on 18 Oct 08) 
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2001 290,739 10.8 10.8 
2002 323,957 12.0 22.8 
2003 366,397 13.6 36.3 
2004 504,171 18.7 55.0 
2005 607,335 22.5 77.5 
2006 607,003 22.5 100.0 
Total 2,699,602 100.0 100.0 
Table 3.4. Number of Professional Services/Outpatient Treatment 
for PTSD Diagnosed Personnel between FY2001 and FY2006 
 
From the table, there was a significant increase in the number of PTSD related 
professional services/outpatient care at MTFs rendered to the active duty service 
personnel over the six years from 290,739 in FY2001 to 607,003 in FY2006 
(about 52% increase). 
b. TRICARE Encounter Data – Non-Institutional (TEDN) 
MTF patients may require medical care that is not available at the 
MTF (e.g., MRI).    When the MTF refers a patient for civilian medical care 
(usually a specific test, procedure or consultation), including services rendered 
by an internal resource sharing provider, claims for this type of care will usually 
be submitted by the provider; however, the patient or the Services (e.g., the 
MTF) may submit the claim depending on the particular situation. 
A non-institutional TED record (TEDN) reflects either inpatient or 
outpatient health care services exclusive of inpatient institutional facility services.  
All other treatment encounter data including institutional care in connection with 
ambulatory surgery must be reported on a non-institutional TED Record.   The 
data set included not only similar medical and personal information as of TEDI 
(institutional claims) records, but also comprised of total pharmacy costs and the 
allowable pharmacy bill claimable from TRICARE.    The data set has a total of 
29,472,160 records and out of which 1,130,720 counts of EDIPN observations 
were denoted as PTSD related claims between the FY2001 and FY2006. 
The detailed breakdown of the non-institutional claims is as follows: 
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FY Frequency Percent Cumulative 
2001 71,590 6.4 6.4 
2002 97,874 8.8 15.2 
2003 126,821 11.3 26.5 
2004 184,702 16.5 43.0 
2005 292,806 26.2 69.2 
2006 344,927 30.8 100.0 
Total 1,118,720 100.0 100.0 
Table 3.5. Number of Non-Institutional TRICARE Claims (TEDN) for 
PTSD Diagnosed Personnel between FY2001 and FY2006 
 
There was a significant increase of 79% (273,337 counts) of non-institutional 
claims between FY2001 and FY2006 by active duty service personnel who have 
been diagnosed with PTSD. 
4. DEPLOYMENT DATA FROM CONTINGENCY TRACKING 
SYSTEM (CTS) FROM DMDC 
As one focus of this study is on the impact of deployment characteristics 
(i.e. location, deployment duration and frequency of deployment) on the 
incidence of PTSD among the active duty service personnel between FY2001 
and 2006, the deployment data from the CTS system of DMDC is essential for 
this analysis.  This deployment data of 390,921 active duty service personnel 
(which were the non-PTSD population denoted by unique EDIPNs) from Defense 
Manpower Data Centre’s (DMDC) Contingency Tracking System (CTS), only 
depicted 10% of all active duty personnel (a randomly selected sample) who 
have been deployed for GWOT, in view of the confidentiality of deployment 
characteristics and personnel profiles vis-à-vis the GWOT environment and 
mission requirements.   Of the overall deployed population, there are a total of 
24,826 EDIPN observations of personnel whom have been diagnosed with PTSD 
between FY2001 and FY2006.  A summary of the total number of observations in 
the CTS deployment data is shown in Table 3.6 below: 
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Table 3.6. Summary of Observations in the CTS Deployment Data 
for FY2001 to FY2006 
 
The dataset included the deployment details (i.e. deployment location, 
deployment duration, number of deployments etc) of all the active duty service 
personnel from the different branches between the FY2001 to FY2006.  
The dataset consist of a total of 24 deployment profiles of each active duty 
service personnel during the period of FY2001 to FY2006.    Out of the four 
services, there were a total of 38,985 EDIPN observations of active duty service 
personnel whom were diagnosed with PTSD in the same period.   This data 
represented the 100% PTSD population from all the active duty service 
personnel whom were deployed overseas between FY2001 and FY2006.   As 
EDIPN is the common personal unique identifier across the DEERS and CTS 
data sets, these two data sets would be merged for the analysis on the impact of 
deployment characteristics on the prevalence of PTSD among active duty service 
personnel in GWOT from FY2001 to FY2006.  The detailed analysis would be 
covered under Chapter VI of the study. 
C. DATA SAMPLES 
For the analysis of research question 1, the DEERS data set from 
TRICARE has been reorganized into the four separate branches of the armed 
services, namely, Army, Marine Corp, Navy and Air Force between FY2001 and 
FY2006.    As EDIPN is the key unique personnel identifier across all the data 
Data Groups Number of Non-PTSD 
Observations 
Number of PTSD Observations
Army 284,437 22,050 
Navy 34,978 5,472 
Marine Corps 37,558 4,575 
Air Force 23,622 4,118 
Total 380,595 35,715 
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sets used in this study, all missing values of EDIPN in the DEERS data set were 
dropped from the analytical sample. These data would be sub-divided into the 
two distinct populations of non-PTSD and PTSD38 observations with the relevant 
demographic variables (i.e. gender, race, ethnicity, marital status, and military 
rank/paygrade) and fiscal year dummies from FY2001 to FY2006.   All missing or 
unknown values for the demographic variables were dropped as well since no 
further information could be derived.   To analyze the potential differences 
between the officer and enlisted populations in the PTSD incidences, the four 
services’ DEERS data files were further sub-divided into these two categories 
respectively39. 
The CTS deployment data set from DMDC is organized into five separate 
files, comprising of the deployment information (demographics, military 
rank/paygrade, deployment locations, duration of deployment, military 
operational specialty (MOS) etc) of the active duty service personnel from the 
different branches of services and the consolidated data information pertaining to 
all active duty service personnel whom were diagnosed with PTSD during the 
period of FY2001 to FY2006.    In view of the sensitivity of the detailed 
deployment information on the military personnel, DMDC only provided 20% of 
the entire non-PTSD population (via random sampling) whom were deployed 
during FY2001 to FY2006.   In other words, the entire CTS deployment data 
which would be used for the analysis of the deployment effects on PTSD 
occurrences is actually a weighted sample of the overall non-PTSD deployed 
population across the four military services.    
                                            
38 The PTSD observations in all the data sets were denoted as “T” under the variable 
“ptsdflag”.  
39 The Warrant Officers within the Army, Marine and Navy were grouped under the “Officers” 
category. 
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For the inpatient and outpatient data files of SIDR, TEDI, SADR and 
TEDN, this information would be merged with the CTS data via EDIPN so as to 
derive the patterns of PTSD treatment across the different branches of service.   
The study would concentrate on the PTSD related cases denoted in these data 
sets to assess the comorbidity risks and treatment costs of PTSD and determine 
if there were different patterns to comorbidity distribution and treatment across 
the different branches between FY2001 and FY2006.    All missing values of the 
EDIPN would be dropped since the information would be meaningless without an 
unique personnel identifier. 
D. DATA RESTRICTIONS  
The DEERS data set would be used to identify the PTSD prevalence 
across the different branches of armed services in the U.S military between 
FY2001 and FY2006.   There are basically two restrictions derived from the data 
sets obtained from TRICARE and DMDC.  Given the large DEERS data sets of 
the different branches of services in the U.S military, the study could have been 
more precise from the clinical perspective, if not for the fact that there were many 
observations without the information on EDIPN.   Without these unique identifiers 
for personnel, it was impossible to pursue the analysis further as the different 
data sets could not be merged to derive results.  Thus, all observations in the 
DEERS data with missing EDIPN have to be omitted from the study, resulting in 
much bigger standard errors in the distribution, though still significant data 
sample for the purpose of this study.  In addition, a large number of the DEERS 
observations with missing demographics information (gender, marital status, race 
or ethnicity) and military rank/paygrade were dropped as well.  
The second restriction is one that is imposed by DMDC on the complete 
release of the overall deployment details from FY2001 to FY2006 across the 
different branches of services in the U.S military.   In view of the confidentiality of 
deployment profiles of the military personnel, different operational environment 
and mission requirements in GWOT, DMDC only released the data of 20% 
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random sample of the non-PTSD population on top of the PTSD population 
between the years of FY2001 and FY2006.   As such, the study would be based 
solely on the weighted sample of the non-PTSD and the PTSD population for the 
analysis of the deployment effects on PTSD occurrences amongst the active duty 
personnel from the different branches of services in the U.S. military. 
E. SUMMARY 
This chapter provides an overview of the 6 data sets, namely the DEERS 
data set, the data sets of SIDR, SADR, TEDI and TEDN and the CTS 
Deployment Data as gathered from TRICARE and DMDC.   These data sets 
provide both the clinical information as well as the deployment characteristic of 
the PTSD diagnosed cases amongst the active duty service personnel between 
the FY2001 and FY2006 for the analysis of PTSD prevalence, the deployment 
effects on PTSD incidences and the comorbidity risks among the active duty 
service personnel across the four main armed services of the U.S military. 
However, there is a need to note the two data restrictions and its possible 
impact on this study.    The omission of large numbers of missing EDIPN (from 
the DEERS data set) from the sample used for the study may affect the precision 
of the analysis given the large standard errors present in the frequency 
distribution of the data.  In addition, the restriction on the availability of the 
deployment data by DMDC that could be used to formulate the overall model for 
the analysis of deployment effects on PTSD incidences among the active duty 
service personnel may render a less precise outcome of the multivariate analysis 
on the impact of deployment characteristics on PTSD occurrences among the 
deployed troops. 
The next chapter would be the discussion on the methodology with a 
detailed breakdown of the regression models which would be used for this study, 
followed by the subsequent chapters that would focus on the respective research 
questions with in-depth analysis.  
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IV. ANALYTICAL METHODOLOGY 
A. INTRODUCTION 
This chapter will describe the hypotheses and the analytical methodology 
used to examine the three research questions outlined in the introduction. The 
three research questions are:  
• What is the probability of being diagnosed with PTSD across different 
branches of the U.S. military and how is this affected by different 
demographic characteristics? 
• How do risk factors including deployment intensity (such as deployment 
location, tour length and frequency of deployment) affect the probability of 
being diagnosed with PTSD, and do these effects differ across the 
branches? 
• What are the comorbidity risks and treatment costs of PTSD, and are 
there different patterns to comorbidity distribution and treatment across 
the different branches? 
The rest of this chapter will be organized as follows: Section B will lay out 
the research hypotheses for the research questions.  Sections C, D and E will 
describe the empirical methods used to analyze each research question.  Section 
F will provide a summary. 
B. RESEARCH HYPOTHESES 
One of the main objectives of the thesis is to examine the effect of 
deployment intensity (such as deployment location, duration and location type of 
deployment) on the probability of being diagnosed with PTSD across the different 
branches of the U.S. military. Most of the prevailing studies have focused on 
Army active duty personnel deployed to Iraq and/or Afghanistan, and established 
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that the increasing deployment intensity in the GWOT have raised the probability 
of PTSD amongst these personnel. We hypothesize that as the number and 
duration of deployments to Iraq and/or Afghanistan increases, the probability of 
being diagnosed with PTSD will also increase for personnel from other branches 
of the armed services.  
We also hypothesize that the effect of deployment intensity (deployment 
location, duration and frequency) on the probability of being diagnosed with 
PTSD will be greater for deployed personnel from the Army and Marine Corps, 
compared to their counterparts in the Air Force and Navy. Due to their 
operational profiles and the nature of their deployments, personnel from the Army 
and Marine Corps are mostly deployed in ground combat operations and more 
likely to be exposed to the “war-zone trauma” that induces PTSD. Sailors who 
are deployed on ships, and airmen, on the other hand, are less likely to be 
exposed to the violent conditions in a “war-zone.” These airmen and sailors 
typically do not engage in close-range combat as their targets are often beyond 
visible range in modern aerial and naval warfare. Hence, we postulate that for the 
same deployment location, a soldier from the Army or the Marine Corps will be 
more likely to be diagnosed with PTSD compared to a sailor deployed onboard a 
ship or an airman.  
In addition, we postulate that different deployment locations have different 
effects on the probability of being diagnosed with PTSD. The ongoing military 
operations in Iraq and Afghanistan represent the most sustained ground combat 
operations involving American forces since the Vietnam era. Personnel deployed 
in Iraq and Afghanistan is frequently exposed to high intensity guerilla warfare 
and the chronic threat of improvised explosive devices (IED). We hypothesize 
that personnel who have been deployed to Iraq and/or Afghanistan will have a 
higher probability of having PTSD, compared to personnel deployed elsewhere.  
Finally, we hypothesize that the effect of deployment duration on the 
probability of being diagnosed with PTSD is dependent on the deployment 
location. Due to the intense threat environment in Iraq and Afghanistan, the effect 
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of deployment duration on the probability of being diagnosed with PTSD is 
expected be exacerbated if the deployment location is Iraq or Afghanistan, 
compared to other countries. 
We employ a combination of descriptive and multivariate analyses to 
examine the effect of different measures of deployment intensity on the 
probability of being diagnosed with PTSD. Separate analyses are conducted for 
officers and enlisted personnel. In addition, separate multivariate analyses are 
performed for the four branches of the U.S. military. The results of these 
analyses are compared and discussed in the following chapters.   
C. PREVALENCE OF PTSD IN THE ACTIVE DUTY U.S. ARMED 
SERVICES 
The first research objective of our thesis is to examine the probability of 
being diagnosed with PTSD across the four services of active duty U.S. military 
and the various service and demographic characteristics (rank, gender, marital 
statue, race and age). Descriptive data analyze are used to analyze the data 
from the Defense Enrollment Eligibility Reporting System (DEERS) provided by 
TRICARE, to establish the probability of being diagnosed with PTSD across the 
different service branches and demographic characteristics. The descriptive data 
provides a summary of the DEERS data and the distribution of the service and 
demographic characteristics for the PTSD and non-PTSD populations. In 
addition, it also indicates whether any particular sub-population has a higher 
probability of being diagnosed with PTSD.  
An initial analysis of the DEERS data shows that a higher percentage of 
personnel from the Army and Marine Corps are diagnosed with PTSD, compared 
to personnel from the Air Force and Navy. The initial analysis also indicates that 
enlisted personnel have a higher rate of PTSD than officers in all service 
branches. These initial findings were expected and agree with results from 
prevailing studies.    
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We conduct trend analyses using data from the DEERS and the Defense 
Manpower Data Centre’s (DMDC) Contingency Tracking System (CTS). Trend 
analyses on the number of new PTSD cases diagnosed and the cumulative 
PTSD incidence rate between FY2001 to FY2006 across the services are 
conducted. In this thesis, the cumulative PTSD incidence rate is the percentage 
of the study population who has been diagnosed with PTSD since FY2001, up to 
the respective study year. For example, the cumulative PTSD incidence rate for 
FY2005 will include all PTSD cases diagnosed between FY2001 up to FY2005. 
Trend analyses are conducted for the following three different populations.  
1. All Active Duty TRICARE Beneficiaries 
The DEERS data provide the date of the PTSD diagnoses for the PTSD 
population. The first trend analysis utilizes the DEERS data and analyzes new 
occurrences of PTSD cases and the cumulative PTSD incidence rate for all 
enrolled active duty TRICARE beneficiaries across the services. Separate 
analyses are conducted for the officer and enlisted populations. The result of 
these analyses allow readers to compare the trend in the number of new PTSD 
cases diagnosed each year, and the cumulative percentage of all active duty 
TRICARE beneficiaries who are diagnosed with PTSD across the different 
services from FY2001 to FY2006.  
2. Active Duty TRICARE Beneficiaries Who Were Ever Deployed 
Overseas 
The second trend analysis utilizes both the DEERS and CTS data. The 
CTS data contains the deployment history (deployment date, location and 
duration) of all the active duty personnel between FY2001 and FY2006. Due to 
the sensitivity of the detailed deployment information on the military personnel, 
the CTS data is only available for the active duty PTSD population, and a 20% 
random sample of the active duty non-PTSD TRICARE beneficiaries.40 
                                            
40 This is the same sample that will be used for the multivariate analysis, i.e. the regression 
sample will consist of all the active duty TRICARE beneficiaries who are diagnosed with PTSD 
between FY2001 to FY2006, and a randomly selected 20% sample of non-PTSD beneficiaries.  
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Probability weights are used in this trend analysis to account for the data 
restriction and sampling design. The DEERS and CTS data are merged using a 
unique identifier that is common to both datasets. The merged data contains both 
the demographics characteristics and deployment histories of the PTSD and non-
PTSD populations.   
This second analysis considers only the active duty TRICARE 
beneficiaries who were ever deployed overseas outside the United States, 
between FY2001 and their date of being diagnosed with PTSD. Beneficiaries 
who have been diagnosed with PTSD, but have not been deployed overseas 
between FY2001 and their date of PTSD diagnoses are excluded in this trend 
analysis. The results of the second analysis, when compared to those of the first 
analysis, indicate the effect of overseas deployment on the probability of being 
diagnosed with PTSD across the service branches. 
3. Active Duty TRICARE Beneficiaries Who Were Ever Deployed 
to Iraq and/or Afghanistan  
 
The third trend analysis also utilizes both the DEERS and CTS data. Most 
of the deployments in the current GWOT, e.g. Operation Enduring Freedom 
(OEF) and Operation Iraqi Freedom (OIF) occur in Afghanistan and/or Iraq. 
Therefore the third analysis focuses on the active duty TRICARE beneficiaries 
who were ever deployed to Iraq and/or Afghanistan between FY2001 and their 
dates of being diagnosed with PTSD. The results of the third analysis show the 
effect of deployment to Iraq and/or Afghanistan on the probability of being 
diagnosed with PTSD. This analysis also uses probability weights to account for 
the data restriction in the CTS data and the sampling design.  
D. EFFECT OF DEPLOYMENT INTENSITY ON THE PROBABILITY OF 
BEING DIAGNOSED WITH PTSD 
A combination of descriptive and multivariate analyses is used to examine 
the effect of deployment intensity on the probability of being diagnosed with 
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PTSD. Due to data restriction, the sample for the multivariate analyses only 
consists of the PTSD beneficiaries and a 20% random sample of the non-PTSD 
beneficiaries. Descriptive analyses are first used to provide a summary of the 
sample for the multivariate analyses, and their service and demographic 
characteristics’ distribution. The descriptive summary allows us to verify that the 
regression sample is representative of the DEERS population and validates the 
sampling design.  
The DEERS dataset contains a monthly database of active duty service 
members who are entitled to TRICARE benefits. Hence a single unique service 
member (represented by his or her EDIPN) may have had up to 72 monthly 
observations in the DEERS dataset in the 6-year study period (FY2001 to 
FY2006) of this thesis. For the multivariate analyses, a single observation is 
required for each unique service member or EDIPN. For the PTSD population, 
i.e., those who were diagnosed with PTSD between FY2001 to FY2006, the 
monthly observation that corresponded to their PTSD diagnosis date is selected 
for the multivariate analysis. For the non-PTSD population, an observation is 
randomly selected from their monthly records. 
Four multivariate analysis models are used to test the hypotheses and 
examine the effect of deployment intensity on the probability of being diagnosed 
with PTSD. For each model, separate analyses are conducted for the four 
service branches. In addition, separate analyses are carried out for the officer 
and enlisted populations.   
1. Theoretical Model 
The dependent variable in the four multivariate models is a binary 
indicator which captures whether a personnel is diagnosed with PTSD. The 
dependent variable takes on the value of one if the person is diagnosed with 
PTSD, and zero otherwise. Due to the dependent variable being dichotomous, 
the probit model is used to estimate the effect of deployment intensity on the 
probability of being diagnosed with PTSD. The probit model is preferred over the 
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Linear Probability Model (LPM) for this thesis. In a LPM, the predicted value of 
the dependent variable is not constrained within the interval of zero and one, and 
the marginal effect of any independent variable is constant throughout its entire 
range of value. The probit model, on the other hand, is non-linear and restricts 
the predicted value of the dependent variable to between zero and one.  
2. Independent Variables 
The base model for the multivariate analysis is described below: 
P( y = 1 | x) = β0 + β1X1 + β2X2,  
where X1 = deployment characteristics 
where X2 = service and demographic characteristics  
The vector X1 contains the key variables of interest for the respective 
probit model. These key variables are based on the deployment characteristics in 
the CTS data, namely deployment location and duration and location type of the 
deployment (ground or shipboard) and are different for each of the four models. 
The specific variables of interest for the respective probit model are described in 
a later section of this chapter. 
The vector X2 contains the service and demographic characteristics. 
These service and demographic characteristics are the control variables and 
remain the same across the four probit models for each service branch and study 
population. The service and demographic characteristics are described below. 
a. Service Characteristics 
(1) Military Occupation Codes.  The Military Occupation 
Code is provided in the CTS data. The four service branches use different sets of 
military occupation codes. The Army and Marine Corps use a Military 
Occupational Specialty (MOS) code, while a system of Air Force Specialty Codes 
(AFSC) is used in the Air Force. The Navy uses a system of naval ratings and 
designators along with the Naval Enlisted Classification (NEC) system. All 
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observations are categorized into the various military occupation categories 
using binary variables. The categories are combat arms, combat support, combat 
service support, aviation, medical and others. The combat arms and medical 
categories are expected to have the largest effect on the probability on being 
diagnosed with PTSD. The combat arms are the reference group for the 
multivariate analyses. For some service branches, some of the categories are 
merged due to small numbers of observations in the individual categories.   
(2) Pay Grade.  The pay grade information is provided in 
the DEERS data. The observations are categorized into several pay grade 
categories using binary variables. The categories are: O1 to O2, O3, O4, O5, O6, 
O7 to O10 and W1 to W5 for officers, and E1 to E3, E4, E5, E6, and E7 to E9 for 
enlisted personnel. The reference group is the most junior pay grade category for 
the respective population. For example, the reference group for the officer 
population in the Army, Marine Corps and Navy is W1 to W5, while O1 to O2 is 
the reference group for the Air Force as there are no warrant officers in the Air 
Force.  
b. Demographics Characteristics 
(1) Gender (Male, Female). The gender information is 
provided by the DEERS data and encoded by the binary variable FEMALE. It 
takes on a value of one if the gender is Female, and zero otherwise.  Males are 
the reference group, as the populations are pre-dominantly male.  
(2) Race (White, Black, Hispanic, Asian, Others). The 
race and ethnic information found in the DEERS data is transformed into binary 
variables for the races. Whites are the reference group for the multivariate 
analyses. 
(3) Marital Status (Single, Married). The marital status 
information is included in the DEERS data and is encoded by the binary variable 
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SINGLE. It takes on a value of one if the marital status is single, and zero, 
otherwise. Married personnel are the reference group.   
(4) Age. The CTS data contains the personnel’s date of 
birth. The age variable is a continuous variable and reflects the age of the 
personnel at the time of observation.  Observations with missing age information 
take on the average value of the non-missing age.  
The models also contain binary variables for the fiscal years (FY01, FY02, 
FY03, FY04, FY05 and FY06, in order to capture changes across the years. The 
fiscal-year variables indicate the fiscal year of the PSTD diagnosis date for the 
PTSD population and the date of the DEERS observation for the non-PTSD 
population respectively. The reference year is FY2001.    
3. Model Specification 
 Four probit models are set up to test the hypotheses and estimate the 
effect of deployment characteristics on the probability of being diagnosed with 
PTSD. The service and demographics variables are held constant in all four 
models. The models and their respective key variables of interest are described 
below. 
a. Effect of Last Deployment Location 
The first model estimates the effect of the last deployment location 
on the probability of being diagnosed with PTSD. For the PTSD population in the 
regression sample, the last deployment refers to the most recent deployment 
prior to the date of being diagnosed with PTSD. For the non-PTSD population, 
the last deployment refers to the most recent deployment prior to the DEERS 
observation’s date.  The key variables of interest are the last deployment location 
and the location type. 
(1) Deployment Location (Iraq, Afghanistan, Other 
Middle East countries, Other countries). The deployment locations are found 
in the CTS data. The location variables are binary variables for being deployed to 
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Afghanistan, Iraq, Middle East countries other than Iraq and Afghanistan, and 
other countries. The reference group constitutes of those with no deployment 
prior to their PTSD diagnosis date for the PTSD population, or the date of 
observation for the non-PTSD population. Due to the chronic threats experienced 
by personnel deployed in Afghanistan and Iraq, these two deployment locations 
are expected to have the largest effect on the probability of being diagnosed with 
PTSD.  
(2) Deployment Location Type (Shore, Afloat). This 
variable is applicable only for observations from the Navy. The CTS data 
contains information that indicates the location type of the deployment for the 
sailor. A sailor can be deployed ashore or afloat. Besides the location effect, the 
model also estimates the effect of the location type of the deployment on the 
probability of being diagnosed with PTSD. Hence in the analyses for the Navy, 
the binary location variables incorporate the location type of the deployment. 
These location variables are: shore deployment in Afghanistan, shore 
deployment in Iraq, ship deployment in Afghanistan or Iraq, shore deployment in 
Middle East countries other than Afghanistan or Iraq, ship deployment in Middle 
East countries other than Afghanistan or Iraq, shore deployment in other 
countries, and ship deployment in other countries. The reference group is 
comprised of those without any deployment prior to their PTSD diagnosis date or 
date of observation. Sailors on shore deployment are expected to be more likely 
to be diagnosed with PTSD, compared to sailors deployed on ships, as the 
former are likely to face higher threats.    
b. Interactive Effect of Last Deployment Location and 
Duration 
The second model is an expansion of the first model. The second 
model takes into account the interaction of the location and duration variables of 
the last deployment, to examine whether the effect of deployment duration on 
being diagnosed with PTSD is dependent on the deployment location. The last 
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deployment refers to the most recent deployment prior to the PTSD diagnosis 
date or date of observation. The key variables of interest for the second models 
are the last deployment location, its duration and the interaction terms between 
the last deployment location and duration.  
(1) Deployment Location. The binary location variables 
for the second model are identical to the location variables in the first model.  
(2) Deployment Duration (Short, Medium, Long). The 
CTS data contains the duration of the deployment. All deployments are 
categorized, based on their duration, as short, medium or long deployments. 
These duration categories are represented by binary variables. As the 
deployment duration differed between the services, the interval definition for 
short, medium and long deployment was determined by the distribution of the 
deployment duration for each service in the empirical data. The cutoffs for the 
intervals for each service are chosen such that each interval contains 
approximately the same percentage of observations for each service. For 
example, a 130-day deployment is categorized as a short deployment for the 
Army and Marine Corps, while a 130-day deployment in the Air Force and Navy 
is considered a medium deployment. The reference group is those who had not 
been deployed overseas prior to their PTSD diagnosis date or date of DEERS 
observation. We expect a long deployment to have a larger effect on the 
probability of being diagnosed with PTSD, compared to a short deployment. The 
interval definition for the four service branches is shown in Table 4.1.  
 
 Army Air Force Marine Corps Navy 
Short 1 to 180 days 1 to 90 days 1 to 180 days 1 to 120 days 
Medium 181 to 270 days 91 to 150 days 181 to 270 days 121 to 180 days 
Long 271 days or more 151 days or more 271 days or more 181 days or more 
Table 4.1. Deployment Duration Interval Definition for the Services 
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(3) Interaction between Deployment Location and 
Duration. This set of variables is the set of interaction terms between the last 
deployment location and its duration.  This set of variables captures whether the 
effect of deployment duration is exacerbated or mitigated by the deployment 
location. Based on an initial analysis of the sample size for the various 
deployment locations and duration categories, the model requires only two 
interaction terms, namely “medium deployment duration in Afghanistan or Iraq” 
and “long deployment duration in Afghanistan or Iraq.” Due to the chronic threats 
faced by the personnel in Afghanistan and Iraq, the duration effect is expected to 
be exacerbated for personnel deployed in these two countries, compared to 
personnel deployed elsewhere.    
c. Effect of Deployment Location History 
While the first two models focus on the effect of the last deployment 
on being diagnosed with PTSD, the third model extends the study to include all 
the past deployments in the individual’s deployment history in the study period. 
Specifically the third model considers if a personnel has ever been deployed to 
the various locations between FY2001 and FY2006, prior to their PTSD 
diagnosis date or date of observation, and estimates the effect of ever being 
deployed to these locations on the probability of being diagnosed with PTSD. 
The key variables of interest are the locations of the past deployments.  
(1)  Past Deployment Location. The binary location 
variables in the third model are different from the location variables in the first two 
models. The binary variables in the third model capture whether the person has 
ever been deployed to the various locations between FY2001 to FY2006, prior to 
their PTSD diagnosis date or date of observation. Deployments that occurred 
after the PTSD diagnosis date or date of observation are considered, as these 
post-diagnosis deployments (if any) do not affect the value of the location 
variables. For example, the location variable for Afghanistan takes on the value 
of one if a person had ever been deployed to Afghanistan between FY2001 to 
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FY2006, and prior to his PTSD diagnosis date or date of observation. The 
location variable takes on the value of zero if the personnel had never been 
deployed to Afghanistan between FY2001 to FY2006, or if the deployment to 
Afghanistan occurred after his PTSD diagnosis date or date of observation. The 
reference group is made up of the personnel with no past deployments prior to 
their PTSD diagnosis date or date of observation, within FY2001 to FY2006. 
In the multivariate analyses for the Navy, these past 
deployment location variables also reflect the location type (shore or afloat) of the 
past deployments, e.g. for a sailor who has been deployed to Afghanistan, the 
model differentiates and estimates the effect of having ever been deployed 
ashore in Afghanistan, or deployed onboard a ship in Afghanistan separately.     
d. Effect of Single and Multiple Deployments to the Same 
Location 
Repeated deployments to certain locations could have a cumulative and 
exacerbated effect on the probability of being diagnosed with PTSD. The fourth 
model expands on the third model by considering all past deployments in a 
person’s deployment history between FY2001 to FY2006, which occurred prior to 
his PTSD diagnosis date or date of observation, and estimates the effect of 
single and multiple deployments to the same location on the probability of being 
diagnosed with PTSD. The key variables of interest are thus two sets of binary 
location variables.  
(1) Single Deployment to a Location. The first set of 
location variables takes on the value of one if the person has been deployed only 
once to the respective locations within FY2001 to F2006, and prior to his PTSD 
diagnosis date or date of observation. Deployments that occurred after the PTSD 
diagnosis date or date of observations (if any) are not considered. The reference 
group is those personnel who have not been deployed prior to the PTSD 
diagnosis date or date of observation, within FY2001 to FY2006.  
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(2)  More than One Deployment to the Same Location.  
This set of location variables takes on the value of one only if the person has 
been deployed more than once to the respective locations within FY2001 to 
FY2006, and prior to his PTSD diagnosis date or date of observation.  
Deployments that occurred after the PTSD diagnosis date or date of 
observations (if any) are not considered. This set of variables captures whether 
the effect of the deployment location is exacerbated or mitigated by the number 
of deployments to the same location. The reference group is those personnel 
who had not been deployed prior to the PTSD diagnosis date or date of 
observation, within FY2001 to FY2006.   
Besides the two sets of location variables above, the model for the 
Navy includes two other variables to estimate the effect of a single and multiple 
shore deployment on the sailors’ probability of being diagnosed with PTSD. 
These two binary variables take on the value of one if the sailor has been 
deployed only once on a shore deployment, or has been deployed in more than 
one shore deployment respectively.  
E. COMORBIDITY RISKS AND TREATMENT COSTS AMONG THE PTSD 
POPULATION 
The third research objective is to analyze the pattern of comorbidity risks 
and treatment costs for PTSD across the four service branches. Hence the study 
population for the third research objective is limited to only the PTSD population, 
i.e., those who had been diagnosed with PTSD between FY2001 to FY2006.  
The DEERS data set containing the demographics characteristics of the PTSD 
population is merged with the TRICARE inpatient and outpatient claim records 
(SADR, SIDR, TEDI and TEDN) for this analysis. We use descriptive analyses to 
analyze the pattern of comorbidity risks and treatment costs at two different 
levels of resolution, namely at the claim and person level. We establish the 
pattern of comorbidity and treatment cost associated with each claim, as well as 
for each TRICARE beneficiary diagnosed with PTSD. Separate analyses are 
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conducted for officers and enlisted personnel.  In addition, we analyze whether 
there is a differential comorbidity distribution or treatment cost between males 
and females, and between white and non-white population. The results of these 
analyses are discussed in Chapter VII.      
1. Comorbidity Risks 
The inpatient and outpatient claim records (SADR, SIDR, TEDI and 
TEDN) contains the ICD-9 CM (International Classification of Diseases, 9th 
Edition, Clinical Modification) diagnosis codes for each observation. We focus on 
the patterns of comorbidity risks for claims whose primary and secondary 
diagnosis is PTSD (ICD-9 CM code 30981). The common comorbidities 
associated with PTSD have been identified and categorized into several groups. 
Descriptive statistics are used to analyze the distribution of these comorbidities 
across the four services and the demographics characteristics such as gender 




Category of Comorbidities ICD-9 CM Codes / Remarks 
1. Major depression 292.2, 296.3 
2. Substance abuse 291 – 292,  303 – 305 
3. Other psychoses 295 – 299, excluding 296.2 and 296.3 
4. Any other mental health problems 290 – 312, excluding 291 - 292, 295 – 
299, 303 – 305 
5. Unspecified mental and behavioral 
problems  
V40 
6. Acute illness Numerical ICD-9 CM codes less than 
290 and more than 319, excluding E 
and V codes.  
Table 4.2. Categories of Comorbidities for PTSD 
                                            
41  Robert Rosenheck and Alan Fontana. Use of Mental Health Services by Veterans 
with PTSD After the Terrorist Attacks of September 11 
http://ajp.psychiatryonline.org/cgi/content/full/160/9/1684, accessed 27 Nov 2008 
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2. Treatment Costs 
The inpatient and outpatient claim records also provide valuable 
information on the treatment costs and duration for PTSD. We compute and 
analyze how the treatment cost of PTSD at military treatment facilities (MTFs), 
and civilian hospitals and institutions, differs across the service branches and 
demographics characteristics. We use data from the inpatient claims records 
(SIDR and TEDI) to compare the average total inpatient treatment cost at MTFs 
against the average bill charged and average claim allowed for inpatient health 
care services rendered by the TRICARE providers. Similarly, we evaluate the 
patterns in the average total outpatient treatment cost and pharmacy cost at 
MTFs, versus the patterns in the average bill charged and average claim allowed 
for outpatient treatment by TRICARE providers, based on data in the outpatient 
claims records (SADR and TEDN). 
In addition, we also analyze the patterns in the treatment duration and 
usage of MTFs and civilian care facilities across the various study populations.  
F. SUMMARY  
This chapter describes our methodological approach, as well as the 
statistical and multivariate analysis models used to analyze the three research 
objectives of this thesis. A combination of descriptive and multivariate analysis 
models are used to evaluate the probability of PTSD across the service branches 
and to examine the effect of deployment intensity on the probability of being 
diagnosed with PTSD. In addition, descriptive analyses are used to analyze the 
patterns of comorbidity risks and treatment cost of PTSD. The results of these 
statistical and multivariate analysis models are discussed in depth in the next 
three chapters.  
 49
V. DESCRIPTIVE RESULTS AND TREND ANALYSIS OF PTSD 
 PREVALENCE: COMPARISON ACROSS BRANCHES 
A. OVERVIEW 
While most of the prevailing studies have drawn conclusions that the 
prevalence of PTSD has increased over time and the increased incidence of 
combat exposure by military personnel has raised the probability of having 
PTSD, there are limitations in these studies. One of the main shortcomings of the 
current literature is their weak generalizability (i.e., the prevalence estimates 
were only specific to the respective samples examined in the various studies).42 
The current literature is based mostly on data inferences from deployed troops 
from the Army and Marine Corps. There is little or no information on statistics for 
the Air Force and the Navy and thus little is known about the prevailing medical 
health conditions of those active duty service personnel from the Air Force and 
the Navy who were also deployed in combat zones similar to their Army and 
Marine Corps counterparts. 
This chapter will focus on the assessment of the trends of PTSD across 
the different service branches from FY2001 to FY2006. Data from the Defense 
Enrollment Eligibility Reporting System (DEERS) provided by TRICARE and from 
the Contingency Tracking System (CTS) provided by Defense Manpower Data 
Centre (DMDC) are used to provide a more comprehensive view into the 
prevalence of PTSD across the four services (the Army, Air Force, Marine Corps 
and Navy) of the U.S military. Section B of the chapter provides summary 
statistics of the samples by PTSD and non-PTSD population. Section C presents 
                                            
42 Rajeev Ramchand, Benjamin R. Karney, Karen Chan Osilla, Rachel M. Burns and Leah 
Barnes Caldarone (2008). Prevalence of PTSD, Depression, and TBI among Returning Service 
members. In Terri Tanielian & Lisa H. Jaycox. (Eds.), Invisible Wounds of War- Psychological & 
Cognitive Injuries, Their Consequences, & Services to Assist Recovery (pp. 35-84). RAND 
Corporation.  
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a detailed trend analysis of PTSD cases during the study period. Section D 
provides a summary of the findings. 
B. SUMMARY STATISTICS OF THE DATA SAMPLES – PTSD AND NON 
PTSD POPULATION 
The entire DEERS data set is composed of 3,390,387 unique EDIPN 
observations of active duty service personnel from all four services (Army, 
Marine Corp, Navy and Air Force) and their respective demographic information 
(gender, race, age, marital status, military rank/paygrade).  To facilitate a better 
understanding of the summary statistics of the data samples of the different 
service branches, the overall data set is organized into two broad categories of 
officers and warrant officers, and enlisted personnel respectively. These are 
further divided into the non-PTSD and PTSD populations in accordance with their 
respective services. 
1. Officers and Warrant Officers Population 
The officers and warrant officers data samples consisted of a total of 
423,658 observations (12.6% of total observations). The detailed breakdown for 
the DEERS officers and warrant officers’ sample is as shown in Table 5.1. 
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Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 183,603 1,314 121,450 401 28,930 135 87,559 312 421,542 2,162
% of observations / service 99.3% 0.7% 99.7% 0.3% 99.5% 0.5% 99.6% 0.4% 99.5% 0.5%
Sex
Female 15.5% 27.0% 18.8% 51.1% 6.1% 14.1% 16.0% 42.3% 15.9% 32.9%
Male 84.5% 73.0% 81.2% 48.9% 93.9% 85.9% 84.0% 57.7% 84.1% 67.1%
Marital Status
Single 31.4% 27.8% 31.3% 36.4% 31.5% 27.4% 40.6% 37.5% 33.3% 30.8%
Married 68.6% 72.2% 68.7% 63.6% 68.5% 72.6% 59.4% 62.5% 66.7% 69.2%
Race
White 77.3% 72.6% 82.6% 78.3% 82.8% 88.1% 83.1% 80.1% 80.4% 75.7%
Black 11.9% 14.3% 7.1% 9.0% 6.7% 4.4% 7.2% 6.1% 9.2% 11.5%
Hispanic 2.4% 4.0% 1.6% 3.5% 2.6% 3.0% 3.5% 5.8% 2.4% 4.1%
Asian 3.8% 2.5% 2.1% 1.7% 1.6% 0.7% 3.6% 4.5% 3.1% 2.5%
Other races 4.6% 6.5% 6.6% 7.5% 6.3% 3.7% 2.6% 3.5% 4.9% 6.1%
Age
Mean age (year) 35.9 38.8 34.8 37.5 34.3 36.7 34.5 37.7 35.2 38.3
423,704184,917 121,851 29,065 87,871
Army
Officers and Warrant Officers
Air Force Marine Corps Navy Total
 
Table 5.1. Summary Statistics of the DEERS Data Samples of the 
Four Services (Officers and Warrant Officers) 
 
Table 5.1 shows that less than 1% of the active duty officer population 
across the four services enrolled in TRICARE was diagnosed with PTSD.  The 
officer sample was comprised predominantly of male service personnel (84%). 
Males also dominated the non-PTSD population (ranging from 81% to 94%) 
across all four services. For instance, the non-PTSD population in the Air Force 
consisted of 81% male and 19% female. However, females have a higher rate of 
being diagnosed with PTSD (ranging from 14% to 51%) across all four services, 
particularly in the Air Force and Navy. In the Air Force, females constituted only 
19% of the non-PTSD population, but they constituted 51% of the PTSD 
population. Similarly, females constituted a disproportionately higher percentage 
of the PTSD population (42%), compared to the PTSD population (16%) in the 
Navy.  
Table 5.1 indicates that there was a higher percentage of married officers 
(except for the Air Force) among the PTSD population, compared to the non-
PTSD population. Married officers constituted more than 60% of the PTSD 
population across all four services, most notably in the Army. Among the PTSD 
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population in the Army, 72% of them were married. It could be inferred that 
across all four services, married officers were more likely to be diagnosed with 
PTSD (69%), compared to the 31% who were single.    
The race distribution in Table 5.1 shows that the overall officer sample 
was predominately white for all the four services. White officers (except in the 
Marine Corps) appeared to be relatively less affected by PTSD. For the Army, Air 
Force and Navy, the percentage of white officers in the PTSD population (73%, 
78% and 80% respectively) were lower than the percentage of white officers in 
the non-PTSD population (77%, 83% and 83% respectively). On the other hand, 
there was a higher percentage of black officers in the Army and Air Force’s 
PTSD population 14% and 9% respectively), compared to their non-PTSD 
population (12% and 6% respectively).  Nonetheless, the descriptive statistics did 
not indicate that any particular race is significantly more or less vulnerable to 
PTSD.   
Table 5.1 shows that the average age for the PTSD population was higher 
than the average age for the non-PTSD population across all four services. The 
average age for the overall PTSD population was 38 while the average age for 
the overall non-PTSD population was 35. This could indicate that the risk of 
PTSD for officers increased with age, particularly during the late thirties. The 
positive relationship between PTSD risk and age could be due to the fact that an 
older officer is more likely to have experienced more deployments, and hence 
potentially greater exposure to war trauma, compared to a younger officer.   
2 Enlisted Population 
The enlisted personnel data samples for the four services consisted of 
2,966,729 unique EDIPN observations or 87.4% of the overall DEERS data files. 
Because the demographic characteristics and deployment and operational 




enlisted population was analyzed separately from the officers. The detailed 
breakdown of the demographic characteristics of the enlisted personnel data 
samples is shown in Table 5.2. 
Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 1,354,012 20,987 597,536 3,848 385,588 4,476 595,011 5,225 2,932,147 34,536
% of observations / service 98.5% 1.5% 99.4% 0.6% 98.9% 1.1% 99.1% 0.9% 98.8% 1.2%
Sex
Female 17.2% 19.5% 20.5% 53.2% 6.2% 13.0% 15.4% 41.7% 16.1% 25.8%
Male 82.8% 80.5% 79.5% 46.8% 93.8% 87.0% 84.6% 58.3% 83.9% 74.2%
Marital Status
Single 57.9% 38.5% 49.3% 48.9% 69.9% 51.4% 57.1% 54.5% 57.6% 43.8%
Married 42.1% 61.5% 50.7% 51.1% 30.1% 48.6% 42.9% 45.5% 42.4% 56.2%
Race
White 63.4% 65.5% 73.5% 73.3% 70.8% 71.5% 60.1% 62.4% 65.8% 66.7%
Black 21.1% 19.0% 16.3% 15.5% 11.9% 9.9% 20.5% 16.7% 18.8% 17.1%
Hispanic 6.2% 5.9% 3.0% 3.8% 7.0% 8.5% 6.4% 7.4% 5.7% 6.3%
Asian 3.7% 2.5% 2.2% 1.4% 2.6% 2.1% 5.3% 3.9% 3.6% 2.5%
Other races 5.6% 7.0% 4.9% 6.0% 7.7% 8.0% 7.6% 9.6% 6.1% 7.4%
Age
Mean age (year) 27.2 29.6 28.7 27.7 23.3 24.6 27.0 26.9 26.9 28.4
2,966,6831,374,999 601,384 390,064 600,236
Enlisted
Army Air Force Marine Corps Navy Total
 
Table 5.2. Summary Statistics of the DEERS Data Samples of the 
Four Services (Enlisted Personnel) 
Table 5.2 shows that about 1.2% of the entire sample for the enlisted 
personnel (34,536 service members) was diagnosed with PTSD during the study 
period. This is higher than the corresponding rate of 0.5% for the officers in Table 
5.1. In fact, the percentage of enlisted personnel diagnosed with PTSD is twice 
or more, than the percentage of officers diagnosed with PTSD for the respective 
services. For instance, in the Army, about 0.5% of its officers were diagnosed 
with PTSD, but 1.5% of its enlisted personnel were affected by PTSD. Similar to 
the officer population, the Army (1.5%) and Marine Corps (1.1%) also have a 
higher percentage of their enlisted population diagnosed with PTSD compared to 
the Air Force (0.6%) and Navy (0.9%). 
Similar to the officer population, female enlisted personnel (Table 5.2) 
were more likely to be diagnosed with PTSD compared to the males across all 
four services. Females constituted a higher percentage of the enlisted personnel 
PTSD population, compared to the non-PTSD population across all services, 
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most notably for the Air Force. Female enlisted personnel constituted only 21% 
of the non-PTSD population in the Air Force, but they accounted for 53% of the 
PTSD cases in the Air Force.  
Table 5.2 also shows that there is a higher percentage of PTSD 
population who are married, compared to the non-PTSD population, particularly 
for the Army and Marine Corps. Married enlisted personnel constituted 42% and 
30% of the Army and Marine Corps’ non-PTSD population respectively. 
However, 62% and 49% of the PTSD population in the Army and Marine Corps 
respectively, were married. A higher probability of being diagnosed with PTSD 
among the married personnel was observed in the officer population too.  
The race distribution in Table 5.2 shows that the whites and the blacks are 
the two main race groups in both the PTSD and non-PTSD populations across all 
services. However, similar to the officer population, no single race group in the 
enlisted population appeared to be particularly susceptible to PTSD.  
Compared to the officer population, the average age of the enlisted 
population across the different branches of services was much younger. The 
average age of the officer population was mid to late thirties, while the average 
age of the enlisted population was mid to late twenties. The younger average age 
of the enlisted population could be due to the fact that the enlisted population 
generally consisted of a larger number of junior and younger service members. 
The differences in the average age between the enlisted PTSD and non-PTSD 
population across the four services were also smaller, compared to the officers.  
C. TREND ANALYSIS OF THE PREVALENCE OF PTSD ACROSS 
DIFFERENT BRANCHES OF THE ARMED SERVICES  
The purpose of this section is to analyze the trends of PTSD incidences 
across the different branches of the armed services during the study period of 
FY2001 to FY2006. This thesis focuses on: (1) the trend of new cases of PTSD 
in each year and (2) the cumulative PTSD incidence rate for each year. For the 
purpose of this thesis, the cumulative PTSD incidence rate is defined as the 
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percentage of the study population who has been diagnosed with PTSD since 
FY2001, up to the respective study year. For example, the cumulative PTSD 
incidence rate for FY2005 will include all PTSD cases diagnosed between 
FY2001 up to FY2005.   
Trend analyses were conducted for three different populations: (1) all 
active duty TRICARE beneficiaries during the study period FY2001 to FY2006, 
regardless of whether they were deployed or not; (2) those who were deployed 
overseas during the study period as indicated by the CTS data; and, (3) those 
who were deployed to Iraq and/or Afghanistan during the study period.  As usual, 
we analyzed the officer and the enlisted populations separately.  The rest of 
section C is organized as follows: Sections C1.1-1.4 present the trend analysis 
for the entire sample, sections C2.1-2.4 present the trend analysis for those who 
were deployed overseas, and sections C3.1-3.4 present the trend analysis for 
those who were deployed to Iraq and/or Afghanistan. Section C4.1 shows a 
summary table that compares the trend analyses across the three different 
populations. 
1.1. New PTSD Cases among All Active Duty TRICARE 
Beneficiaries (Officers and Warrant Officers)  
The annual TRICARE enrollment of the active service personnel across 
the different branches of services from FY2001 to FY2006, based on the DEERS 
dataset, is summarized in Table 5.3 below.    
TRICARE Enrollment (Officers and Warrant Officers) 
FY Army Air Force Marine Navy Total 
2001 99,518 76,525 18,139 59,357 253,539 
2002 108,411 85,021 20,285 64,717 278,434 
2003 122,507 91,758 22,203 68,234 304,702 
2004 130,399 90,709 22,294 65,629 309,031 
2005 130,806 90,470 22,042 64,098 307,416 
2006 130,708 89,103 21,979 63,404 305,194 
Total 722,349 523,586 126,942 385,439 1,758,316 
Table 5.3. Summary of TRICARE Enrollment (Officers and Warrant 
Officers) from FY2001 to FY2006 
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Table 5.3 shows a significant increase in the officer TRICARE enrollment 
for all services between FY2001 to FY2003. Thereafter, the TRICARE enrollment 
had remained relatively constant between FY2004 to FY2006. The increase in 
TRICARE enrollment coincided with the commencement of Operation Enduring 
Freedom (OEF) and Operation Iraqi Freedom (OIF). Overall, the officer 
TRICARE enrollment has increased from 253,539 in FY2001 to 305,194 in 
FY2006.   
Figure 5.1 shows the number of new PTSD cases diagnosed among the 
entire active duty officer population who were enrolled in TRICARE between 
FY2001 to FY2006 for the four services. The number of new PTSD cases was 
obtained from the DEERS dataset.   
Figure 5.1 shows a dramatically rising trend in the number of new PTSD 
cases diagnosed among the active duty TRICARE beneficiaries (officer and 
warrant officer) between FY2001 and FY2006, across all four services. The total 
number of new PTSD cases per year in the four services had remained fairly 
constant, below 200, between FY2001 to FY2003. However there was a surge 































Figure 5.1. Number of Active Duty TRICARE Beneficiaries (Officers and 
Warrant Officers) Diagnosed with PTSD between FY2001 and FY2006 
 
A time lag between the increase in officer TRICARE enrollment (from 
FY2001 to FY2003) described in Table 5.1, and the surge in the number of new 
PTSD cases among the officer enrollment (from FY2004 onwards) depicted in 
Figure 5.1 was observed. After an individual’s deployment and exposure to war-
zone trauma, it is reasonable to expect a time lapse before the individual will 
seek treatment and be diagnosed clinically with PTSD. This could explain the 
time lag between the increase in officer enrollment and the surge in new PTSD 
cases. 
The rising trend in the number of new PTSD cases was most pronounced 
in the Army and the Marine Corps. Since the start of the GWOT following the 
9/11 incident, the number of new PTSD cases diagnosed per year in the Army 
has increased by 420% between FY2001 (86 cases) to FY2006 (448 cases). 
Similarly, the number of new PTSD cases diagnosed per year in the Marine 
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Corps has increased by 460%, from 9 cases in FY2001 to 51 cases in FY2006. 
Due to their operational and deployment profiles, personnel from the Army and 
Marine Corps were most likely to be deployed in ground combats and have 
greater exposure to war–zone trauma. Hence the rising trend in the number of 
new PTSD cases was most pronounced in the Army and Marine Corps, 
compared to the other two services.   
Although the number of new PTSD cases has remained relatively low and 
stable for the Air Force and Navy, a slow but certainly rising trend could be 
observed in these two services too. Similarly to the Army and Marine Corps, the 
rising trend in the number of new PTSD cases in the Air Force and Navy was 
most prominent from FY2004 onwards.  
1.2. New PTSD Cases among All Active Duty TRICARE 
Beneficiaries (Enlisted Personnel)  
The breakdown for the annual TRICARE enrollment for the enlisted  
population across the four services is summarized in Table 5.4. 
TRICARE Enrollment (Enlisted Personnel) 
FY Army Air Force Marine Navy Total 
2001 609,004 334,428 191,591 377,248 1,512,451 
2002 678,452 385,949 206,620 392,209 1,663,230 
2003 738,179 406,900 219,202 397,317 1,761,598 
2004 785,395 398,091 219,917 378,782 1,782,185 
2005 757,185 376,815 218,870 367,520 1,720,390 
2006 751,546 366,578 218,247 362,490 1,698,861 
Total 4,319,761 2,268,761 1,274,447 2,275,746 10,138,715 
Table 5.4.. Summary of TRICARE Enrollment (Enlisted Personnel) 
from FY2001 to FY2006 
Similar to officer enrollment, there was an increase in TRICARE 
enrollment for enlisted personnel following the 9/11 incident, from FY2001 to 
FY2003. From FY2004 to FY2006, the enlisted personnel enrollment had either 
remained constant or dipped slightly for the various services.    
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Figure 5.2 shows the number of new PTSD cases diagnosed among the 
enlisted TRICARE enrollees between FY2001 and FY2006 for the four services. 
Similar to the officer population, a rising trend in the number of new PTSD cases 
was observed across all four services, and a time lag between the increase in 
enlisted TRICARE enrollment and the surge in new PTSD cases was observed. 
The rising trend was most noticeable from FY2004 onwards, and the surge was 
most pronounced in the Army and Marine Corps. The number of new PTSD 
cases diagnosed per year in the Army increased by 550% between FY2001 
(1,084 cases) to FY2006 (7,116 cases). Similarly, the number of new PTSD 
cases diagnosed per year in the Marine Corps increased by 380%, from 315 
cases in FY2001 to 1,527 cases in FY2006. The surge in the number of new 
PTSD cases in the Army and Marine Corps is again likely due to their operational 




























Figure 5.2.  Number of Active Duty TRICARE Beneficiaries (Enlisted 
Personnel) Diagnosed with PTSD Between FY2001 to FY2006 
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1.3. Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Officers and Warrant Officers) 
Besides analyzing the number of new PTSD cases among the active duty 
service personnel, it would be beneficial to examine the cumulative trends of 
PTSD diagnoses among these personnel. PTSD is classified as a mental health 
illness. It often takes time for the medical conditions and symptoms related to 
PTSD to be diagnosed clinically and for its treatment to take effect.   
Figure 5.3 shows the cumulative number of active duty TRICARE 
beneficiaries (officer and warrant officer) diagnosed with PTSD from FY2001 to 
FY2006. For instance, the cumulative number of PTSD cases (1,494) for all 
services in FY2005 includes all PTSD cases diagnosed from FY2001 up to, and 
including FY2005. Figure 5.3 shows that the number of new PTSD cases 
diagnosed each year increased at a growing rate for the entire U.S. military, as 
well as across the individual services, from FY2004 onwards. Among the four 

































Figure 5.3. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Officers and Warrant Officers) Diagnosed with PTSD between FY2001 to 
FY2006 
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The corresponding cumulative percentage of active duty TRICARE 
beneficiaries (officer and warrant officer) diagnosed with PTSD between FY2001 
and FY2006 is shown in Figure 5.4.   For this thesis, the cumulative percentage 
of PTSD incidence refers to the percentage of the study population who has 
been diagnosed with PTSD since FY2001 up to the respective study year. The 
study population in this section refers to the entire TRICARE enrollment.  For 
instance, the cumulative percentage of 1% for the Army in FY2006 indicates that 
1% of the Army officer TRICARE enrollment in FY2006, have been diagnosed 




































Figure 5.4. Cumulative Percentage of PTSD Incidence (Officers and 
Warrant Officers) 
                                            
43 The Army officer TRICARE enrollment in FY2006 was 130,708. A total of 1,314 cases of 
PTSD were diagnosed from FY2001 to FY2006 in the Army. This results in a cumulative 
percentage of 1.01%. 
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The officer population from the Army has the highest cumulative 
percentage of PTSD incidence among the four services throughout the entire 
study period (except FY2002). Interestingly, the officer population from the Navy 
has the second highest cumulative percentage of PTSD incidence (except 
FY2006). The relatively high cumulative percentage of PTSD incidence in the 
Navy might be partly attributed to the slight decline in its TRICARE officer 
enrollment and increasing number of new PTSD diagnoses, particularly from 
FY2003 onwards.  
The cumulative percentage of PTSD incidence in FY2006 was 0.7% for 
the four services. Among the services, it ranged from 0.5% for the Air Force to 
1% for the Army. These low cumulative percentages may be attributed to the fact 
that the study population in this section included all active duty TRICARE 
beneficiaries, regardless of their deployment history during the study period. The 
analysis in the next section shows that a significant portion of these TRICARE 
beneficiaries were not deployed overseas during the study period. This caused 
the cumulative percentage of PTSD incidence to be lower than one would 
expect, based on current literature.   
1.4. Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Enlisted Personnel) 
Figure 5.5 shows that the trend in the cumulative number of PTSD cases 
for enlisted personnel is similar to the trend in the officer population. The 
cumulative number of PTSD cases increased at a growing rate for every service 
from FY2004 onwards, i.e., the number of new PTSD cases diagnosed each year 
increased. The cumulative number of PTSD cases for the enlisted personnel in 
the U.S. military grew from 2,835 cases in FY2001 to 34,536 cases in FY2006. 
The rate of increase is again most pronounced in the Army. The cumulative 
number of PTSD cases in the Army has increased from 1,084 in FY2001 to 






































Figure 5.5. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Enlisted Personnel) Diagnosed with PTSD between FY2001 and FY2006 
The corresponding cumulative percentage of PTSD incidence for the 
enlisted personnel is shown in Figure 5.6. These cumulative percentages of 
PTSD incidence reflect the percentage of TRICARE enrollment for the enlisted 
personnel diagnosed with PTSD between FY2001 up to the respective study 
year.  A comparison of Figure 5.4 and Figure 5.6 reveals that the cumulative 
percentage of PTSD incidence for enlisted personnel is at least twice that of the 
officers, across all services. This suggests that the enlisted population was more 





































Figure 5.6. Cumulative Percentage of PTSD Incidence (Enlisted 
Personnel) 
Despite the surge in the number of new PTSD cases, the cumulative 
percentage of PTSD across all the services appeared relatively low, compared to 
findings in current literature. The cumulative percentage of PTSD for the enlisted 
personnel in the four services was 2% in FY2006. As explained in the analysis 
for the officer population, the cumulative percentages in this section are based on 
the entire TRICARE enrollment, regardless of whether were they deployed 
overseas during the study period. Even with the ongoing GWOT, a significant 
portion of the enrollment was not deployed overseas during the period. This 
lowered the cumulative percentage of PTSD incidence. 
Among the enlisted population, the rate of increase in the number of new 
PTSD cases appeared to be greater in the Army and Marine Corps. For the 
enlisted personnel in the Army, the cumulative percentage of PTSD incidence 
has increased from 0.2% in FY2001 to 2.8% in FY2006, while the corresponding 
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percentage for the Marine Corps has increased from 0.2% to 2% in the same 
time span. The rate of increase in the number of new PTSD cases in the Air 
Force and Navy appeared to be flatter. The cumulative percentages for the Air 
Force and Navy have increased from 0.2% and 0.3% in FY2001 to 1.1% and 
1.4% in FY2006 respectively. However, these percentages may not truly reflect 
the effect of the GWOT or overseas deployments on the probability of being 
diagnosed with PTSD among the services, because the study population in this 
section consisted of the entire TRICARE population, regardless of deployment 
history. In order to study the effect of deployments on the probability of being 
diagnosed with PTSD, the following two sections will consider the deployment 
history of the TRICARE beneficiaries in their analyses.   
2.1. New PTSD Cases Among Active Duty TRICARE Beneficiaries 
(Officer and Warrant Officer) Who Were Ever Deployed 
Overseas   
In order to better understand the effect of overseas deployment on the 
likelihood of being diagnosed with PTSD, this section restricts the study 
population to the TRICARE beneficiaries who were ever deployed overseas 
between FY2001 to FY2006. The number of TRICARE beneficiaries (Officers 
and Warrant Officers) who were ever deployed overseas during the study period 
is tabulated in Table 5.5.  
TRICARE Enrollment (Officers and Warrant Officers) Who Were Ever 
Deployed Overseas 
FY Army Air Force Marine Navy Total 
2001 35,379 39,256 8,681 19,900 93,216 
2002 42,790 34,367 10,457 22,171 109,785 
2003 50,948 37,597 11,908 23,484 123,937 
2004 55,835 37,903 12,229 23,767 129,734 
2005 54,861 37,017 12,306 23,748 127,932 
2006 53,110 35,503 11,844 23,319 123,776 
Total 292,923 211,643 67,425 34,184 708,380 
Table 5.5. Summary of TRICARE Enrollment (Officers and Warrant 
Officers) Who Were Ever Deployed Overseas from FY2001 to FY2006 
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The general trend in the number of TRICARE officer beneficiaries who 
were ever deployed overseas was similar to the trend observed in the officer 
TRICARE enrollment in the previous section. The number of officers ever 
deployed overseas (except for the Air Force) increased from FY2001 to FY2003, 
and thereafter remained relatively constant or declined slightly. The number of 
officers ever deployed overseas in the four services had increased by more than 
30,000, from 93,216 in FY2001 to 123,776 in FY2006.  Among the four services, 
the increase was most noticeable in the Army. The number of Army officers ever 
deployed overseas increased by 50% from 35,379 to 53,110 over the study 
period.  
A comparison of Table 5.3 and Table 5.5 shows that the percentage of 
officers deployed overseas has increased from all services except the Air Force. 
For instance, in FY2001, 35,379 or 36% of the 99,158 Army officers had ever 
been deployed overseas. In FY2006, among the 130,708 Army officers, 41% or 
53,110 of them had ever been deployed overseas. The percentage of officers 
deployed for the Marine Corps and Navy had also increased slightly, from 48% 
and 34% respectively in FY2001, to 54% and 37% in FY2006. The percentage 
for the Air Force however declined from 51% in FY2001 to 40% in FY2006.  
Figure 5.7 shows the number of new PTSD cases among the TRICARE 
beneficiaries (officer) who were ever deployed overseas between FY2001 to 
FY2006. A surge from FY2003 onwards was evident across all services, 
particularly for the Army. The number of new PTSD cases diagnosed per year 
increased from 26 cases in FY2003, to 435 cases in FY2006 for the four 
services, while the Army registered an increase from 12 new cases in FY2003 to 
311 new cases in FY2006. Interestingly, the Air Force had the second highest 
number of new PTSD cases (54) in FY2006, whereas both the Marine Corps and 
Navy had less than 40 new cases each. A time lag between the increase in the 
number of officers ever deployed overseas, and the surge in new PTSD cases 

































Figure 5.7. Number of Active Duty TRICARE Beneficiaries (Officers and 
Warrant Officers) Who Were Ever Deployed Overseas and Diagnosed with 
PTSD between FY2001 and FY2006 
 
Tables 5.3 and 5.5 show that in FY2006, 123,776 or 40% of the 305,194 officers 
in the services were ever deployed overseas. However, the officers who were 
ever deployed overseas constituted 65% or 435 of the 668 new PTSD cases in 
FY2006.  This disproportionate distribution was observed across all services, and 
was most prominent in the Army and Marine Corps.  In FY2006, 41% and 54% of 
the officers in the Army and Marine Corps were ever deployed respectively, but 
these officers accounted for 69% and 75% of the new PTSD cases in their 
services.  Similarly, about 40% of the officers in the Air Force and Navy were 
ever deployed, but they constituted 51% of the new PTSD cases in their 
services. These clearly point to the increase in the probability of being diagnosed 
with PTSD due to overseas deployments.       
 68
2.2. New PTSD Cases Among Active Duty TRICARE Beneficiaries 
(Enlisted Personnel) Who Were Ever Deployed Overseas   
Table 5.6 summarizes the number of TRICARE enlisted beneficiaries who 
were ever deployed overseas between FY2001 and FY2006.  
TRICARE Enrollment (Enlisted Personnel) Who Were Ever Deployed 
Overseas 
FY Army Air Force Marine Navy Total 
2001 186,244 142,746 64,183 176,635 569,808 
2002 240,300 174,677 86,484 201,645 703,106 
2003 293,917 189,606 104,941 217,034 805,498 
2004 318,579 188,442 111,866 215,755 834,662 
2005 296,001 180,531 103,872 210,650 782,054 
2006 267,501 166,283 88,668 181,173 703,625 
Total 1,602,542 1,042,285 560,014 1,193,912 4,398,753 
Table 5.6. Summary of TRICARE Enrollment (Enlisted Personnel) 
Who Were Ever Deployed Overseas from FY2001 to FY2006 
Table 5.6 shows that the GWOT has clearly increased the number of 
enlisted personnel who were ever deployed across all services. The number of 
enlisted personnel who were ever deployed was 569,808 in FY2001, and the 
corresponding number in FY2006 was 703,625. The Army and Marine Corps had 
the largest increase in the number of enlisted personnel who were ever 
deployed, based on the numbers for the start and end of the study period.  
Similar to the officer population, the percentage of enlisted personnel who 
were ever deployed also increased due to the GWOT. In FY2001, 569,808 or 
38% of the 1,512,451 enlisted personnel from the four services were ever 
deployed. In FY2006, 41% or 703,625 of the 1,698,861 enlisted personnel were 
ever deployed. The percentage increase for the enlisted personnel was, 
however, smaller than the percentage increase for the officers.  
Figure 5.8 shows the number of new PTSD cases diagnosed among the 
enlisted personnel who were ever deployed overseas. Similar to the officer 
population, a surge was observed from FY2003 onwards across all services. The 
number of new PTSD cases for all services surged from 609 in FY2003 to 7,452 
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in FY2006. The magnitude of the surge was again larger for the Army and Marine 
Corps, compared to the Air Force and Navy. The number of new PTSD cases in 
the Army and Marine Crops increased from 320 and 86 respectively in FY2003 to 






























Figure 5.8. Number of Active Duty TRICARE Beneficiaries (Enlisted 
Personnel) Who Were Ever Deployed Overseas and Diagnosed with PTSD 
Between FY2001 and FY2006 
Similar to the officer population, the enlisted personnel who were ever 
deployed overseas also constituted a disproportionately high percentage of the 
new PTSD cases diagnosed across all services, except the Navy. In FY2006, 
703,625 or 41% of the 1,698,861 enlisted personnel in the four services were 
ever deployed overseas. However, they accounted for 7,452 or 71% of the 
10,540 new PTSD cases. The uneven distribution was most significant in the 
Army and Marine Corps. About 40% of the enlisted personnel in the Army and 
Marine Corps were ever deployed overseas, but they accounted for about 75% of 
the new PTSD cases in their services in FY2006. On the other hand, the enlisted 
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personnel in the Air Force and Navy who were ever deployed overseas, 
constituted a proportionate percentage of the new PTSD cases in their services. 
This suggests that the effect of overseas deployments on the likelihood of being 
diagnosed with PTSD might be less severe on the enlisted personnel in the Air 
Force and Navy, compared to their counterparts in the Army and Marine Corps, 
as hypothesized in this thesis.     
2.3. Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Officers and Warrant Officers) Who 
Were Ever Deployed Overseas 
Figures 5.9 and 5.10 show the cumulative number of PTSD diagnoses 
and the cumulative percentage of PTSD incidences among the officers who were 
ever deployed overseas. The previous section noted that the cumulative 
percentage of PTSD incidence for the entire TRICARE beneficiaries (officer) for 
the four services was 0.7% in FY2006, i.e. 0.7% of the officer population in the 
U.S. military in FY2006 had been diagnosed with PTSD between FY2001 to 
FY2006. This cumulative percentage of PTSD incidences increased to 0.8% 
when the study population was restricted to only those officers who were ever 
deployed overseas. As seen from Figure 5.10, this percentage increase was 
primarily attributable to the Army. The cumulative percentage of PTSD incidence 
for the Army increased from 1% to 1.3% when the deployment histories of the 
officers were taken into consideration, while the cumulative percentage for the 
other three services remained relatively unchanged. This indicates that the effect 
of overseas deployment on the probability of being diagnosed with PTSD may 



































Figure 5.9. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Officers and Warrant Officers) Who Were Ever Deployed Overseas and 






































Figure 5.10. Cumulative Percentage of PTSD Incidence (Officers and 
Warrant Officers Who Were Ever Deployed Overseas) 
 
2.4. Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Enlisted Personnel) Who Were Ever 
Deployed Overseas 
Figures 5.11 and 5.12 show the cumulative number of PTSD diagnose 
and the cumulative percentage of PTSD incidences among the enlisted 
personnel who were ever deployed overseas. In FY2006, the cumulative 
percentage of PTSD incidence for the enlisted personnel in the four services 
increased from 2% (for the entire TRICARE enlisted beneficiaries in the previous 
section), to 2.5% when the deployment histories of the enlisted personnel were 
taken into account, and the study population was restricted to only those enlisted 
personnel who were ever deployed overseas. Among the services, the 
cumulative percentage for the Army and Marine Corps had both increased, from  
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2.8% and 2.1% to 4.7% and 3% respectively. On the other hand, the cumulative 
percentage for the Air Force and Navy had decreased from 1.1% and 1.4% to 






































Figure 5.11. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Enlisted Personnel) Who Were Ever Deployed Overseas and Diagnosed 
with PTSD between FY2001 and FY2006 
 
The different changes in the cumulative percentages suggest that the 
overseas deployment effect may differ across the services. In addition, the 
magnitude of the changes in the cumulative percentages for the enlisted 
personnel was larger than the changes for the officers. This indicates that the 
effect of overseas deployments may be more pronounced in the enlisted 










































Figure 5.12. Cumulative Percentage of PTSD Incidence (Enlisted Personnel 
Who Were Ever Deployed Overseas) 
 
This section has discussed the effect of overseas deployments on the 
likelihood of developing PTSD, through the changes in the cumulative 
percentage of PTSD incidences when the study population was restricted to only 
those TRICARE beneficiaries who were ever only deployed overseas.  The crux 
of the GWOT is in Afghanistan and Iraq (OEF and OIF). Hence, in order to study 
the effect of the GWOT, the next section will further restrict the study population 
to only those who were ever deployed to Afghanistan and/or Iraq.     
3.1. New PTSD Cases Among Active Duty TRICARE Beneficiaries 
(Officers and Warrant Officers) Who Were Ever Deployed to 
Afghanistan and/or Iraq  
This section will specifically examine the effect of deployments to 
Afghanistan and/or Iraq by restricting the study population to the TRICARE 
beneficiaries who were ever deployed to Afghanistan or Iraq between FY2001 to 
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FY2006. Table 5.7 summarizes the number of officers who were ever deployed 
to Afghanistan and/or Iraq during the study period.  
TRICARE Enrollment (Officers and Warrant Officers) Who Were Ever 
Deployed to Afghanistan and/or Iraq 
FY Army Air Force Marine Navy Total 
2001 17,424 3,623 2,191 918 24,156 
2002 20,505 4,275 2,764 1,065 28,609 
2003 23,438 4,867 3,397 1,136 32,838 
2004 26,164 5,333 3,773 1,155 36,425 
2005 26,555 5,436 4,051 1,175 37,217 
2006 25,960 5,356 3,987 1,232 36,535 
Total 140,046 28,890 20,163 6,681 195,780 
Table 5.7. Summary of TRICARE Enrollment (Officers and Warrant 
Officers) Who Were Ever Deployed to Afghanistan and/or Iraq between 
FY2001 and FY2006 
Table 5.7 shows an increasing trend in the number of officers who were 
ever deployed to Afghanistan and/or Iraq across all services. The number of 
officers who were ever deployed to Afghanistan and/or Iraq has increased from 
24,156 in FY2001 to 36,535 in FY2006. The increase was most significant in the 
Marine Corps. The number of officers ever deployed to Afghanistan and/or Iraq 
increased by 82%, from 2,191 in FY2001 to 3,987 in FY2006.  
A comparison of Tables 5.3, 5.5, and 5.7 provides insight into the 
deployment pattern for the officer population. The previous section had noted 
that 123,776 or 40% of the TRICARE officer enrollment (305,194) for the four 
services in FY2006 were ever deployed overseas. Of these officers who were 
ever deployed overseas, 36,535 or 30% were ever deployed to Afghanistan 
and/or Iraq. In FY2001, only 24,156 or 26% of the 93,126 officers who were ever 
deployed overseas, were ever deployed to Afghanistan and/or Iraq. This 
indicated that deployments to Afghanistan and/or Iraq constituted an increasing 
percentage of the overseas deployments for officers due to the GWOT. Among 
the four services, the larger percentage increase was observed in the Air Force 
and Marine Corps. In FY2001, among the officers ever deployed overseas, 9% of 
the officers in the Air Force and 25% of their counterparts in the Marine Corps, 
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were ever deployed to Afghanistan and/or Iraq. In FY2006, the percentage 
increased to 15% and 34% respectively.   
 Figure 5.13 shows the number of new PTSD cases among the officers 
who were ever deployed to Afghanistan and/or Iraq. The surge in the number of 
new PTSD cases for the Army is most noticeable. Similar to the previous 
sections, a time lag between the increased deployments to Afghanistan and/or 
Iraq and a surge in new PTSD cases was observed.  
It was noted above that in FY2006, 36,535 or 30% of the officers who 
were ever deployed overseas, were ever deployed to Afghanistan and/or Iraq. 
However, these officers who were ever deployed to Afghanistan and/or Iraq, 
accounted for 277 or 64% of the 435 new PTSD cases diagnosed among officers 
who were ever deployed overseas. This suggests that the officers, who were 
ever deployed to Afghanistan and/or Iraq, were more susceptible to PTSD, 
compared to officers who were ever deployed to overseas locations other than 
Afghanistan and/or Iraq.  
The adverse effect of deployments to Afghanistan and/or Iraq on the 
officer population was even more obvious if the entire TRICARE officer 
enrollment was taken into consideration, i.e., including those who were never 
deployed overseas during the study period. In FY2006, 36,535 or 12% of the 
entire TRICARE officer beneficiaries were ever deployed to Afghanistan and/or 
Iraq, but they constituted 277 or 41% of the 668 new PTSD cases among the 






























Figure 5.13. Number of Active Duty TRICARE Beneficiaries (Officers and 
Warrant Officers) Who Were Ever Deployed to Afghanistan and/or Iraq, and 
Diagnosed with PTSD Between FY2001 and FY2006 
 
3.2. New PTSD Cases Among Active Duty TRICARE Beneficiaries 
(Enlisted Personnel) Who Were Ever Deployed to Afghanistan 
and/or Iraq  
Table 5.8 summarizes the number of TRICARE enlisted beneficiaries who 
were ever deployed to Afghanistan and/or Iraq. A general increasing trend can 
be observed from Table 5.8. The number of enlisted personnel who were ever 
deployed to Afghanistan and/or Iraq had increased from 139,492 in FY2001, to 
230,974 in FY2006, i.e. a 66% increase. Interestingly, the Air Force, Marine 
Corps and Navy all had a higher percentage increase in the number of enlisted 
personnel ever deployed to Afghanistan and/or Iraq, than the Army. The 
percentage increase for the Air Force, Marine Corps and Navy between FY2001 
and FY2006 was 70%, 208% and 64% respectively, compared to 48% for the 
Army. The huge percentage increase for the Air Force, Marine Corps and Navy is 
 78
partly due to their small number of enlisted personnel ever deployed to 
Afghanistan and/or Iraq in FY2001.    
TRICARE Enrollment (Enlisted Personnel) Who Were Ever Deployed to 
Afghanistan and/or Iraq 
FY Army Air Force Marine Navy Total 
2001 105,623 17,080 12,829 3,960 139,492 
2002 138,212 22,883 20,843 4,821 186,759 
2003 162,808 26,507 30,443 5,589 225,347 
2004 179,486 29,332 39,030 6,160 254,008 
2005 170,836 29,971 41,611 6,691 249,109 
2006 155,813 29,187 39,491 6,483 230,974 
Total 912,778 154,960 184,247 33,704 1,285,689 
Table 5.8. Summary of TRICARE Enrollment (Enlisted Personnel) 
Who Were Ever Deployed to Afghanistan and/or Iraq between FY2001 
and FY2006 
Similar to that of the officer population, among the enlisted personnel who 
were ever deployed overseas, a growing percentage of them were deployed to 
Afghanistan and/or Iraq. Based on Tables 5.6 and 5.8, in FY2001, 139,492 or 
24% of the 569,808 enlisted personnel who were ever deployed overseas, were 
ever deployed to Afghanistan and/or Iraq. In FY2006, it had increased to 33%, 
i.e., among the 703,625 enlisted personnel ever deployed overseas, 230,974 of 
them were ever deployed to Afghanistan and/or Iraq. This increasing percentage 
is most significant in the Marine Corps. In FY2001, 12,829 or 20% of the 64,183 
enlisted personnel in the Marine Corps ever deployed overseas were ever 
deployed to Afghanistan and/or Iraq.  In FY2006, among the 88,668 enlisted 
personnel ever deployed overseas, 45% or 39,491 of them were ever deployed 
to Afghanistan and/or Iraq.    
Figure 5.14 shows the number of new PTSD cases among the enlisted 
personnel who were ever deployed to Afghanistan and/or Iraq. Similar to the 
officer population, the enlisted personnel who were ever deployed to Afghanistan 
and/or Iraq accounted for a disproportionately high percentage of the new PTSD 
among the enlisted personnel who were ever deployed overseas. As noted 
above, in FY2006, the number of enlisted personnel ever deployed to 
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Afghanistan and/or Iraq accounted for 33% of the enlisted personnel who were 
ever deployed overseas. However, these enlisted personnel ever deployed to 
Afghanistan and/or Iraq constituted 5,107 or 68% of the 7,452 new PTSD cases 





























Figure 5.14. Number of Active Duty TRICARE Beneficiaries (Enlisted 
Personnel) Who Were Ever Deployed to Afghanistan and/or Iraq, and 
Diagnosed with PTSD between FY2001 and FY2006 
 
From Table 5.2, the number of TRICARE enlisted enrollment in FY2006 
for all services totaled 1,698,861, 14% or 230,974 of them were ever deployed to 
Afghanistan and/or Iraq.  Yet they accounted for 48% or 5,107 of the 10,540 new 
PTSD cases diagnosed among all the enlisted personnel. This shows the effect 
of deployments to Afghanistan and/or Iraq on the probability of being diagnosed 
with PTSD.  
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3.3. Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Officers and Warrant Officers) Who 
Were Ever Deployed to Afghanistan and/or Iraq  
The increased tempo of OEF and OIF in Afghanistan and Iraq between 
the years 2003 to 2005 has exerted its toll on the military personnel who were 
deployed for missions in the GWOT. Figure 5.15 shows the cumulative number 
of PTSD cases among officers ever deployed to Afghanistan and/or Iraq. The 
cumulative number of PTSD cases rose at an increasing rate across all services 
from FY2003 onwards. The increasing rate was most notable in the Army. 
Among the Army officers ever deployed to Afghanistan and/or Iraq, only 5 cases 
of PTSD was diagnosed between FY2001 up to FY2003. By FY2006, a total of 


































Figure 5.15. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Officers and Warrant Officers) Who Were Ever Deployed to Afghanistan 
and/or Iraq, and Diagnosed with PTSD between FY2001 and FY2006 
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Figure 5.15 showed that the Army had the highest number of cumulative 
PTSD cases among the officer population. However, interestingly, Figure 5.16 
shows that the Navy has the highest cumulative percentage of PTSD incidences 
among the officer population in the four services. To recap, the cumulative 
percentage of PTSD incidence refers to the percentage of the study population 
who has been diagnosed with PTSD up to the year of interest. Figure 5.16 shows 
that the cumulative percentage of PTSD incidence for the Navy officers was 
1.6% in FY2006, i.e., 1.6% of the Navy officers who were ever deployed to 
Afghanistan and/or Iraq, had been diagnosed with PTSD between FY2001 to 
FY2006. The cumulative percentage of PTSD incidence for officers in the Army 
and Marine Corps was 1.5% and 1% respectively. Both the Army and Marine 
Corps have a higher number of cumulative PTSD cases compared to the Navy. 
The Army and Marine Corps have 384 and 38 cases respectively, compared to 
the 20 cases in the Navy. However, a larger number of officers in the Army and 
Marine Corps were ever deployed to Afghanistan and/or Iraq than the Navy. This 
resulted in a lower cumulative percentage of PTSD incidences for the Army and 








































Figure 5.16. Cumulative Percentage of PTSD Incidence (Officers and 
Warrant Officers) Among Who Were Ever Deployed to Afghanistan and/or 
Iraq 
 
In Section C1.3 of this chapter, it was noted that the cumulative 
percentage of PTSD incidence for the entire TRICARE officer enrollment in 
FY2006 was 0.7%. This cumulative percentage increased to 0.8% in Section 
C2.3 when the deployment histories of the officers were taken into consideration, 
and the study population was restricted to only officers who were ever deployed 
overseas. This section shows that the cumulative percentage has further 
increased to 1.4% when the study population was narrowed to include officers 
who were ever deployed to Afghanistan and/or Iraq. These percentage changes 
illustrate the upward effect of deployments to Afghanistan and/or Iraq on the 
probability of being diagnosed with PTSD for officers in the U.S. military.    
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3.4 Cumulative PTSD Incidence Rate Among All Active Duty 
TRICARE Beneficiaries (Enlisted Personnel) Who Were Ever 
Deployed to Afghanistan and/or Iraq  
Figure 5.17 shows the cumulative number of PTSD cases among enlisted 
personnel who were ever deployed to Afghanistan and/or Iraq. Similar to the 
results of the officer population, the cumulative number of PTSD cases 
increased.  In FY2006, the Army had the largest cumulative total of 7,867 PTSD 
cases among its enlisted personnel who were ever deployed to Afghanistan 
and/or Iraq. The cumulative number of PTSD cases for the Air Force, Marine 

































Figure 5.17. Cumulative Number of  Active Duty TRICARE Beneficiaries 
(Enlisted Personnel) Who Were Ever Deployed to Afghanistan and/or Iraq, 
and Diagnosed with PTSD between FY2001 and FY2006 
 
The analysis of the cumulative percentage of PTSD incidence across the 
different services’ enlisted population yields similar outcomes as does the 
analysis of the officer population. The Navy has the highest cumulative 
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percentage of PTSD incidence (6.2%) among its enlisted personnel who were 
ever deployed to Afghanistan and/or Iraq, as seen in Figure 5.18. Although the 
enlisted personnel from the Army has the highest cumulative number of PTSD 
diagnosis counts from FY2001 to FY2006, the Army had a slightly lower 
cumulative percentage of 5.1% due to its larger number of enlisted personnel 
ever deployed to Afghanistan and/or Iraq. Enlisted personnel in the Air Force 




































Figure 5.18. Cumulative Percentage of PTSD Incidence (Enlisted Personnel) 
Among Who Were Ever Deployed to Afghanistan and/or Iraq 
 
Similar to the officer population’s percentage, the cumulative percentage 
of PTSD incidence for the enlisted personnel increased when their deployment 
history was taken into consideration. The cumulative percentage for the entire 
TRICARE enrollment for enlisted personnel in FY2006 was 2%, as noted in 
Section C1.4 of this chapter. The cumulative percentage increased to 2.5% when 
the study population was narrowed to those ever deployed overseas. The 
cumulative percentage increased to 4.3% when the study population was further 
 85
restricted to those ever deployed to Afghanistan and/or Iraq. The magnitude in 
the percentage changes for the enlisted personnel was larger than those 
observed for the officers. This further suggests that the effect of deployments to 
Afghanistan and/or Iraq on the likelihood to develop PTSD may be more/is more 
significant on the enlisted personnel than the officers. This agrees with the 
findings in current literature. This thesis will further discuss the effect of 
deployments to Afghanistan and/or Iraq on officers and enlisted personnel based 
on results of the multivariate analyses in the next chapter.    
4.1 Comparison of PTSD Incidence Across the Study Population 
In order to facilitate the comparison of the trends in PTSD incidence 
across the four services and the three study populations, namely a) all active 
duty TRICARE enrollment, b) active duty personnel who were ever deployed 
overseas, and c) active duty personnel who were ever deployed to Afghanistan 
(AF) and/or Iraq (IZ), the number of new PTSD case diagnosed each year for the 
officer and enlisted population is summarized in Tables 5.9 and 5.10. The 
cumulative percentage of PTSD incidence, i.e., the percentage of the study 
population diagnosed with PTSD up the respective year of interest, based on the 
number of PTSD cases diagnosed between FY2001 to FY2006, for the officer 
and enlisted population is tabulated in Tables 5.11 and 5.12.    
Number of New PTSD Cases Diagnosed Each Year for Officers and Warrant Officers 
  Army Air Force Marine Corp Navy 
FY All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ
2001 86 0 0 51 0 0 9 0 0 47 0 0 
2002 63 3 1 47 2 0 13 0 0 48 0 0 
2003 86 12 4 57 6 0 13 3 0 34 5 0 
2004 237 119 51 60 21 6 16 11 1 58 13 1 
2005 394 263 120 80 33 17 33 23 10 62 23 8 
2006 448 311 208 106 54 31 51 38 27 63 32 11 
Total 1,314 708 384 401 116 54 135 75 38 312 73 20 
Table 5.9. Number of New PTSD Case Diagnosed Each Year for 
Officers and Warrant Officers 
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Number of New PTSD Cases Diagnosed Each Year for Enlisted Personnel 
  Army Air Force Marine Corp Navy 
FY All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ
2001 1.084 0 0 564 0 0 315 0 0 872 0 0 
2002 976 23 9 481 30 0 257 3 0 727 31 9 
2003 1,412 320 127 543 92 1 312 86 1 649 111 130 
2004 3.731 2,241 1,328 633 183 49 604 378 6 822 253 1,414
2005 6,668 4,715 2,607 794 344 172 1,461 1,034 155 1,091 477 3,351
2006 7,116 5,332 3,796 1833 427 238 1,527 1,159 239 1,064 534 5,107
Total 20,987 12,631 7,867 3,848 1,076 460 4,476 2,660 401 5,225 1,406 20 
Table 5.10. Number of New PTSD Case Diagnosed Each Year for Enlisted Personnel 
 
Cumulative Percentage of PTSD Incidence (Based on PTSD Cases Diagnosed between FY2001 to FY2006) 
for Officers and Warrant Officers 
  Army Air Force Marine Corp Navy 
FY All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ
2001 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 
2002 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 
2003 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 
2004 0.4 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.1 
2005 0.7 0.7 0.7 0.3 0.2 0.4 0.4 0.3 0.3 0.4 0.2 0.8 
2006 1.0 1.3 1.5 0.5 0.3 1.0 0.6 0.6 1.0 0.5 0.3 1.6 
Table 5.11. Cumulative Percentage of PTSD Incidence for Officers and Warrant Officers 
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Cumulative Percentage of PTSD Incidence (Based on PTSD Cases Diagnosed between FY2001 to 
FY2006) for Enlisted Personnel 
  Army Air Force Marine Corp Navy 
FY All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ All Overseas AF/IZ
2001 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 
2002 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 
2003 0.5 0.1 0.1 0.4 0.1 0.0 0.4 0.1 0.0 0.6 0.2 0.0 
2004 0.9 0.8 0.8 0.6 0.2 0.2 0.7 0.4 0.1 0.8 0.2 0.1 
2005 1.8 2.5 2.4 0.8 0.4 0.7 1.4 1.5 1.1 1.1 0.4 2.4 
2006 2.8 4.7 5.1 1.1 0.7 1.6 2.1 3.0 3.3 1.4 0.8 6.2 
Table 5.12. Cumulative Percentage of PTSD Incidence for Enlisted Personnel 
A significant increase in the number of new PTSD cases diagnosed per year among both the officers and enlisted 
personnel can be easily observed across all three study populations from Tables 5.9 and 5.10, particularly from FY2004 
onwards. The cumulative percentages of PTSD incidence shown in Tables 5.11 and 5.12 are computed based on the 
number of new PTSD cases between FY2001 and FY2006, as well as the size of the study population. These 
percentages show that among the three study populations, personnel who were ever deployed to Afghanistan and/or Iraq 
have the largest percentage increase in the number of new PTSD cases. This suggests that overseas deployments, 
particularly deployments to Afghanistan and Iraq, were a significant cause for the rising number of new PTSD cases 
diagnosed per year during the study period.   
D. SUMMARY 
The prolonged duration of OIF and OEF seemed to have exacerbated the toll on those deployed to Afghanistan 
and Iraq, as the statistics for PTSD continue to climb across all services. The DEERS data from TRICARE has provided a 
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more comprehensive insight into the rising PTSD incidence trends across the 
four services of the U.S military between FY2001 to FY2006. 
The trend analyses across the three different study populations took into 
consideration the deployment history of the TRICARE beneficiaries, and showed 
that personnel deployed to Afghanistan and/or Iraq were more susceptible to 
PTSD risks. The trend analyses suggest that sailors deployed to Afghanistan 
and/or Iraq may be equally susceptible to PTSD risks as the soldiers and 
marines deployed. In addition, the enlisted population appeared to be more 
susceptible to PTSD risks, compared to the officers.  
The biggest surprise arising from the information in this chapter is perhaps 
the low percentage of overall studied population diagnosed with PTSD, 
compared to the findings in current literature. Current literature has found that, at 
least among the Army and Marine Corps, the prevalence of PTSD is about 11-
18%.  It is important to keep in mind the differences between this thesis and the 
prevailing literature.  First, this thesis only examines the active duty members 
who were enrolled in the TRICARE health care system from FY2001 to FY2006.  
Personnel who have suffered combat-related injuries and were rendered unfit for 
active duty, would have been transferred to the VA system. These personnel 
would not be captured in the DEERS data provided by TRICARE. 
Secondly, this thesis uses clinical data from TRICARE, while prevailing 
literature had relied primarily on survey research on a selected group. Due to the 
stigma associated with mental health illness, it is not surprising that few people 
will come forth and seek treatment for PTSD, especially while they are still on 
active duty.  
Thirdly, the full sample was comprised of all active duty service insured by 
TRICARE, regardless of whether they have ever been deployed overseas. The 
sub-sample analysis (especially the analysis on personnel ever deployed to 
Afghanistan and/or Iraq) shows a higher rate of PTSD incidence, and is 
consistent with the expectations of the authors. 
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Since the rising trends of PTSD incidence across the different service 
branches of the U.S military between FY2001 to FY2006 have been established, 
it would be appropriate to evaluate the impact of deployment intensity 
(deployment location and duration) on the probability of being diagnosed with 
PTSD among deployed active duty personnel. The results of these multivariate 
analyses will be discussed in the next chapter. 
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VI. RESULTS OF ANALYSIS: EFFECT OF DEPLOYMENT 
INTENSITY ON PROBABILITY OF BEING DIAGNOSED 
WITH PTSD 
A. OVERVIEW 
This chapter will discuss the results of the various probit models used to 
estimate the effects of deployment intensity on the probability of being diagnosed 
with PTSD. Separate analyses were conducted for the four services of the U.S 
military. In addition, separate analyses were performed for officers and enlisted 
personnel. These results were compared to examine how the effects of 
deployment intensity differ across these eight different study populations.  
A total of four probit models were used for each of the study populations. 
Besides a set of service and demographics characteristics such as rank, gender, 
race, marital status and age that was kept constant across the four models, a 
different set of key variables of interest was used in each of the models to 
estimate the various effects of deployment intensity. A review of the four probit 
models is provided below. 
1. Model 1: Effect of Last Deployment Location 
The first model estimates the effect of the last deployment location on the 
probability of being diagnosed with PTSD. The last deployment refers to the most 
recently completed deployment prior to the PTSD diagnosis date for the PTSD 
population and the date of DEERS observation for the non-PTSD population 
respectively. This model also examines the difference in the effect (if any) of a 





2. Model 2: Interactive Effect of Last Deployment Location and 
 Duration 
 
The second model estimates the effect of the last deployment location and 
its duration on the probability of being diagnosed with PTSD. The model also 
uses interactive terms of the last deployment location and duration to determine 
whether the effect of deployment duration was exacerbated or mitigated by the 
deployment location.  
3. Model 3: Effect of Deployment Location History 
 
The third model considers all the deployments (between FY2001 to 
FY2006) that have occurred prior to the PTSD diagnosis date or date of 
DEERS observation in the individual’s deployment history, and estimates 
the effect of being ever deployed to the respective locations on the 
probability of being diagnosed with PTSD. Deployments that occurred 
after the PTSD diagnosis date or date of observations were excluded from 
the analysis. The model also incorporates the effect of the nature of the 
deployment (ashore or afloat) for the sailors.  
4. Model 4: Effect of Single and Multiple Deployments to the 
 Same Location 
 
The fourth model looks at the effect of single and multiple deployments to 
various deployment locations on the probability of being diagnosed with PTSD. 
All deployments that occurred between FY2001 to FY2006 and prior to the PTSD 
diagnosis date or date of observation were included in the analysis. In addition, 
the model also examines the effect of single and multiple shore deployments for 
the sailors.  
The rest of this chapter will be organized as follows: Section B will provide 
a descriptive analysis of the sample for the multivariate analysis. Sections C, D, 
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E and F will present and discuss the results of the multivariate analyses from the 
four probit models, respectively. Section G will provide a summary of the chapter. 
B. DESCRIPTIVE STATISTICS OF SAMPLE FOR MULTIVARIATE 
ANALYSIS 
The original DEERS dataset is comprised of 3,353,689 and 36,698 unique 
EDIPN observations for the non-PTSD and PTSD populations, respectively (after 
excluding DEERS observations with missing values). These DEERS 
observations contain the demographic information (gender, race, military 
rank/paygrade and marital status, etc.) of active duty personnel from all four 
services of the U.S. military. However, due to the sensitivity of the detailed 
deployment information on the military personnel, only the corresponding CTS 
deployment data for the PTSD population and a 20% random sample of the non-
PTSD population was made available for our multivariate analyses. The sample 
for the multivariate analyses thus consisted of 740,772 and 35,355 unique 
EDIPN observations for the non-PTSD and PTSD samples, respectively (after 
excluding CTS observations with missing values).  
It was essential to validate the sampling design and processes used in the 
random sampling of the non-PTSD observations. Verifying that the random non-
PTSD sample for the multivariate analyses was representative of the non-PTSD 
population in the original DEERS dataset allowed the results of the multivariate 
analyses derived from the sample to be generalized for the entire DEERS 
population. The descriptive statistics of the regression sample’s demographic 
characteristics can be compared against those of the original DEERS dataset 
(depicted in Tables 5.1 and 5.2) to establish whether the regression sample was 
representative of the DEERS population.  
1. Officers and Warrant Officer Population 
Table 6.1 shows the descriptive statistics for the demographic 
characteristics from the DEERS data and the deployment characteristics 
(deployment location and duration, MOS, etc.) from the CTS data for the officer 
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population in the regression sample. The distribution of the demographic 
characteristics for the random non-PTSD officer sample in Table 6.1 was 
compared against those for the non-PTSD officer population in Table 5.1. The 
distributions of the demographic characteristics (gender, marital status, race and 
age) for the regression sample and the original DEERS dataset were found to be 
similar. The differences in the distributions of the three demographic 
characteristics (gender, marital status and race) were 5% or less, across the non-
PTSD and PTSD samples for all four services. For instance, 15.5% of the officers 
in the Army’s non-PTSD population (Table 5.1) are females, while 11.6% of the 
Army’s random non-PTSD sample are females. In addition, the differences in the 
average age for the original DEERS observations and the regression sample was 
one year or less. These factors indicate that the sampling design was valid and 
the regression sample was representative of the original DEERS dataset for the 
officers.        
Since the regression sample is representative of the original DEERS 
dataset, similar observations pertaining to demographic characteristics were 
made from Table 5.1 and Table 6.1. Table 6.1 suggests that a disproportionately 
larger percentage of females were diagnosed with PTSD across the four 
services, particularly in the Air Force and Navy. In the Air Force, females 
constituted only 14% of the non-PTSD sample, but they constituted 52% of the 
PTSD sample. Table 6.1 also suggests married officers (except for the Air Force) 
may be more likely to be diagnosed with PTSD compared to the singles, no 
particular race appeared to be significantly more or less vulnerable to PTSD.    
Similar to the original DEERS dataset, the average age of the PTSD 
sample was higher than the average age for the non-PTSD sample across all 
four services. This suggests that PTSD risks may be positively correlated with 
age since an older officer is likely to have experienced more deployments, and 
hence potentially greater exposure to the violent conditions in the war zones, 
compared to a younger officer.   
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Besides the demographic characteristics, Table 6.1 also tabulates the 
deployment characteristics for the officer sample. This includes the distribution of 
the last deployment location, its type (ashore or shipboard) and duration, 
deployment location history, frequency of deployment, and MOS. Several 
observations were made from the descriptive statistics of these deployment 
characteristics in Table 6.1. 
In this thesis, the last deployment of the service members referred to the 
most recent completed deployment prior to the PTSD diagnosis date for the 
PTSD population and date of DEERS observation for the non-PTSD population 
respectively. Table 6.1 shows that approximately 25% of the officers in the PTSD 
sample for the Army and Marine Corps were last deployed to Afghanistan or Iraq,  
while a lower percentage of 14% and 7% were observed deployed to Afghanistan 
or Iraq for the Air Force and Navy respectively. Table 6.1 also shows that the 
PTSD sample for all services had a disproportionately high percentage of officers 
whose last deployment location was Iraq, compared to the respective non-PTSD 
sample. For instance, 23% of the PTSD sample in the Army had their last 
deployment to Iraq, but only 8% of the non-PTSD sample was last deployed to 
Iraq. This suggests that officers, whose last deployment location was Iraq, have a 
disproportionately higher probability of being diagnosed with PTSD.  
The increase in PTSD risk due to deployments in Iraq was also inferred 
from the descriptive statistics on the past deployment location history. Table 6.1 
shows that there is a disproportionately high percentage of service members who 
were ever deployed to Iraq in the PTSD sample for all services, compared to the 
non-PTSD sample. For instance, only 8% of the non-PTSD sample in the Marine 
Corps was ever deployed to Iraq prior to their PTSD diagnosis date or date of 
DEERS observations, while 26% of the PTSD sample was ever deployed to Iraq.     
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Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 47,715 1,273 22,228 390 8,799 134 15,246 294 93,988 2,091
% of observations for respective service 97.4% 2.6% 98.3% 1.7% 98.5% 1.5% 98.1% 1.9% 97.8% 2.2%
Location of Last Deployment Prior to PTSD
Diagnosis or DEERS Extraction Date
Afghanistan 3.1% 4.2% 1.2% 1.0% 0.9% 1.5% 0.5% 0.3% 2.0% 2.9%
Iraq 7.9% 22.6% 3.4% 12.8% 8.2% 23.9% 1.0% 6.5% 5.8% 18.6%
Other Middle East countries 10.7% 24.4% 17.8% 9.5% 12.8% 20.9% 8.3% 10.2% 12.2% 19.4%
Other countries 4.3% 4.4% 15.1% 6.4% 7.7% 9.7% 23.8% 7.8% 10.3% 5.6%
No overseas deployment 74.0% 44.4% 62.5% 70.3% 70.4% 44.0% 66.3% 75.2% 69.7% 53.5%
Last Deployment Prior to PTSD Diagnosis or
DEERS Extraction Date was:
Onboard ship - - - - - - 6.7% 11.9% - -
On shore - - - - - - 27.0% 12.9% - -
No overseas deployment - - - - - - 66.3% 75.2% - -
Duration of Last Deployment Prior to PTSD
Diagnosis or DEERS Extraction Date
Short 13.2% 20.5% 18.2% 6.9% 16.9% 31.3% 14.0% 7.1% 14.9% 16.8%
Medium 4.9% 11.4% 13.8% 15.6% 9.6% 19.4% 7.0% 6.5% 7.8% 12.0%
Long 7.9% 23.7% 5.4% 7.2% 3.1% 5.2% 12.6% 11.2% 7.6% 17.7%
Have ever been Deployed to the Following
Country / Region Prior to PTSD Diagnosis or
DEERS Extraction Date
Afghanistan 3.9% 5.7% 1.6% 1.3% 1.1% 2.2% 0.6% 0.7% 2.5% 4.0%
Iraq 8.5% 25.8% 3.7% 12.8% 8.4% 26.1% 1.1% 6.5% 6.2% 20.7%
Other Middle East Countries 14.4% 38.4% 20.7% 12.3% 16.0% 32.1% 9.0% 10.9% 15.2% 29.3%
Other Countries 5.2% 7.5% 18.1% 9.0% 10.0% 17.9% 24.8% 9.2% 11.9% 8.7%
No overseas deployment 74.0% 44.4% 62.5% 70.3% 70.4% 44.0% 66.3% 75.2% 69.7% 53.5%
Number of Deployment Prior to PTSD Diagnosis or
DEERS Extraction Date
Once only 18.3% 32.1% 24.1% 21.3% 21.6% 29.1% 25.7% 20.7% 21.2% 28.3%
More than once 7.7% 23.6% 13.4% 8.5% 8.0% 26.9% 8.0% 4.1% 9.1% 18.2%
No overseas deployment 74.0% 44.4% 62.5% 70.3% 70.4% 44.0% 66.3% 75.2% 69.7% 53.5%
Army
Officers and Warrant Officers
Air Force Marine Corps Navy Total
96,07948,988 22,618 8,933 15,540
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Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 47,715 1,273 22,228 390 8,799 134 15,246 294 93,988 2,091
% of observations for respective service 97.4% 2.6% 98.3% 1.7% 98.5% 1.5% 98.1% 1.9% 97.8% 2.2%
MOS*
Combat Arms 29.2% 16.5% 0.4% 0.0% 28.0% 16.4% 0.9% 0.0% 17.7% 11.1%
Combat Support 15.8% 10.9% 0.2% 0.0% 8.3% 6.7% 11.0% 2.7% 10.6% 7.5%
Combat Service Support 19.9% 14.3% 1.2% 0.5% 29.1% 24.6% 85.6% 36.7% 27.0% 15.5%
Aviation - - - - 30.6% 18.7% - - 2.9% 1.2%
Medical 11.1% 11.7% - - - - - - 5.6% 7.1%
Other MOS 24.0% 46.6% 98.2% 99.5% 4.0% 33.6% 2.5% 60.5% 36.2% 57.6%
Sex
Female 11.6% 26.9% 13.8% 51.5% 5.3% 14.2% 11.3% 41.8% 11.5% 32.8%
Male 88.4% 73.1% 86.2% 48.5% 94.7% 85.8% 88.7% 58.2% 88.5% 67.2%
Marital Status
Single 32.2% 28.2% 31.4% 36.2% 34.6% 27.6% 39.7% 36.1% 33.5% 30.8%
Married 67.8% 71.8% 68.6% 63.8% 65.4% 72.4% 60.3% 63.9% 66.5% 69.2%
Race
White 77.4% 72.5% 85.2% 77.9% 82.8% 88.1% 81.8% 79.9% 80.5% 75.6%
Black 11.5% 14.5% 5.3% 9.0% 6.1% 4.5% 7.8% 5.8% 8.9% 11.6%
Hispanic 2.7% 4.0% 1.7% 3.6% 2.8% 3.0% 4.2% 5.8% 2.7% 4.1%
Asian 3.7% 2.5% 2.0% 1.8% 2.0% 0.7% 3.8% 4.8% 3.2% 2.6%
Other races 4.7% 6.5% 5.8% 7.7% 6.3% 3.7% 2.4% 3.7% 4.7% 6.2%
Age at Last Deployment Prior to PTSD 
Diagnosis or DEERS Extraction Date
Mean age (years) 35.0 38.9 34.4 37.5 33.3 36.7 34.2 37.9 34.5 38.4
* Air Force: Medical is combined with Other MOS due to small sample size in Medical MOS
*Navy: Medical and Aviation are combined with Other MOS due to small sample size in Medical and Aviation
96,07948,988 22,618 8,933 15,540
Officers and Warrant Officers
Army Air Force Marine Corps Navy Total
 
Table 6.1. Descriptive Statistics of Sample for Multivariate Analyses (Officers and Warrant Officers)
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On the other hand, officers whose last deployment was shore-based 
constituted 27% of the non-PTSD sample, while only 13% of the PTSD sample 
had a last shore-based deployment. We had hypothesized that sailors on shore 
deployment were expected to be more likely to be diagnosed with PTSD, 
compared to sailors deployed on ships, as the former were likely to face higher 
threats. The effect of the last deployment location type on the probability of being 
diagnosed with PTSD is further examined in the first probit model.   
Table 6.1 also suggests that as the duration of the last deployment 
increased, the probability of being diagnosed with PTSD increased too. All 
deployments were categorized as a short, medium or long deployment based on 
their duration. As the distribution of the deployment duration differs between 
service branches, the interval definition for short, medium or long deployment 
was determined by the distribution of the deployment duration in the empirical 
data, and thus varied between the service branches. The interval definition for 
the services was tabulated in Table 4.1. The PTSD sample for all services, 
except for the Navy, had a higher percentage of officers whose last deployment 
was categorized as medium or long, compared to the non-PTSD sample. For 
example, for the Army, 35% of its PTSD sample had a last deployment that was 
categorized as medium or long, while only 12% in its non-PTSD sample had a 
medium or long deployment. 
The descriptive statistics of the MOS categories suggests that service 
members in the combat support and combat service support arms had a lower 
probability of being diagnosed with PTSD compared to the other MOS 
categories. Officers in the combat support and combat service support arms 
constituted a larger percentage of the non-PTSD sample across the services, 
compared to the PTSD sample.      
The marginal effects of these deployment characteristics are further 
analyzed in the multivariate analyses in the subsequent sections of this chapter. 
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2. Enlisted Population 
Table 6.2 shows the descriptive statistics of the enlisted population for the 
regression sample. A comparison of Table 6.2 against Table 5.2 suggests that 
the regression sample for the enlisted personnel was also representative of the 
enlisted population in the original DEERS dataset. The differences in the 
distributions of the three demographic characteristics (gender, marital status and 
race) were 5.9% or less across the non-PTSD and PTSD samples, and the 
differences in the average age for the original DEERS observations and the 
regression sample were 0.2 years or less, for across all four services.   
Similar observations were drawn from the descriptive statistics of the 
officer sample and enlisted personnel sample. Similar to the officer sample, a 
larger percentage of the PTSD enlisted personnel sample in the Army and 
Marine Corps was last deployed to Afghanistan and/or Iraq, compared to the Air 
Force and Navy. There was a higher percentage of enlisted personnel whose last 
deployment location was Iraq in the PTSD sample, compared to the non-PTSD 
sample for all services too. Service members from all services who were ever 
deployed to Iraq also constituted a larger percentage in the PTSD sample, 
compared to the non-PTSD sample. These indicate that the deployments to Iraq 
increased the probability of being diagnosed with PTSD for both the officers and 
enlisted personnel across all services. 
Enlisted personnel who were last deployed ashore also appeared to have 
a lower probability of being diagnosed with PTSD, compared to the enlisted 
personnel who were last deployed onboard ships. Similar to the officer sample, 
this contradicts our hypothesis.  
The duration of the last deployment also appeared to be positively 
correlated with the probability of being diagnosed for the enlisted personnel in the 
Army and Marine Corps. There was a larger percentage of enlisted personnel 
with a last deployment that was categorized as medium or long in their PTSD 
sample, compared to the non-PTSD sample. 
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Finally, Table 6.2 also suggests that enlisted personnel in the combat 
support and combat service support arms may have a lower probability of being 
diagnosed with PTSD compared to the other MOS categories. Similar to the 
officers, enlisted personnel in the combat support and combat service support 
arms constituted a larger percentage of the non-PTSD sample across the 
services, compared to the PTSD sample.      
 101
Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 313,489 20,277 109,278 3,728 94,491 4,441 129,526 5,178 646,784 33,624
% of observations for respective service 93.9% 6.1% 96.7% 3.3% 95.5% 4.5% 96.2% 3.8% 95.1% 4.9%
Location of Last Deployment Prior to PTSD
Diagnosis or DEERS Extraction Date
Afghanistan 2.2% 3.3% 1.0% 0.9% 0.9% 1.5% 0.2% 0.7% 1.4% 2.4%
Iraq 8.7% 31.0% 4.4% 11.0% 7.5% 25.6% 0.8% 7.0% 6.2% 24.4%
Other Middle East countries 8.0% 24.0% 18.9% 10.6% 10.1% 23.8% 6.0% 10.1% 9.7% 20.3%
Other countries 2.4% 3.9% 14.3% 6.4% 5.7% 9.1% 28.7% 9.4% 10.2% 5.7%
No overseas deployment 78.7% 37.7% 61.5% 71.1% 75.8% 40.1% 64.3% 72.8% 72.5% 47.1%
Last Deployment Prior to PTSD Diagnosis or
DEERS Extraction Date was:
Onboard ship - - - - - - 9.2% 18.8% - -
On shore - - - - - - 26.5% 8.4% - -
No overseas deployment - - - - - - 64.3% 72.8% - -
Duration of Last Deployment Prior to PTSD
Diagnosis or DEERS Extraction Date
Short 9.0% 19.9% 13.4% 5.6% 12.5% 25.8% 11.2% 6.5% 10.7% 17.0%
Medium 4.2% 11.0% 18.3% 14.5% 10.1% 30.7% 8.3% 6.3% 8.3% 13.3%
Long 8.0% 31.4% 6.8% 8.8% 1.5% 3.4% 16.2% 14.4% 8.5% 22.6%
Have ever been Deployed to the Following
Country / Region Prior to PTSD Diagnosis or
DEERS Extraction Date
Afghanistan 2.7% 5.1% 1.2% 1.0% 1.0% 1.9% 0.2% 0.9% 1.7% 3.6%
Iraq 9.4% 35.4% 4.7% 11.5% 7.7% 27.4% 0.8% 7.0% 6.6% 27.3%
Other Middle East Countries 12.1% 43.1% 21.8% 14.6% 12.2% 33.9% 6.6% 12.1% 12.6% 33.9%
Other Countries 3.0% 5.6% 16.5% 9.0% 7.4% 15.2% 29.2% 10.7% 11.2% 8.1%
No overseas deployment 78.7% 37.7% 61.5% 71.1% 75.8% 40.1% 64.3% 72.8% 72.5% 47.1%
Number of Deployment Prior to PTSD Diagnosis or
DEERS Extraction Date
Once only 14.6% 34.9% 27.6% 19.3% 18.9% 35.2% 28.1% 20.5% 20.1% 31.0%
More than once 6.7% 27.4% 10.9% 9.6% 5.3% 24.7% 7.6% 6.6% 7.4% 21.8%
No overseas deployment 78.7% 37.7% 61.5% 71.1% 75.8% 40.1% 64.3% 72.8% 72.5% 47.1%
680,408333,766 113,006 98,932 134,704
Army
Enlisted
Air Force Marine Corps Navy Total
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Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD Non-PTSD PTSD
Sample Size
Number of observations 313,489 20,277 109,278 3,728 94,491 4,441 129,526 5,178 646,784 33,624
% of observations for respective service 93.9% 6.1% 96.7% 3.3% 95.5% 4.5% 96.2% 3.8% 95.1% 4.9%
MOS*
Combat Arms 29.3% 25.1% 10.7% 3.8% 38.6% 33.8% 4.8% 1.2% 22.6% 20.2%
Combat Support 11.0% 6.0% 0.2% 0.0% 16.8% 10.4% 9.6% 1.7% 9.7% 5.2%
Combat Service Support 26.8% 20.0% 79.2% 31.3% 28.0% 20.0% 5.7% 1.9% 31.6% 18.4%
Aviation - - - - 15.1% 6.0% 3.4% 0.7% 2.9% 0.9%
Medical 10.3% 6.4% - - - - - - 5.0% 3.9%
Other MOS 22.6% 42.5% 9.8% 64.9% 1.3% 29.9% 76.5% 94.5% 28.1% 51.3%
Sex
Female 11.3% 19.1% 15.7% 53.5% 3.6% 12.6% 12.5% 41.5% 11.2% 25.5%
Male 88.7% 80.9% 84.3% 46.5% 96.4% 87.4% 87.5% 58.5% 88.8% 74.5%
Marital Status
Single 53.9% 38.4% 48.2% 49.0% 69.6% 51.4% 55.1% 54.5% 55.5% 43.8%
Married 46.1% 61.6% 51.8% 51.0% 30.4% 48.6% 44.9% 45.5% 44.5% 56.2%
Race
White 63.6% 65.4% 74.0% 73.1% 71.2% 71.6% 57.0% 62.6% 65.2% 66.7%
Black 19.7% 19.1% 15.3% 15.7% 10.3% 9.9% 21.7% 16.7% 18.0% 17.1%
Hispanic 6.9% 5.9% 3.4% 3.8% 8.2% 8.4% 7.2% 7.4% 6.6% 6.2%
Asian 3.9% 2.5% 2.2% 1.4% 2.8% 2.2% 6.0% 3.8% 3.9% 2.5%
Other races 5.9% 7.1% 5.0% 6.0% 7.6% 7.9% 8.0% 9.4% 6.4% 7.4%
Age at Last Deployment Prior to PTSD 
Diagnosis or DEERS Extraction Date
Mean age (years) 27.4 29.6 28.5 27.7 23.3 24.6 27.0 26.9 26.9 28.4
* Air Force and Navy: Medical is combined with Other MOS due to small sample size in Medical MOS
680,408333,766 113,006 98,932 134,704
Enlisted
Army Air Force Marine Corps Navy Total
 




C. RESULTS OF MULTIVARIATE ANALYSIS MODEL 1 – EFFECT OF 
LAST DEPLOYMENT LOCATION 
The first multivariate probit model estimated the effect of the last 
deployment location on the probability of being diagnosed with PTSD. This 
model also examined the difference in the effect (if any) of a shore or 
shipboard deployment for a sailor. The dependent variable was a binary 
variable which captured whether a service member was diagnosed with 
PTSD. The key variables of interest for the first model were the last 
deployment location and its location type. In addition, this model, as well as 
the remaining three models, also included a set of control variables for the 
service and demographic characteristics of the sample.   
Due to data restriction, only a random 20% sample of the non-PTSD 
observations in the original DEERS dataset was available for the multivariate 
analyses. In order to account for the sampling, weights were assigned to the 
observations in the sample for the multivariate analyses. The assigned 
weights varied across the four service branches and reflected the different 
sampling ratios44 among the four services, as well as between the officer and 
enlisted personnel populations. These weights were kept constant across the 
four probit models.   
1. Officers and Warrant Officers 
Table 6.3 shows the result of the first probit model for the officers and 
warrant officers across the services. It shows that the effect of the last 
deployment on the probability of being diagnosed with PTSD was dependent 
on the location of the deployment, and differed across the services. The effect 





                                            
44 The sampling ratio was defined as the ratio of the number of unique EDIPNs in the 
sample for the multivariate analyses, to the number of unique EDIPNs in the original DEERS 
dataset for the respective study population.  
 104
Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 





    
Afghanistan 0.004*** -0.001 0.006 - 
 (0.001) (0.001) (0.005)  
Iraq 0.013*** 0.003*** 0.008*** - 
 (0.001) (0.001) (0.002)  
Other Middle East 
Countries 
0.009*** -0.001*** 0.004*** - 
 (0.001) (0.000) (0.001)  
Other Countries 0.001* -0.001*** 0.003* - 
 (0.001) -0.001 (0.002)  
Shore Deployment in 
Afghanistan 
- - - -0.000* 
    (0.000) 
Shore Deployment in 
Iraq 
- - - 0.003 
    (0.002) 
Shipboard Deployment 
in Afghanistan or 
Iraq 
- - - 0.001 
    (0.001) 
Shore Deployment in 
Other Middle East 
Countries  
- - - -0.000* 
    (0.000) 
Shipboard Deployment 
in Other Middle East 
Countries 
- - - 0.002* 
    (0.001) 
Shore Deployment in 
Other Countries 
- - - -0.001*** 
    (0.000) 
Shipboard Deployment 
in Other Countries 
- - - 0.000 
    (0.000) 
Military Occupation 
Codes 
    
Combat Support 0.000 - -0.000 0.401** 
 (0.000)  (0.001) (0.164) 
Combat Service 
Support 
-0.000 - 0.000 0.002*** 
 (0.000)  (0.001) (0.001) 
Aviation - - -0.000 - 
   (0.001)  
Medical 0.000 - - - 
 (0.000)    
Other MOS 0.007*** - 0.089*** 0.980*** 
 (0.001)  (0.024) (0.017) 
Paygrade     
O1 to O2 0.003*** - -0.001* 0.002 
 (0.001)  (0.001) (0.001) 
O3 0.003*** 0.000 -0.001* 0.006* 
 (0.001) (0.000) (0.000) (0.003) 
O4 0.001 -0.001* -0.002*** 0.005 
 (0.000) (0.000) (0.000) (0.003) 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
O5 0.000 -0.000 -0.002*** 0.003 
 (0.001) (0.000) (0.000) (0.003) 
O6 to O10 -0.001 -0.001 -0.002*** 0.003 
 (0.001) (0.000) (0.000) (0.003) 
Demographics     
Black 0.001* 0.000 -0.001*** -0.000 
 (0.000) (0.000) (0.000) (0.000) 
Hispanic 0.003** 0.002* -0.001 0.000 
 (0.001) (0.001) (0.001) (0.000) 
Asian -0.001* -0.000 -0.001 -0.000 
 (0.001) (0.001) (0.001) (0.000) 
Other Races 0.002*** 0.001 -0.001 0.000 
 (0.001) (0.001) (0.001) (0.000) 
Female 0.009*** 0.008*** 0.004** 0.001*** 
 (0.001) (0.001) (0.002) (0.000) 
Single -0.000 0.000 -0.000 -0.000 
 (0.000) (0.000) (0.000) (0.000) 
Age 0.000*** 0.000*** 0.000*** 0.000*** 
 (0.000) (0.000) (0.000) (0.000) 
Fiscal Year of 
Observation 
    
FY2002 -0.001*** 0.000 0.001 0.000 
 (0.001) (0.000) (0.001) (0.000) 
FY2003 -0.002*** 0.001 -0.000 -0.000 
 (0.000) (0.001) (0.001) (0.000) 
FY2004 -0.000 0.001 0.000 0.001** 
 (0.001) (0.001) (0.001) (0.000) 
FY2005 0.001* 0.001* 0.001 0.000 
 (0.001) (0.001) (0.001) (0.000) 
FY2006 0.001 0.002** 0.002 0.000 
 (0.001) (0.001) (0.002) (0.000) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.3. Marginal Effect of Last Deployment Location and 
Type on Probability of Being Diagnosed with PTSD (Officers and 
Warrant Officers) 
a. Army 
The coefficient estimates for Afghanistan, Iraq and other Middle 
East countries were statistically significant at the 0.01 level. The average 
Army officer’s probability of being diagnosed with PTSD increased by 0.004 or 
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0.013 if he was last deployed to Afghanistan or Iraq respectively, compared to 
those not deployed overseas.  The probability of being diagnosed with PTSD 
also increased by 0.009 if he was last deployed to other Middle East 
countries, ceteris paribus.   
b. Air Force   
The coefficient estimates for Iraq, other Middle East countries 
and other countries were statistically significant at the 0.01 level. The average 
Air Force officer’s probability of being diagnosed with PTSD increased by 
0.003 if he was last deployed to Iraq. However, the magnitude of the 
coefficient estimate for Iraq was smaller than those observed for the Army or 
Marine Corps. This finding is consistent with our hypothesis that the exposure 
to threats and violent conditions in war-zones increases significantly for 
officers in the Army or Marine Corps who were deployed overseas on ground 
missions, compared to officers who were not deployed overseas. For the Air 
Force, the differential in exposure to threats and violent conditions between 
officers who were deployed overseas and those who were not deployed 
overseas was expected to be smaller due to their deployment and mission 
profiles in modern aerial warfare. Hence, the differential in the probability of 
being diagnosed with PTSD due to overseas deployments was expected to be 
smaller for the Air Force officers, compared to those in the Army or Marine 
Corps.  
c. Marine Corps 
For officers in the Marine Corps, the coefficient estimates for 
Iraq and other Middle East countries were statistically significant at the 0.01 
level. For an average officer in the Marine Corps, his probability of being 
diagnosed with PTSD increased by 0.008 if he was last deployed to Iraq. The 
coefficient estimate for Afghanistan was however not statistically significant at 
the 0.05 level.   
 107
d. Navy 
The coefficient estimate for shore deployment in other countries 
was the only statistically significant estimate at the 0.05 level, and its 
magnitude was small at -0.1 percentage point. This indicates that there was 
no significant difference in the probability of being diagnosed with PTSD for a 
Navy officer who was last deployed overseas, compared to those with no 
overseas deployment. Similar to the Air Force, this could be due to the small 
differential increase in exposure to the violent conditions or threats in war-
zones between a Navy officer who was last deployed overseas, compared to 
an officer who was not deployed, due to the mission profile in modern naval 
warfare. In addition, there was no significant difference between the effect of a 
shore or shipboard deployment on the probability of being diagnosed with 
PTSD for the officers.  
Table 6.3 shows that officers from the Army, Air Force and Marine 
Corps had the largest increase in their probability of being diagnosed with 
PTSD if they were last deployed to Iraq. This is consistent with the analysis of 
the descriptive statistics in Table 6.1. The descriptive statistics have 
suggested that officers, whose last deployment location was Iraq, had a 
disproportional higher risk of being diagnosed with PTSD.  
Among the last deployment location coefficient estimates that were 
statistically significant, the Army’s coefficient estimate for deployment to Iraq 
had the largest magnitude of 1.3 percentage point. The small magnitudes of 
these coefficient estimates understate the effect of the last deployment 
location on the probability of being diagnosed with PTSD. We conducted an 
alternate analysis for Army officers using a logit multivariate model with the 
same model specification as the probit model, i.e. the logit model contained 
the same independent and dependent variables, and sampling weights as the 
probit model. 
Similar to the probit model, the logit model is a nonlinear binary 
response model and the value of the dependent variable is restricted to 
between zero and one. The probit model was preferred for this thesis, as it is 
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generally easier to interpret the results of a probit model, compared to that of 
a logit model. However, due to the small magnitudes of the coefficient 
estimates in the probit model and the low baseline probability of being 
diagnosed with PTSD in the sample, a logit model helps to illustrate the effect 
of the last deployment location on the probability of being diagnosed with 
PTSD.       
The result of the logit model shows that if an Army officer was last 
deployed to Iraq, his odds of being diagnosed with PTSD increased by 4.2 
times, compared to those not deployed overseas, ceteris paribus. Likewise, 
the odds of being diagnosed with PTSD increased by 2 times if an Army 
officer was last deployed to Afghanistan. Therefore we can conclude that 
despite the small magnitudes of the coefficient estimates in the probit models, 
they represented a significant increase in the probability of being diagnosed 
with PTSD for officers who were deployed overseas. 
Besides the coefficient estimates for the last deployment location, 
several other coefficient estimates for the service and demographic 
characteristics in the probit model were also statistically significant.  Table 6.3 
shows that all the coefficient estimates for the military occupation codes were 
statistically significant and positive at the 0.05 level for the Navy. The effect of 
“Other MOS” was particularly striking. For an average Navy officer, his 
probability of being diagnosed increased by 0.98 if he belonged to the “Other 
MOS” category, compared to an average navy officer in the Combat Arms 
(reference group). The descriptive statistics in Table 6.1 show that 61% of the 
Navy PTSD sample belonged to the “Other MOS” category, while only 2.5% 
of the Navy non-PTSD sample belonged to the “Other MOS” category. The 
disproportionately higher percentage of officers categorized as “Other MOS” 
in the Navy PTSD sample, compared to its non-PTSD sample, could explain 
the large magnitude and high statistical significance of the “Other MOS” 
coefficient estimate for the Navy.  
The descriptive statistics in Table 6.1 also showed that the “Other 
MOS” category constituted the largest percentage in the PTSD sample across 
the four services. This could explain why the coefficient estimates for the 
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“Other MOS” were statistically significant at the 0.01 level for all services 
(except for the Air Force). The military occupation codes were not included in 
the model for Air Force officers, because more than 98% of the observations 
were classified as “Other MOS” based on the information provided in the CTS 
data. Some of the categories for the military occupation codes were also 
merged for some services, e.g., “Medical,” were merged with “Other MOS” for 
the Air Force and Navy due to the small sample size in the individual 
categories. As the effect of MOS on the probability of being diagnosed with 
PTSD was not within the intended scope of this thesis, no further analysis was 
conducted to examine its effect. However, this is an area recommended for 
further research.   
The coefficient estimates for the paygrades showed that the probability 
of being diagnosed with PTSD is 0.3 percentage point higher for Army officers 
with paygrade O1 to O3, compared to the warrant officers (reference group). 
The coefficient estimates for the Marine Corps also indicated that the 
probability of being diagnosed with PTSD was 0.002 lower for officers with 
paygrade O4 and above, compared to the warrant officers. These estimates 
were statistically significant at the 0.01 level, and suggested that junior 
officers were more likely to be diagnosed with PTSD compared to senior 
officers.   
Most of the coefficient estimates for the various races were statistically 
insignificant. These indicated that no particular race was more vulnerable to 
PTSD risk among the officers in the four services.  
The coefficient estimate for females was statistically significant at the 
0.05 level across all four services. This indicated that female officers had a 
higher probability of being diagnosed with PTSD, compared to the male 
officers. The same observation was derived from the analysis of the 
descriptive statistics in Table 6.1. The coefficient estimate showed that the 
probability of a female officer being diagnosed with PTSD was 0.1 to 0.9 
percentage points higher than for a male officer.  
The coefficient estimate for marital status was not statistically 
significant at the 0.05 level across all four services. This indicated that there 
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was no significant difference in the probability of being diagnosed with PTSD 
between a married or a single officer.   
The coefficient estimate for age was statistically significant at the 0.01 
level across all four services, and indicated that the probability of being 
diagnosed with PTSD increased with age. The analysis from the descriptive 
statistics had also suggested that PTSD risk increased with age for the 
officers. However, the magnitudes of the coefficient estimates were very small 
at less than 0.03 percentage point. 
Age is generally, but not necessarily, positively correlated with rank 
seniority and paygrades, i.e., an older service member is usually more senior 
in rank and paygrade, compared to a younger service member. The 
coefficient estimates for the paygrade and age had shown two contradicting 
effects on the probability of being diagnosed with PTSD. The estimates 
indicated that PTSD risk increased with age, but decreased with paygrade 
seniority. Based on the magnitudes of the estimates, we had expected the 
effect of the paygrade to be more significant than that of age.     
2. Enlisted Personnel 
Table 6.4 shows the result of the first probit model for the enlisted 
personnel across the services.  Similar to the officers, most of the coefficient 
estimates for the last deployment location were statistically significant at the 
0.01 level. In addition, the magnitudes of the coefficient estimates were larger 
than those of the officers. These indicated that the last deployment location 
had a larger effect on the enlisted personnel than on the officers. The effect of 
the last deployment location for the enlisted in each service is described 
below. 
Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 





    
Afghanistan 0.016*** 0.000 0.013*** - 
 (0.001) (0.001) (0.002)  
Iraq 0.039*** 0.006*** 0.027*** - 
 (0.001) (0.001) (0.001)  
Other Middle East 0.032*** -0.001*** 0.020*** - 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Countries 
 (0.001) (0.000) (0.001)  
Other Countries 0.015*** -0.001*** 0.013*** - 
 (0.001) (0.000) (0.001)  
Shore Deployment in 
Afghanistan 
- - - 0.003 
    (0.002) 
Shore Deployment in 
Iraq 
- - - 0.044*** 
    (0.005) 
Shipboard Deployment 
in Afghanistan or 
Iraq 
- - - 0.029*** 
    (0.003) 
Shore Deployment in 
Other Middle East 
Countries  
- - - -0.001*** 
    (0.000) 
Shipboard Deployment 
in Other Middle East 
Countries 
- - - 0.023*** 
    (0.002) 
Shore Deployment in 
Other Countries 
- - - -0.006*** 
    (0.000) 
Shipboard Deployment 
in Other Countries 
- - - 0.001*** 
    (0.000) 
Military Occupation 
Codes 
    
Combat Support -0.004*** - -0.001*** -0.001 
 (0.000)  (0.000) (0.000) 
Combat Service 
Support 
-0.003*** 0.001*** -0.001*** 0.001 
 (0.000) (0.000) (0.000) (0.001) 
Aviation - - -0.003*** -0.000 
   (0.000) (0.001) 
Medical -0.003*** - - - 
 (0.000)    
Other MOS 0.008*** 0.029*** 0.179*** 0.003*** 
 (0.000) (0.002) (0.009) (0.000) 
Paygrade     
E4 0.001*** -0.000 -0.001*** 0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
E5 -0.001*** -0.001*** -0.001*** 0.000 
 (0.000) (0.000) (0.000) (0.000) 
E6 -0.003*** -0.002*** -0.002*** -0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
E7 to E9 -0.004*** -0.002*** -0.004*** -0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
Demographics     
Black -0.002*** -0.000*** -0.001*** -0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
Hispanic -0.002*** 0.000 -0.001*** -0.000*** 
 (0.000) (0.000) (0.000) (0.000) 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Asian -0.004*** -0.001*** -0.001*** -0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
Other Races 0.000 0.000 -0.000 -0.000 
 (0.000) (0.000) (0.000) (0.000) 
Female 0.011*** 0.007*** 0.010*** 0.012*** 
 (0.000) (0.000) (0.001) (0.001) 
Single -0.004*** -0.001*** -0.003*** -0.001*** 
 (0.000) (0.000) (0.000) (0.000) 
Age 0.000*** 0.000*** 0.000*** 0.000*** 
 (0.000) (0.000) (0.000) (0.000) 
Fiscal Year of 
Observation 
    
FY2002 -0.001*** 0.000 0.001* -0.000 
 (0.000) (0.000) (0.001) (0.000) 
FY2003 -0.001*** 0.001*** 0.001* 0.001*** 
 (0.000) (0.000) (0.001) (0.000) 
FY2004 0.001** 0.001*** 0.003*** 0.002*** 
 (0.000) (0.000) (0.001) (0.000) 
FY2005 0.005*** 0.002*** 0.009*** 0.001*** 
 (0.001) (0.000) (0.001) (0.000) 
FY2006 0.004*** 0.001*** 0.005*** -0.001*** 
 (0.000) (0.000) (0.001) (0.000) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.4. Marginal Effect of Last Deployment Location and Type on 
Probability of Being Diagnosed with PTSD (Enlisted Personnel) 
 
a. Army 
All the coefficient estimates for the last deployment location 
were statistically significant and positive at the 0.01 level. The average Army 
enlisted personnel’s probability of being diagnosed with PTSD increased by 
0.016 or 0.039 if he was last deployed to Afghanistan or Iraq respectively, 
ceteris paribus. Similar to the officers, the enlisted personnel experienced the 
largest percentage point increase in their probability of being diagnosed with 
PTSD if they were last deployed to Iraq.  
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b. Air Force 
The coefficient estimates for Iraq, other Middle East countries 
and other countries were statistically significant at the 0.01 level. The 
probability of being diagnosed with PTSD for an average Air Force enlisted 
personnel increased by 0.006 if he was last deployed to Iraq, compared to 
those who were not deployed overseas Similar to the officers, the magnitude 
of the coefficient estimate for enlisted personnel in the Air Force was much 
smaller than those for the Army or Marine Corps. These indicated that the 
increase in PTSD risk for both officers and enlisted personnel in the Air Force 
due to overseas deployment was smaller, compared to their peers in the Army 
or Marine Corps.  
c. Marine Corps 
Similar to the Army, all the coefficient estimates for the last 
deployment location were statistically significant and positive at the 0.01 level, 
and the probability of being diagnosed with PTSD for officers in the Marine 
Corps increased by the highest percentage point if they were last deployed to 
Iraq. However, the magnitudes of all the coefficient estimates for the Marine 
Corps were smaller than the corresponding estimates for the Army.   
d. Navy 
Unlike the coefficient estimates for the officers, most of the 
coefficients estimates for the Navy enlisted personnel were statistically 
significant at the 0.01 level. The coefficient estimates for the enlisted 
personnel had different signs, but the magnitudes of the positive coefficient 
estimates had much larger magnitudes than those of the negative coefficient 
estimates. The probability of being diagnosed with PTSD for an average 
enlisted sailor increased the greatest (by 0.044) if he was last deployed 
ashore in Iraq, while the probability increased only by 0.029 if he was last 
deployed afloat in Iraq or Afghanistan. These estimates supported our 
hypothesis that the probability of being diagnosed with PTSD was higher for 
sailors who were last deployed ashore, compared to sailors who were last 
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deployed onboard ship. As a matter of fact, the magnitude of the Navy 
coefficient estimate for shore deployment in Iraq was larger than the 
magnitude of the Army coefficient estimate for Iraq.  
Most of the coefficient estimates for the military occupation codes were 
statistically significant at the 0.01 level. The coefficient estimates indicated 
that for the Army and Marine Corps, enlisted personnel in the Combat Support 
and Combat Service Support Arms had a lower probability of being diagnosed 
with PTSD, compared to those in the Combat Arms (reference group). This 
was also observed from the analysis of the descriptive statistics in Table 6.2.  
Similar to the “Other MOS” category for the officers, the coefficient estimate 
for the “Other MOS” category was statistically significant and positive at the 
0.01 level for all four services  
Almost all the coefficient estimates for the paygrades were statistically 
significant and negative at the 0.01 level. These indicated that the reference 
group, i.e., the most junior enlisted personnel (E1 to E3) had higher probability 
of being diagnosed with PTSD, compared to the more senior enlisted 
personnel.  
The race coefficient estimates for the “Black,” “Hispanic” (except for the 
Air Force) and “Asian” were statistically significant and negative at the 0.01 
level for all services. These indicated that black, Hispanic and Asian enlisted 
personnel had a lower probability of being diagnosed with PTSD compared to 
whites (reference group). 
Similar to the officers, the coefficient estimate for females was 
statistically significant at the 0.01 level for all services, and indicated that 
females were more likely to be diagnosed with PTSD compared to the male 
enlisted personnel. The probability of female enlisted personnel in the Army, 
Marine Corps and Navy being diagnosed with PTSD was more than 1 
percentage point higher than the male enlisted personnel.    
Table 6.4 also shows that single enlisted personnel across all services 
were less likely to be diagnosed with PTSD, compared to married enlisted 
personnel. These estimates were statistically significant at the 0.01 level. The 
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probability of single enlisted personnel in the Army and Marine Corps being 
diagnosed with PTSD was 0.4 and 0.3 percentage points lower than the 
married personnel.     
Similar to the officers, the coefficient estimate for age was statistically 
significant at the 0.01 level across all four services, and indicated that the 
probability of being diagnosed with PTSD increased with age. The 
magnitudes of the age coefficient estimates were again very small at less than 
0.03 percentage points. Therefore similar to the officers, the coefficient 
estimates for paygrade and age showed opposite effects on the probability of 
being diagnosed with PTSD, even though paygrade and age were usually 
positively correlated. We had expected the paygrade effect to dominate the 
age effect, as the magnitudes of the paygrade estimates were greater than 
the magnitudes of the age estimates.     
Finally, it was observed that all of the coefficient estimates for FY2004 
to FY2006 were positive and statistically significant at the 0.05 level for all 
services (except FY2006 for Navy). These estimates indicated that the 
probability of being diagnosed with PTSD increased in these years, compared 
to the base year FY2001.  The trend analysis in Chapter V also identified a 
surge in the number of PTSD cases during the period FY2004 to FY2006. 
These clearly showed the effects of OIF and OEF on the enlisted personnel.  
D. RESULTS OF MULTIVARIATE ANALYSIS MODEL 2 – 
INTERACTIVE EFFECT OF LAST DEPLOYMENT LOCATION AND 
DURATION 
The second multivariate probit model was an expansion of the first 
model. The second model estimated the effect of the last deployment location 
and duration on the probability of being diagnosed with PTSD. All 
deployments were categorized as short, medium and long deployments based 
on their duration. As the deployment duration differed between the services, 
the interval definition for short, medium and long deployments was 
determined by the distribution of the deployment duration for each service in 
the empirical data. The cutoffs for the intervals for each service were chosen 
so that each interval contained approximately the same percentage of 
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observations across the four services.45 In addition, the model also employed 
interaction terms between the last deployment location and duration to 
examine whether the effect of deployment duration on being diagnosed with 
PTSD was exacerbated or migrated by the deployment location.  
Similar to the first model, the last deployment refers to the most 
recently completed deployment prior to the PTSD diagnosis date or date or 
observation. The key variables of interest for the second models were the last 
deployment location, its duration and the interaction terms between the last 
deployment location and duration.   
The second model also included a set of control variables for the 
service and demographic characteristics of the sample. The result of the 
second model shows that the effects of these control variables on the 
probability of being diagnosed with PTSD were similar to those in the first 
model. Hence the effects of these control variables were not reported in the 
second and subsequent models, unless their effects varied significantly.  
1. Officers and Warrant Officers 
Table 6.5 shows the result of the second probit model for the officers 
and warrant officers across the services. Due to small sample size for some of 
the interaction terms, only two interaction terms, namely “medium deployment 
duration in Afghanistan or Iraq” and “long deployment duration in Afghanistan 
or Iraq”, were included in the model.  
Reference group: Married white male, in the most junior rank category 
and in combat arms, with a short last deployment. Base year FY2001 




    
Medium 0.002* 0.001 -0.001 0.000 
 (0.001) (0.001) (0.001) (0.000) 
Long 0.003*** 0.004** -0.001 -0.000 
 (0.001) (0.002) (0.001) (0.000) 
Last Deployment 
Location 
    
Afghanistan 0.003** -0.001* 0.007 -0.000*** 
                                            
45 Based on the deployment duration, approximately 80% of the observations in each 
service were categorized as a short deployment, while the next 10% of the observations were 
categorized as a medium deployment. The remaining 10% of the observations was 
categorized as a long deployment. 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with a short last deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
 (0.001) (0.000) (0.006) (0.000) 
Iraq 0.009*** 0.002 0.009** 0.000 
 (0.002) (0.000) (0.004) (0.001) 
Other Middle East 
Countries 
0.007*** -0.002*** 0.005*** -0.000 
 (0.001) (0.002) (0.002) (0.000) 
Other Countries 0.001 -0.002*** 0.004** -0.001*** 
 (0.001) (0.000) (0.002) (0.000) 
Interaction Terms     
Medium Deployment * 
(Afghanistan or 
Iraq) 
-0.000 -0.000 0.000 0.000 
 (0.001) (0.001) (0.001) (0.002) 
Long Deployment * 
(Afghanistan or 
Iraq) 
-0.001 -0.001** -0.000 0.004 
 (0.001) (0.000) (0.002) (0.005) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.5. Marginal Effect of Last Deployment Location and 
Duration on Probability of Being Diagnosed with PTSD (Officers and 
Warrant Officers) 
 
In general, Table 6.5 shows that the effect of the last deployment 
location was more statistically and numerically significant than the effect of the 
last deployment duration, i.e., the last deployment location had a larger effect 
on the officers’ probability of being diagnosed with PTSD than their last 
deployment duration, except for the Air Force. The effect of the last 
deployment duration also appeared to be independent of the last deployment 
location for the officers. The result of the model for each service is described 
below.  
a. Army 
The coefficient estimate for the long deployment was statistically 
significant at the 0.01 level. For an average Army officer, his probability of 
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being diagnosed with PTSD increased by 0.003 if the duration of his last 
deployment was long, as compared to an officer who had had a short last 
deployment.  Similar to model 1, the coefficient estimates for Afghanistan, Iraq 
and other Middle East countries were statistically significant and positive. 
However, the magnitudes of these estimates were smaller than those in 
model 1. For instance, the coefficient estimate for Iraq was 1.3 and 0.9 
percentage point in model 1 and 2 respectively. The coefficient estimate for 
the last deployment location in model 1 had included the effect of the 
deployment duration, while the effect of the last deployment location and 
duration was analyzed separately in model 2.  
b. Air Force 
Similar to the Army, the magnitudes of the coefficient estimates 
for the last deployment location in model 2 were smaller than those in model 
1, when the effect of the last deployment duration was analyzed separately 
from the effect of the deployment location in model 2. The result also showed 
that for an average Air Force officer, the probability of being diagnosed with 
PTSD increased by 0.004 if the last deployment was long compared to an 
officer who had a short last deployment. These indicated that Air Force 
officers were more affected by the duration of their last deployment than its 
location. Interestingly, the increase in the probability of being diagnosed with 
PTSD due to a long last deployment (0.4 percentage point) was mitigated or 
decreased by 0.1 percentage point if the last deployment was in Afghanistan 
or Iraq.    
c. Marine Corps 
The coefficient estimates for Iraq, other Middle East countries 
and other countries were statistically significant at the 0.05 level. Contrary to 
the Army and Air Force, the magnitudes of the coefficient estimates for the 
last deployment location increased slightly when the effect of the last 
deployment duration was analyzed separately from the last deployment 
location, and the coefficient estimates for the deployment duration (medium 
and long deployments) were not statistically significant.  
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d. Navy 
Model 1 has shown that there is little differential effect on the 
probability of being diagnosed with PTSD for officers who are deployed 
ashore or afloat. Hence the deployment location type was omitted in model 2 
for the Navy. The coefficient estimates for Afghanistan and other countries 
were statistically significant and negative at the 0.01 level.  However the 
magnitude of these estimates was small at 0.1 percentage point and less. 
2. Enlisted Personnel 
Table 6.6 shows the result of the second probit model for the enlisted 
personnel across the four services. The coefficient estimates show that the 
enlisted personnel were more affected by the last deployment location and 
duration than the officers. Enlisted personnel from all services experienced 
the largest percentage point increase in their probability of being diagnosed 
with PTSD if they were last deployed to Iraq. Similar to the effects on the 
officers, the effect of the last deployment location was more numerically 
significant than the effect of the last deployment duration for all services, 
except the Air Force. The duration effect also generally appeared to be 
independent of the last deployment location. The result for each service is 
described below.   
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with a short last deployment. Base year FY2001 




    
Medium 0.000 0.001*** 0.001*** 0.002*** 
 (0.000) (0.000) (0.000) (0.001) 
Long 0.005*** 0.003*** -0.001 0.000 
 (0.000) (0.001) (0.001) (0.000) 
Last Deployment 
Location 
    
Afghanistan 0.012*** -0.001*** 0.015*** 0.004 
 (0.001) (0.000) (0.003) (0.002) 
Iraq 0.028*** 0.002** 0.031*** 0.017*** 
 (0.001) (0.001) (0.002) (0.005) 
Other Middle East 
Countries 
0.028*** -0.001*** 0.018*** 0.002*** 
 (0.001) (0.000) (0.001) (0.000) 
Other Countries 0.014*** -0.001*** 0.012*** -0.005*** 
 (0.001) (0.000) (0.001) (0.000) 
Interaction Terms     
Medium Deployment * 
(Afghanistan or 
Iraq) 
0.001* 0.001 -0.002*** 0.006* 
 (0.001) (0.001) (0.000) (0.003) 
Long Deployment * 
(Afghanistan or 
Iraq) 
0.000 0.001 0.000 0.008** 
 (0.000) (0.001) (0.001) (0.003) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.6. Marginal Effect of Last Deployment Location and 
Duration on Probability of Being Diagnosed with PTSD (Enlisted 
Personnel) 
a. Army 
The coefficient estimate for the long deployment was statistically 
significant at the 0.01 level. For average Army enlisted personnel, the 
probability of being diagnosed with PTSD increased by 0.005 if the duration of 
the last deployment was long, compared to enlisted personnel who had short 
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last deployments.  Similar to model 1, the coefficient estimates for all locations 
were statistically significant and positive. However, as for the officers, the 
magnitudes of these estimates were smaller than those in model 1.   
b. Air Force 
All the coefficient estimates for the deployment locations and 
duration were statistically significant at the 0.05 level. Similar to the results for 
the officers, the magnitudes of the coefficient estimates for the last 
deployment location in model 2 were smaller than those in model 1. The sign 
and relative magnitude of the coefficient estimates indicated that enlisted 
personnel in the Air Force are more affected by the duration of their last 
deployment than its location. In addition, the coefficient estimate for the 
deployment duration showed that a long deployment increased the probability 
of being diagnosed with PTSD more than a medium deployment, as we 
expected.  
c. Marine Corps 
As in model 1, the coefficient estimates for all locations were 
statistically significant and positive at the 0.01 level. In addition, the coefficient 
estimate for the medium deployment was also statistically significant at the 
0.01 level. For average enlisted personnel in the Marine Corps, the probability 
of being diagnosed with PTSD increased by 0.001 if the last deployment was 
of medium duration, compared to other enlisted personnel with short last 
deployments. Interestingly, the increase in the probability of being diagnosed 
with PTSD due to a medium deployment was negated if the last deployment 
was in Iraq or Afghanistan.  
d. Navy 
Similar to model 1, the coefficient estimates for Iraq, other 
Middle East countries and other countries were statistically significant at the 
0.01 level.  In addition, the coefficient estimate for the medium deployment 
was statistically significant at the 0.01 level. Although the coefficient estimate 
for the long deployment was statistically insignificant, the coefficient estimate 
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for the interaction term “long deployment in Afghanistan or Iraq” was 
statistically significant at the 0.05 level. This indicated that the effect of the 
deployment duration on the probability of being diagnosed with PTSD was 
exacerbated if the last deployment was Afghanistan or Iraq. 
E. RESULTS OF MULTIVARIATE ANALYSIS MODEL 3 – EFFECT OF 
DEPLOYMENT LOCATION HISTORY 
The first two probit models focused on the effect of the last deployment 
on the probability of being diagnosed with PTSD. The third model extended 
the analysis to include all past deployments in the person’s deployment 
history that occurred before his PTSD diagnosis date or date of observation. 
The model considered if a person had ever been deployed to the various 
locations between FY2001 and FY2006, and prior to his PTSD diagnosis date 
or date of observation, and estimated the effect of ever being deployed to 
these locations on the probability of being diagnosed with PTSD. The key 
variables of interest for the third model were the locations of the past 
deployments. 
1. Officers and Warrant Officers 
Table 6.7 shows the result of the third probit model for the officers and 
warrant officers across the services. The result shows that, except for the 
Navy, the probability of an officer being diagnosed with PTSD increased if he 
was ever deployed to Iraq. The result for the services is described below.  
Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Has ever being 
deployed to 
    
Afghanistan 0.002** -0.001 0.002 - 
 (0.001) (0.001) (0.003)  
Iraq 0.006*** 0.004*** 0.004*** - 
 (0.001) (0.001) (0.001)  
Other Middle East 
Countries 
0.007*** -0.001*** 0.003*** - 
 (0.001) (0.000) (0.001)  
Other Countries 0.000 -0.001*** 0.002* - 
 (0.001) (0.000) (0.001)  
Shore Deployment 
in Afghanistan 
- - - -0.000* 
    (0.000) 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 




- - - 0.003* 





- - - 0.000 
    (0.001) 
Shore Deployment 
in Other Middle 
East Countries  
- - - -0.000*** 
    (0.000) 
Shipboard 
Deployment in 
Other Middle East 
Countries 
- - - 0.002 
    (0.001) 
Shore Deployment 
in Other Countries 
- - - -0.001*** 




- - - 0.000* 
    (0.000) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.7. Marginal Effect of Deployment Location History on 
Probability of Being Diagnosed with PTSD (Officers and Warrant 
Officers) 
a. Army 
The coefficient estimate for Afghanistan, Iraq and other Middle 
East countries were statistically significant and positive at the 0.05 level. For 
an average Army officer, his probability of being diagnosed with PTSD 
increased by 0.002 and 0.006 respectively if he was ever deployed to 
Afghanistan or Iraq. Therefore if an officer was ever deployed to both Iraq and 
Afghanistan, his probability of being diagnosed with PTSD increased by 
0.008, ceteris paribus.     
 124
b. Air Force 
The coefficient estimates for Iraq, other Middle East countries 
and other countries were statistically significant at the 0.01 level. However, 
the coefficient estimate for Iraq was the only positive and numerically 
significant estimate. This reflected the adverse effect of deployments to Iraq, 
compared to the other deployment locations.   
c. Marine Corps 
The coefficient estimates for Iraq and other Middle East 
countries were statistically significant at the 0.01 level. The coefficient 
estimate for Afghanistan was, however, not statistically significant at the 0.05 
level.  
d. Navy 
All the coefficient estimates for the Navy incorporated the effect 
of deployment location type (ashore or afloat). Only the coefficient estimates 
for shore deployment in other Middle East countries and shore deployment in 
other countries were statistically significant at the 0.01 level. As a matter of 
fact, these two coefficient estimates were negative and suggested that the 
probability of being diagnosed with PTSD decreased if the officer was ever 
deployed ashore in other countries other than Afghanistan and Iraq. However, 
the magnitudes of these estimates were 0.1 percentage point and less.  
2. Enlisted Personnel 
Table 6.8 shows the result of the third probit model for the enlisted 
personnel across the services. The table indicates that, for all services, the 
probability of enlisted personnel being diagnosed with PTSD increased if they 
were ever deployed overseas. The result for each service is described below.   
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Has ever being 
deployed to 
    
Afghanistan 0.006*** -0.000 0.005*** - 
 (0.001) (0.000) (0.001)  
Iraq 0.016*** 0.007*** 0.014*** - 
 (0.000) (0.001) (0.001)  
Other Middle East 
Countries 
0.019*** -0.000*** 0.012*** - 
 (0.000) (0.000) (0.001)  
Other Countries 0.004*** -0.001*** 0.006*** - 
 (0.000) (0.000) (0.001)  
Shore Deployment 
in Afghanistan 
- - - 0.003 
    (0.002) 
Shore Deployment 
in Iraq 
- - - 0.042*** 





- - - 0.024*** 
    (0.003) 
Shore Deployment 
in Other Middle 
East Countries  
- - - -0.001*** 
    (0.000) 
Shipboard 
Deployment in 
Other Middle East 
Countries 
- - - 0.027*** 
    (0.002) 
Shore Deployment 
in Other Countries 
- - - -0.006*** 




- - - 0.002*** 
    (0.000) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.8. Marginal Effect of Deployment Location History on 




All the coefficient estimates were statistically significant and 
positive at the 0.01 level. However the magnitudes of the estimates for Iraq 
and other Middle East countries were larger than those for Afghanistan and 
other countries. Similar to the results in models 1 and 2, the magnitudes of the 
estimates for the enlisted personnel were larger than those for the officers. 
These estimates indicated that the probability of an enlisted personnel being 
diagnosed with PTSD increased more substantially than for an officer, if he 
was ever deployed to both Afghanistan and Iraq.      
b. Air Force 
Similar to the officers, the coefficient estimates for Iraq, other 
Middle East countries and other countries were statistically significant at the 
0.01 level for enlisted personnel. Again, only the coefficient estimate for Iraq 
was positive and numerically significant. This, again, reflected the adverse 
effect of deployments to Iraq on the probability of being diagnosed with PTSD, 
compared to the other deployment locations.   
c. Marine Corps 
Similar to the Army’s results, all the coefficient estimates were 
statistically significant at the 0.01 level. Likewise, the magnitudes of these 
estimates were larger than the magnitudes of the corresponding estimates for 
the Marine Corps officers.  
d. Navy 
All coefficient estimates, except for the shore deployment in 
Afghanistan, were statistically significant at the 0.01 level. For average 
enlisted personnel in the Navy, the probability of being diagnosed with PTSD 
increased by 0.042 if they were ever deployed ashore in Iraq. The probability 
increased by 0.024 only they were ever deployed onboard ship in Iraq or 
Afghanistan. The relative magnitude of these estimates supported our 
hypothesis that the probability of being diagnosed with PTSD was higher for 
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sailors who ever deployed ashore, compared to sailors who were ever 
deployed onboard ship. Interestingly, the magnitude of the Navy coefficient 
estimate for shore deployment in Iraq was larger than the magnitude of the 
Army coefficient estimate for Iraq.  
F. RESULTS OF MULTIVARIATE ANALYSIS MODEL 4 – EFFECT OF 
SINGLE AND MULTIPLE DEPLOYMENTS TO THE SAME 
LOCATION 
The fourth model was an expansion of the third model. The fourth 
model considered all the past deployments in the person’s deployment history 
between FY2001 to FY2006 that occurred prior to his PTSD diagnosis date or 
date of observation, and estimated the effect of a single deployment (i.e., only 
deployed once) and multiple deployments (i.e., deployed more than once) to 
the same location (as specified) on the probability of being diagnosed with 
PTSD. The key variables of interest were two sets of binary location variables 
for the single and multiple deployments to the various locations.  
1. Officers and Warrant Officers 
Table 6.9 shows the result of the fourth probit model for the officers 
and warrant officers across the four services. The coefficient estimates for 
some of the independent variables were not available due to limited data 
variation for these variables.  
Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Has been deployed 
only once to 
Afghanistan 
0.002*** -0.000 0.003 0.001 
 (0.001) (0.001) (0.003) (0.001) 
Has been deployed 
more than once to 
Afghanistan 
-0.001 - - - 
 (0.001)    
Has been deployed 
only once to Iraq 
0.006*** 0.004*** 0.004*** 0.008** 
 (0.001) (0.001) (0.002) (0.004) 
Has been deployed 
more than once to 
Iraq 
0.009*** - 0.004 - 
 (0.003)  (0.004)  
Has been deployed 0.006*** -0.001*** 0.002*** 0.002** 
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
only once to other 
Middle East 
countries 
 (0.001) (0.000) (0.001) (0.001) 
Has been deployed 
more than once to 
other Middle East 
countries 
0.012*** -0.001*** 0.007* 0.003 
 (0.002) (0.000) (0.004) (0.003) 
Has been deployed 
only once to other 
countries 
0.001 -0.001*** 0.002* 0.000 
 (0.001) (0.000) (0.001) (0.000) 
Has been deployed 
more than once to 
other countries 
-0.000 -0.001*** -0.000 0.000 
 (0.001) (0.000) (0.002) (0.001) 
Has been shore-
deployed only once 
- - - -0.001*** 
    (0.000) 
Has been shore-
deployed more than 
once 
- - - -0.000*** 
    (0.000) 




    
* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.9. Marginal Effect of Single and Multiple Deployments to 
the Same Location on Probability of Being Diagnosed with PTSD 
(Officers and Warrant Officers) 
a. Army 
The coefficient estimates showed that repeated deployments to 
Iraq increased the probability of being diagnosed with PTSD. For an average 
Army officer, his probability of being diagnosed with PTSD increased by 0.006 
if he was deployed only once to Iraq. The probability however increased by 
0.009 if he was deployed more than once to Iraq. If the officer was only 
deployed once to Afghanistan, his probability of being diagnosed with PTSD 
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increased by 0.002. The coefficient estimate for multiple deployments to 
Afghanistan was however statistically insignificant at the 0.05 level.  
b. Air Force 
Similar to the previous model, the coefficient estimates for Iraq, 
other Middle East countries and other countries were statistically significant at 
the 0.01 level. However, only the coefficient estimate for single deployment to 
Iraq was positive and statistically significant. The coefficient estimate for 
multiple deployments to Iraq was not available due to limited data variation for 
multiple deployments to Iraq.    
c. Marine Corps 
For an average Marine Corps officer, his probability of being 
diagnosed with PTSD increased by 0.004 if he was deployed only once to 
Iraq. However, the coefficient estimate for multiple deployments to Iraq was 
statistically insignificant at the 0.05 level. This suggested that there was no 
significant difference in the probability of being diagnosed with PTSD between 
an officer who was deployed only once to Iraq, and an officer who had been 
deployed more than once to Iraq.  
d. Navy 
The probability of an average Navy officer being diagnosed with 
PTSD increased by 0.008 if he was deployed only once to Iraq. The 
magnitude of the increase in the probability of being diagnosed with PTSD for 
the Navy officer was in fact larger than the magnitude of the increase for an 
Army officer. Similar to the Air Force, the coefficient estimate for multiple 
deployments to Iraq was not available due to limited data variation for multiple 
deployments to Iraq.    
2. Enlisted Personnel 
Table 6.10 shows the result of the fourth probit model for the enlisted 
personnel across the four services. The coefficient estimates for the enlisted 
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personnel were more statistically and numerically significant, compared to 
those for the officers. The coefficient estimates showed that repeated 
deployments to Iraq increased the probability of being diagnosed with PTSD 
for enlisted personnel across all services. On the other hand, the probability of 
being diagnosed with PTSD did not increase significantly for enlisted 
personnel who were deployed multiple times to Afghanistan, compared to 
those who were only deployed once to Afghanistan.  
 
Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 
Variable Army Air Force Marines Navy 
 
Has been deployed 
only once to 
Afghanistan 
0.007*** -0.000 0.005*** 0.024*** 
 (0.001) (0.000) (0.001) (0.006) 
Has been deployed 
more than once to 
Afghanistan 
0.000 0.002 0.002 0.026 
 (0.001) (0.003) (0.004) (0.036) 
Has been deployed 
only once to Iraq 
0.016*** 0.007*** 0.014*** 0.073*** 
 (0.000) (0.001) (0.001) (0.006) 
Has been deployed 
more than once to 
Iraq 
0.027*** 0.009*** 0.028*** 0.084*** 
 (0.002) (0.003) (0.005) (0.030) 
Has been deployed 
only once to other 
Middle East 
countries 
0.019*** -0.000*** 0.010*** 0.022*** 
 (0.000) (0.000) (0.001) (0.002) 
Has been deployed 
more than once to 
other Middle East 
countries 
0.030*** 0.000 0.043*** 0.059*** 
 (0.002) (0.000) (0.004) (0.009) 
Has been deployed 
only once to other 
countries 
0.005*** -0.001*** 0.005*** 0.001*** 
 (0.001) (0.000) (0.001) (0.000) 
Has been deployed 
more than once to 
other countries 
0.002* -0.001*** 0.018*** 0.006*** 
 (0.001) (0.000) (0.003) (0.001) 
Has been shore-








    (0.000) 
Has been shore-









    (0.000) 
Observations 332970 112696 98695 134095 
Robust standard     
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Reference group: Married white male, in the most junior rank category 
and in combat arms, with no overseas deployment. Base year FY2001 




* significant at 
10%;  
** significant at 
5%;  
*** significant at 
1% 
    
Table 6.10. Marginal Effect of Single and Multiple Deployments to 
the Same Location on Probability of Being Diagnosed with PTSD 
(Enlisted Personnel) 
 
Although the coefficient estimates for single and multiple deployments 
to Iraq were statistically significant and positive at the 0.01 level across all 
services, the magnitudes of these coefficient estimates varied significantly 
among the services. The magnitudes of the coefficient estimates for the Army 
and Marine Corps were similar, while the magnitudes of the estimates for the 
Air Force were lower than those for the Army or Marine Corps, as expected. 
However, the magnitudes of the coefficient estimate for the Navy were 
significantly larger than those for the other three services. The probability of 
an enlisted personnel in the Navy being diagnosed with PTSD increased by 
0.073 if he was deployed only once to Iraq. The probability increased by 0.084 
if he was deployed more than once to Iraq. In fact, the magnitudes of several 
Navy coefficient estimates, e.g., single deployment to Afghanistan, single and 
multiple deployments to other Middle East countries were larger than the 
magnitudes of the corresponding estimates for the three other services. 
These indicated that Navy enlisted personnel may be more adversely affected 
by overseas deployments, particularly deployments to Iraq, compared to 
enlisted personnel in the three other services.   
The Navy coefficient estimates for shore deployments indicated that 
the probability of a Navy enlisted personnel being diagnosed with PTSD 
decreased by 0.006 or 0.004 if he was deployed ashore once only or more 
than once respectively. By comparing the magnitudes of the coefficient 
estimates for deployment locations and shore deployments, we observed that 
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the effect of the deployment location was more significant than the effect of 
the deployment location type (ashore or afloat).  
G. SUMMARY 
This chapter employed four multivariate analysis models to estimate 
the effect of the various aspects of deployment intensity, including deployment 
location, duration and frequency on the probability of being diagnosed with 
PTSD across the four services. Separate analyses were conducted for 
officers and enlisted personnel.  
The multivariate analyses showed that overseas deployments, 
particularly deployments to Iraq, increased the probability of being diagnosed 
with PTSD. The effect of deployments to Afghanistan was less significant 
compared to the effect of deployments to Iraq. As the duration and frequency 
of deployments increased, the probability of being diagnosed with PTSD also 
increased, particularly for the enlisted personnel. However, the effect of the 
deployment duration was independent of the deployment location for most 
deployment locations across the services.  
The multivariate analyses also showed that the magnitudes of the 
coefficient estimates for the enlisted personnel were consistently larger than 
those for the officers. The increase in the probability of being diagnosed with 
PTSD due to overseas deployments was more significant for the enlisted 
personnel, compared to the officers.   
For officers, the effects of overseas deployment were more 
pronounced in the Army and the Marine Corps, compared to the Air Force and 
Navy, as we had hypothesized. However for enlisted personnel, we observed 
in several of our analyses that overseas deployments had a greater effect on 
the probability of being diagnosed with PTSD for the Navy sailors than for the 
soldiers in the Army and Marine Corps.  
We had hypothesized that the probability of being diagnosed with 
PTSD was higher for sailors who were deployed ashore, compared to the 
sailors who were deployed on ships, as the former were expected to face 
higher threats. The results from the analyses for the Navy enlisted personnel 
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supported this hypothesis. However, we did not observe any statistically 
significant difference in the probability of being diagnosed with PTSD between 
Navy officers who were deployed on ships and those who were deployed 
ashore.  
In summary, the multivariate analyses allowed us to compare the effect 
of the various aspects of deployment intensity across the services, as well as 
between the officers and the enlisted personnel, while holding other factors 
constant. While most results from the multivariate analyses supported our 
hypothesis, we had also gained some new insights. 
The next chapter will analyze the pattern of comorbidity risks and 
treatment costs for PTSD across the four service branches at two different 
levels of resolution, namely at the claim and person level. Chapter VII will 
establish whether there is a differential comorbidity distribution or treatment 
cost between officers and enlisted personnel, males and females, and 
between white and non-white populations in the four services.  
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VII. IN-DEPTH ANALYSIS OF THE PTSD POPULATION OF 
THEIR TREATMENT COST, COMORBIDITY AND OTHER 
USEFUL CLINICAL INFORMATION 
A. OVERVIEW 
The increasing trend of PTSD among active duty service personnel has 
created concerns over the rising trend in the medical costs of PTSD treatment 
across the services.    Rising medical costs specific to PTSD treatment could 
divert funds away from other needs for the military.   In addition to the 
treatment costs, it is important for the military planners to be conversant with 
the PTSD comorbidity distribution across the different services so as to take 
into consideration the appropriate assignment of the combat operational 
profiles of affected active duty service personnel. 
This chapter of the study will be directed towards the assessment of 
comorbidity distribution and patterns of treatment costs for PTSD across the 
different branches of service among the active duty population who have been 
diagnosed with PTSD during the study period from FY2001 to FY2006.   This 
portion of the study uses the clinical data in TRICARE inpatient and outpatient 
claim systems to derive the treatment cost patterns and clinical characteristics 
across the different branches. 
B. ANALYTICAL APPROACH 
For the purpose of analyzing the comorbidity and treatment cost 
patterns among the PTSD population across the services, the study uses the 
five data sets provided by TRICARE.   They are the Defense Enrollment 
Eligibility Reporting System (DEERS) data on the PTSD population across the 
services, which provided the basic demographic information, as well as the 
identification of the PTSD diagnosis of the active duty service personnel; the 
data files of the Standard Inpatient Data Record (SIDR) and the TRICARE 
Encounter Data – Institutional (TEDI) that captured all treatment patterns 
among the PTSD population for those who were admitted under the inpatient 
setting; and the Standard Ambulatory Data Record (SADR) and TRICARE 
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Encounter Data – Non-Institutional (TEDN) data files which captured the 
treatment patterns among the PTSD population for those who were admitted 
to an outpatient setting.46      
The four clinical data files of SIDR, SADR, TEDI and TEDN would be 
used to assess the comorbidities associated with PTSD as well as deriving 
the average treatment costs both at the claims level, i.e. number of 
claims/visits made by all active duty service personnel to the respective MTFs 
and TRICARE providers (civilian medical services providers) and the 
individual encounters with the military and civilian treatment facilities.   While 
the results from the overall claims level would present the overall trends of 
PTSD diagnosed personnel in terms of related comorbidity illnesses and 
treatment cost patterns, the analysis at the individual level would be further 
separated into the demographics component of gender and race to evaluate 
the possible differences in outcomes between the distinct groups of 
personnel.  For the purpose of the study, only non-missing values would be 
evaluated for the comorbidity and treatment costs pattern. 
1. DEFINITIONS OF MEDICAL CLASSIFICATIONS OF PTSD       
COMORBIDITY DISTRIBUTION AND OTHER 
NOMENCLATURES 
There is substantial comorbidity between PTSD and disorders such as 
depression, which are responsive to pharmacotherapy. Up to 80% of patients 
with PTSD meet the criteria for at least one other psychiatric disorder. Other 
common comorbid disorders are many affective disorders, other anxiety 
disorders, somatisation and substance abuse.47   Therefore, it is important to 
                                            
46 The SIDR data set contained 47,610 inpatient records/observations of active duty 
service personnel from the different branches who were diagnosed with PTSD and sought 
treatment or admitted to MTFs; the TEDI consisted of 43,339 records/observations of 
personnel who sought inpatient treatment at the civilian TRICARE medical services providers; 
the SADR included 2,699,758 records/observations of personnel who sought outpatient 
treatment at the MTFs, while the TEDN consisted of 1,130,799 observations of personnel who 
sought outpatient treatment at the TRICARE civilian providers during the entire study period.                           
47KT, Brady (1997). Posttraumatic stress disorder and comorbidity: recognizing the 
many faces of PTSD. The Journal of Clinical Psychiatry 1997; 58 Suppl 9:12-5. 
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identify the definitions of these comorbidities that are associated with PTSD.48  
Based on the Diagnostic and Statistical Manual of Mental Disorders (ICD-9 
CM version) which is the standard classification of mental disorders used by 
mental health professionals in the United States,49 the eight comorbidities 
associated with PTSD which are used in this study are summarized in the 
Table 7.1 below. 
S/No. Categories of Comorbidities Diagnostic Codes (ICD 9 CM) 
1. Major Depression 296.2 and 296.3 
2. Substance Abuse 291 -292 and 303 -305 
3. Other psychoses 295-299, excluding 296.2 and 
296.3 
4. Any other mental health problems 290-312 (excluding the above 3) 
5. External causes of injury ICD-9 Codes starting with "E") 
6. Unspecified Mental and 
Behavioural problems 
V40 
7. Other V-codes Excludes V40 and V70 (general 
health examination) 
8. Acute Illnesses Any ICD 9 code that is <290 and 
> 319, excluding E and V codes. 
Table 7.1. Categories of Comorbidities Associated with PTSD 
 
Given the clinical inpatient and outpatient data sets from TRICARE, the 
diagnostic codes (indicated as “dx” in the data sets) indicated above would be 
used for the in-depth analysis of the PTSD comorbidity distribution amongst 
the active duty service personnel across the different branches of services in 
the U.S military.   For the purpose of the study, only the primary (dx1) and 
secondary (dx2) diagnostic codes for PTSD comorbidity illnesses were 
analyzed throughout the entire span of the study period. 
In this study, all inpatient records/claims (visit) levels refer to all 
admissions to MTFs or TRICARE civilian hospitals as denoted by SIDR, and 
TEDI records and outpatient records/claims (visit) levels refer to all outpatient 
medical services rendered by MTFs or TRICARE civilian providers, as 
                                            
48 Robert Rosenheck & Alan Fontana (2003), Use of Mental Health Services by Veterans 
With PTSD After the Terrorist Attacks of September 11,  American Journal of Psychiatry 
2003; 160:1684–1690. 
49 Diagnostic and statistical manual of mental disorders: DSM-IV-TR. The American 
Psychiatric Association. 
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denoted by SADR and TEDN records respectively.   In addition, the total 
number of claims mentioned in this study refers to the frequency of visits for 
treatment to either MTFs or TRICARE civilian medical providers made by the 
active duty service personnel who were diagnosed with PTSD between 
FY2001 and FY2006.   On the other hand, the total number of individuals 
mentioned in this study would illustrate the number of personnel making the 
visits to MTFs or TRICARE civilian medical providers for their treatment 
regardless of the numbers of times of visits. 
2. MERGING OF CLINICAL DATA SETS WITH DEERS DATA 
FILE ON PTSD POPULATION 
The four clinical data sets of SIDR, TEDI, SADR and TEDN would be 
merged with the DEERS PTSD population data file50 via the unique EDIPNs 
of the active duty service personnel.   These merged data sets would then be 
further grouped according to the inpatient (SIDR and TEDI data sets) and 
outpatient (SADR and TEDN) level entities respectively, to capture the 
potentially different characteristics among different demographics (gender and 
race) seeking treatment at a MTF as compared to a civilian TRICARE 
provider. 
The two merged inpatient (SIDR and TEDI) and outpatient (SADR and 
TEDN) data sets would be differentiated via the claims (visits) levels and the 
individual level respectively.   The merged data sets at claims levels (both 
inpatient and outpatient level) would encompass the numbers of times each 
PTSD diagnosed active service duty personnel received treatment at either 
MTF or civilian TRICARE medical providers or submitted medical claims 
during the entire span of the study period.   At the individual level, the merged 
data sets would only be comprised of one unique EDIPN of each PTSD 
diagnosed personnel regardless of the number of visits or claims he made 
while receiving treatment at MTF or civilian medical providers.   The potential 
                                            
50 The data captured all the demographics information (age, gender, race, military pay 
grade, years of service etc) of the active duty service personnel who were diagnosed with 
PTSD between FY2001 and FY2006. 
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variability between the different gender and race would be evaluated at the 
individual level in the subsequent sections, holding all other factors constant. 
C. ANALYSIS OF PTSD COMORBIDITY DISTRIBUTION AND 
TREATMENT COSTS ACROSS SERVICES AT CLAIMS LEVEL 
This section concentrates on both the analysis of the PTSD 
comorbidity distribution and average treatment costs for inpatient and 
outpatient visits at claims levels for both the officers and enlisted population 
across the four branches of services between FY2001 and FY2006.    The 
analysis includes mental health illness indicators for comorbidity distribution 
associated with PTSD, frequency of visits to MTFs and TRICARE civilian 
medical providers, average treatment costs and average length of stay at 
hospitals or treatment facilities for the officers and enlisted population across 
the services.  The analysis is divided into the officer population and the 
enlisted population based on both inpatient and outpatient level records from 
the military as well as the civilian treatment facilities.   Inpatient settings 
referred to admissions to treatment facilities or civilian hospitals for 
comprehensive treatment for severe PTSD related cases, while outpatient 
visits refers to visits for medication, rehabilitation and behavioral therapy and 
counseling for the affected active duty service personnel across the services. 
1.1 Officers and Warrant Officers PTSD Population – Inpatient 
Visits (Refer to Table 7.2) 
As gathered from the merged inpatient data file, there were only a total 
of 150 claims (visits) among the officers population across the different 
branches of services, with the Army having the most number of officers’ 
claims (90) who sought treatment under all inpatient setting, i.e. had 
incidences of admissions to either MTFs or TRICARE civilian medical 
providers.    
a. Mental Health Illness Indicators 
As derived from the existing data information and shown in 
Table 7.2, it was found that depression remained the dominant comorbidity 
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associated with PTSD across the services and had the highest incidences of 
inpatient treatment/admissions besides PTSD.   Amongst the officer 
population that was diagnosed with PTSD between FY2001 and FY2006, 
there was a significantly higher percentage of the PTSD population being 
diagnosed with depression and seeking treatment across the different 
branches of services.   For instance, 63.6% of the officers from the Marine 
Corps’ PTSD population were also diagnosed with depression and were given 
inpatient treatment; while 60% of the Army officers also suffered from 
depression besides being diagnosed with PTSD.   These results were in line 
with the findings from existing literature on PTSD occurrences among active 
duty service personnel who were deployed in combat zones.   It is also 
meaningful to also note that more than 30% of the officers from the Air Force 
and the Navy were also diagnosed with depression besides PTSD among the 
inpatient records. This could imply that personnel from these two services 
could suffer from the same comorbidity associated with PTSD (depression) 
even though they could have distinctly different operational profiles as 
compared with the Army or the Marine Corps.     
Besides depression being the predominant comorbidity 
associated with PTSD, substance abuse (includes alcohol and drugs) and 
other mental illnesses were also comorbidities that had a certain extent of 
impact on the officers’ PTSD population (as depicted in Table 7.2).   For 
instance, while the officers from Army and Marine Corps had high 
percentages of being diagnosed with substance abuse in conjunction with 
PTSD, it is interesting to note that 18% of the Air Force officers 
(approximately 4% more than the Army officers) suffered from substance 
abuse.   In addition, Air Force officers registered the highest percentage 
(27.3%) among the PTSD officer population of being concurrently diagnosed 
with other mental health related illnesses as compared to either Army or 
Marine Corps.    This finding is especially important when there are no other 
substantial informational statistics on the PTSD incidences from the Air Force 
or the Navy in the current literature.   
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Officers (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Depression  6.0 17.2 36.4 21.2 63.6 23.8 31.3 16.6 
Substance Abuse  14.4 1.8 18.2 1.4 27.3 2.9 12.5 5.4 
Other Psychosis  8.9 1.3 9.1 7.6 27.3 4.0 6.3 2.8 
Other Mental Health Illness  14.4 16.7 27.3 16.8 18.2 12.5 25.0 19.1 
Unspecified mental and behavioral problems 
(V40) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
External causes of Injury  1.1 0.0 3.0 0.1 0.0 1.1 0.0 0.2 
Other V-code diagnoses (excluding V40) 25.6 8.1 30.3 14.0 18.2 12.5 37.5 10.3 
Acute illness (any numerical ICD 9 that is 
<290 and >319, exclude E and V codes)  41.1 8.7 48.5 12.5 9.1 4.3 68.8 6.5 
Count of Mental Illness Comorbidity   
0 14.4 65.2 12.1 58.2 0.0 59.3 31.3 59.1 
1 73.3 32.6 84.9 36.5 63.6 38.2 62.5 38.2 
2 12.2 2.2 3.0 5.3 36.4 2.5 6.3 2.5 
>2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 
Count of Acute Illness Comorbidity   
0 45.6 84.6 30.3 76.7 72.7 83.0 12.5 84.0 
1 41.1 14.0 57.6 19.9 27.3 16.1 68.8 15.0 
2 13.3 1.4 12.1 3.4 0.0 0.9 18.8 1.0 
>2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Visit Sites   
MTF 50.0 64.6 39.4 60.1 45.5 48.4 56.3 74.0 
TRICARE Civilian Providers 45.6 12.3 54.6 18.7 27.3 13.1 31.3 14.4 
Both MTF and TRICARE Civilian 
Providers 4.4 23.1 6.1 21.2 27.3 38.5 12.5 17.8 
Total number of Claims 90 9,727 33 3,500 11 1,230 16 2,978 
Average Treatment Costs ($)   
MTF   
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Officers (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Total Cost  9,635 240 7,616 365 9,131 231 7,817 257 
Total Pharmacy Cost   19  31  26  23 
Total number of Claims 49 8,529 15 2,845 8 1,069 11 2,733 
TRICARE Civilian Providers   
Bill Charged 10,494.6 198.0 16,560.3 175.0 17,309.9 163.5 4,995.6 143.5 
Bill Allowed 4,205.5 131.7 9,725.8 126.9 9,662.1 95.9 2,499.9 95.7 
Total number of Claims 45 3,448 20 1,398 6 635 7 774 
          
Length of Stay(Average number of days) 10.7  12.4  10.5  6.8   
Number of Claims 90  33  11  16   
Table 7.2. PTSD Comorbidity Distribution for Officers and Warrant Officers PTSD Population across Services 
(Claims/Visits level) 
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While it was common for mental health related illness to 
dominate the PTSD comorbidity distribution pattern, acute illnesses (i.e. non 
mental health related illnesses) were also found to be one huge category of 
comorbidity that was associated with PTSD, with 68.8% of the Navy officers 
who sought inpatient treatment for acute illness as well; while more than 40% 
of the officers from the Army and Air Force were diagnosed with acute 
illnesses and admitted for treatment in addition to PTSD during the study 
period as shown in Table 7.2.    
b. Frequency of Site Visits 
Under the current Military Health System (MHS), the active duty 
service personnel could either visit MTFs or their TRICARE civilian medical 
providers for treatment of PTSD.   Drawing reference to the visit sites under 
inpatient claims records, it was clear that the majority of the officer PTSD 
population (especially the Army and Navy) had visited MTFs for PTSD related 
treatment between FY2001 and FY2006, with the exception of 54.6% of the 
Air Force officers being admitted into civilian TRICARE facilities for PTSD 
related treatment.    As found in the data, 27.3% of the officers from the 
Marine Corps (which was the highest percentage across the different 
services) had been admitted to both the MTFs and the civilian treatment 
facilities for PTSD related treatment during the study period.  
c. Average Treatment Costs and Length of Stay 
As found in the inpatient records, the average treatment costs 
for PTSD (and related illnesses) at the MTFs fell within the range of $7,616 to 
$9,635 per claim between FY2001 and FY2006, with the Army officers 
incurring the highest treatment costs of $9,635 for being admitted and 
receiving treatment at MTFs.   These costs were calculated based on the 
number of claims, i.e. 49 claims from the Army officers who were diagnosed 
with PTSD and received treatment at MTFs.  Similarly for the average 
treatment costs at TRICARE civilian medical providers, the officers from the 
Marine Corps incurred the highest costs of $17,309 for PTSD related 
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treatment.   It is important to note that these high costs could be due to the 
small officers’ sample size from the Marine Corps.    Air Force officers 
incurred close to an average of $17,000 of PTSD related treatment costs at 
the civilian medical providers.    The amount of the average treatment costs 
could be further explained by the average length of stay at the treatment 
facilities (military and civilian) in view of the fact that a longer period of stay at 
the treatment facility, the higher the treatment costs.   For instance, the 
average length of stay for Air Force Officers at treatment facilities was the 
longest among the services (12.4 days) while both the Army and Marine 
Corps officers reached an average of about 11 days for similar inpatient 
treatments. 
1.2 Officers and Warrant Officers PTSD Population – Outpatient 
Visits (Refer to Table 7.2) 
In contrast to the inpatient records for the officer population, there were 
many more claims from the officer population for outpatient treatment for a 
PTSD related diagnosis during the study period as shown in Table 7.2.   
There were a total of 17,435 counts of officers’ claims or visits to the military 
and civilian treatment facilities for PTSD related treatment between FY2001 
and FY2006, with the Army officers contributing the largest portion for 
outpatient PTSD treatment, i.e. a total of 9,727 claims made to outpatient 
services rendered at the MTFs or TRICARE civilian medical providers.  The 
Air Force officers had 3,500 outpatient visits for PTSD related treatment 
during the span of the study period. 
a. Mental Health Illness Indicators 
Similar to the inpatient claims records, depression was also the 
dominant comorbidity associated with PTSD across the services and highest 
incidences of outpatient treatment amongst the officers PTSD population, with 
23.8% of the Marine Corps officer population seeking treatment for 
depression as well.    About 21% of the Air Force officers were also diagnosed 
with depression and were given outpatient treatment; while 17.2% of the Army 
officers sought treatment for depression and PTSD.   These results were in 
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line with the findings from existing literature on PTSD occurrences among 
active duty service personnel who were deployed in combat zones.    
Besides the fact that depression is the predominant comorbidity 
associated with PTSD, the percentage of the servicemen being diagnosed 
with other mental illnesses was also high for outpatient visits among the 
officer population.     For instance, within the outpatient claims records as 
shown in Table 7.2, the officers from the Navy comprised the highest 
percentage, i.e. 19% of the officers also seeking treatment for other mental 
illness associated with PTSD.   It is interesting to note that approximately 17% 
of the Air Force and Army officers too were treated for PTSD and other mental 
illnesses.   This finding is especially enlightening as there are no other 
substantial informational statistics on the PTSD incidences from the Air Force 
or the Navy among current literature.   In this case, both the Air Force and the 
Navy officers actually had higher incidences of outpatient visits for treatment 
of other mental illness associated with PTSD than the Army and Marine Corps 
officers.     
b. Frequency of Site Visits 
Drawing reference to the visit sites under outpatient claims 
records, it was clear that the majority of the officers’ PTSD population 
(especially the Army and Navy) had visited MTFs for PTSD related outpatient 
treatment between FY2001 and FY2006, with the Navy officers constituting 
74% of the population visiting only MTFs for outpatient PTSD treatment.    As 
gathered from the data, the Marine Corps officers accounted for over 38% of 
its population which had gone to both the MTFs as well as the civilian 
treatment facilities for PTSD related outpatient treatment during the study 
period.  
c. Average Treatment Costs  
The average outpatient treatment costs for PTSD (and related 
illnesses) were relatively much lower than that of the inpatient admissions, 
with the cost at the MTFs between $231 to $365 per claim between FY2001 
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and FY2006.   This could be due to the fact that there were many more 
outpatient services rendered to the affected service personnel and that their 
PTSD conditions were not severe enough to admit them for inpatient care.    
The Air Force officers contributed to the highest average 
outpatient treatment costs of $365 at MTFs at 2,845 claims, while 8,529 
claims from the Army officers received treatment at MTFs at lower average 
treatment costs of $240 per claim.  Similarly, average treatment costs at the 
TRICARE civilian medical providers for the officers from the Army were the 
highest at $198 for PTSD related treatment.   Air Force officers incurred close 
to an average of $175 of PTSD related treatment costs at civilian medical 
providers.     
2.1 Enlisted PTSD Population – Inpatient Visits (Refer to Table 
7.3) 
Given the operational profiles and mission requirements of the different 
services, the enlisted population accounted for a much higher number of 
claims (visits) for PTSD related treatments at MTFs or the TRICARE civilian 
medical providers.   There were a total of 3,702 inpatient claims (visits) among 
the enlisted population across the different branches of services, with the 
Army having the highest number of claims by enlisted personnel (2,256) 
under inpatient setting, i.e. had incidences of admissions to either MTFs or 
TRICARE civilian medical providers.    
a. Mental Health Illness Indicators 
As derived from the existing data, and shown in Table 7.3, it was 
found that depression remained the dominant comorbidity associated with 
PTSD among the enlisted personnel across the services and had the highest 
incidences of inpatient treatment/admissions.  Amongst the enlisted 
population diagnosed with PTSD between FY2001 and FY2006, there was a 
significantly higher percentage of the PTSD population being diagnosed with 
depression and seeking treatment across the different branches of services.   
For instance, 42.8% of the Air Force enlisted PTSD population were treated 
for depression under an inpatient setting (admitted to hospitals); while nearly 
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35% of both the Army and Navy enlisted personnel were also treated for 
depression.    It is also meaningful to note that a significantly large proportion 
of the enlisted personnel from the Air Force and the Navy suffered from 
similar PTSD comorbidity (depression) despite little evidence being found in 
the existing literature. This could imply that personnel from these two services 
might have suffered from the same comorbidity associated with PTSD 
(depression) even though they had distinctly different operational profiles as 
compared with the Army or the Marine Corps.     
Substance abuse (alcohol and drugs) and other mental illnesses 
were also comorbidities that had a certain extent of impact on the enlisted 
PTSD population (as depicted in Table 7.3).   For instance, as compared to 
the officer population, the enlisted personnel from the Army and the Marine 
Corps have higher percentages (28.6% and 38.3% respectively) of being 
admitted for substance abuse in conjunction with PTSD.   This finding is in 
line with the “common belief” that the enlisted personnel were easily 
susceptible to substance abuse upon PTSD diagnosis.   This could also be 
attributable to the fact that the enlisted personnel were much more likely to 
develop severe PTSD symptoms as compared to the officers, given that the 
enlisted personnel are responsible for the executional roles of the combat 
missions as compared to the officers who hold supervisory roles. 
While it was common for mental health related illness to 
dominate the PTSD comorbidity distribution pattern, acute illnesses (i.e. non 
mental health related illnesses) were also found to be a large category of 
comorbidity that was associated with PTSD, with nearly 40% of the enlisted 
population across the board, being treated for acute illness under inpatient 
admissions during the study period. 
b. Frequency of Site Visits 
Similar to the findings for the officer population, it was clear that 
the majority of the enlisted PTSD population (especially the Army and Navy) 
had visited MTFs for PTSD related treatment between FY2001 and FY2006, 
with the Marine Corps enlisted personnel accounting for 77.9%, and 50% of 
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the Army enlisted personnel being admitted into MTFs only for PTSD related 
treatment.   Overall, the Army enlisted personnel had the highest percentage 
of 8.6% of inpatient admissions at both the MTFs and civilian medical 
providers.   
c. Average Treatment Costs and Length of Stay 
As gathered from information in the inpatient records, the 
average treatment costs for PTSD (and related illnesses) at the MTFs among 
the enlisted population fell within the range of $8,751 to $10,164 per claim 
between FY2001 and FY2006; with the Air Force and Marine Corps enlisted 
personnel incurring the highest treatment costs of over $10,000 per claim for 
being admitted and receiving treatment at MTFs.    Similarly, for the average 
treatment costs at the TRICARE civilian medical providers, the enlisted 
personnel from the Marine Corps incurred the highest costs of $9,894 for 
PTSD related admissions.   The amount of the average treatment costs could 
be further explained by the average length of stay at the treatment facilities 
(military and civilian) in view of the fact that the longer a period of stay at the 
treatment facility, the higher the treatment costs.   For instance, the average 
length of stay for the enlisted personnel at the treatment facilities across the 
Services was approximately 8-10 days, with the longest duration of stay for 
both the Army and Marine Corps enlisted personnel. 
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Enlisted Personnel (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Depression  34.4 9.1 42.3 19.0 28.6 13.3 33.9 15.7 
Substance Abuse  28.6 6.7 22.2 6.0 38.3 13.3 25.2 8.6 
Other Psychosis  10.2 2.0 11.0 2.2 7.2 1.7 6.5 2.9 
Other Mental Health Illness  21.7 14.8 23.6 18.5 22.5 13.8 31.3 19.8 
Unspecified mental and behavioral problems 
(V40) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
External causes of Injury  3.2 0.2 0.7 0.0 4.4 3.5 3.5 0.8 
Other V-code diagnoses (excluding V40) 26.8 9.9 18.7 11.9 47.0 15.9 46.0 9.6 
Acute illness (any numerical ICD 9 that is 
<290 and >319, exclude E and V codes)  43.2 7.5 40.0 5.8 36.2 6.4 40.0 4.6 
Count of Mental Health Illness Comorbidity   
0 18.0 69.3 11.0 58.3 15.2 60.8 13.8 56.5 
1 70.0 28.9 78.5 37.8 73.1 36.4 75.5 40.2 
2 12.6 1.8 10.5 3.8 11.8 2.8 10.7 3.2 
>2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 
 
Count of Acute Illness Comorbidity   
0 43.6 83.8 51.4 83.3 33.5 76.7 35.0 86.3 
1 40.7 14.7 38.1 15.5 47.8 21.1 42.9 12.5 
2 14.6 1.4 10.3 1.1 16.4 2.1 19.7 1.2 
>2 1.2 0.0 0.2 0.0 2.3 0.2 2.4 0.0 
Visit Site (%)   
MTF 50.0 78.6 30.0 67.5 77.9 84.9 64.6 86.9 
TRICARE Providers 41.5 7.0 67.5 11.1 18.5 5.8 32.2 3.5 
Both MTF and TRICARE Civilian Providers 8.6 14.4 2.6 21.4 3.6 9.3 3.1 9.6 
Total Number of Claims 2,256 151,940 428 29,941 475 27,282 543 38,773 
Average Treatment Costs ($)   
MTF   
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Enlisted Personnel (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Total Cost  9,910.86 235.20 10,164.29 370.89 10,127.63 257.91 8,751.18 266.08 
Total Pharmacy Cost   17.47   29.84   24.14   24.17 
Total Number of Claims 1,321 141,273 139 26,621 387 25,698 368 37,426 
TRICARE Civilian Providers   
Bill Charged 9,764.05 249.88 9,654.25 329.87 9,893.54 272.34 8,483.73 223.43 
Bill Allowed 5,123.97 174.69 4,217.74 171.89 5,198.67 136.37 3,961.47 149.12 
Total Number of Claims 1,129 32,468 300 9,731 105 4,124 192 5,065 
Length of Stay(Average number of days) 10.66   9.21   10.68   8.82   
Number of Claims 2,256   428   475   543   
Table 7.3. PTSD Comorbidity Distribution for Enlisted PTSD Population across Services (Claims/Visits level)  
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2.2 Enlisted PTSD Population – Outpatient Visits (Table 7.3) 
In contrast to the inpatient records for the officer population, there were 
many more claims from the enlisted population for outpatient treatment for PTSD 
related diagnosis during the study period as shown in Table 7.3.   There were a 
total of 247,936 enlisted personnel claims or visits to the military and civilian 
treatment facilities for PTSD related illness between FY2001 and FY2006, with 
the Army enlisted personnel contributing the largest portion for outpatient PTSD 
treatment, i.e. a total of 151,940 claims were made out to outpatient services 
rendered at the MTFs or TRICARE civilian medical providers, while the Navy 
enlisted personnel had 38,773 outpatient visits for PTSD related treatment during 
the span of the study period. 
a. Mental Health Illness Indicators 
On enlisted personnel inpatient claims records, other mental health 
illnesses accounted for more than 15% as the dominant comorbidity associated 
with PTSD outpatient treatment across the services.   About 19.8% of the Navy 
enlisted personnel who sought outpatient treatment were also diagnosed with 
other mental health illness; while 18.5% of the Air Force enlisted personnel were 
also diagnosed with other mental health illness and were given outpatient 
treatment.    In this case, both the Air Force and the Navy officers actually had 
higher incidences of outpatient visits for treatment of other mental health illness 
associated with PTSD than the Army and Marine Corps enlisted personnel.     
b. Frequency to Visit Sites 
Drawing reference to the visit sites in outpatient claims records, it 
was clear that majority of the enlisted PTSD population (especially the Marine 
Corps and the Navy with 84.9% and 86.9% respectively) had visited only MTFs 
for PTSD related outpatient treatment between FY2001 and FY2006, while only 
78.6% of the Army enlisted personnel visited only MTFs for their treatment. The 
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Marine Corps enlisted personnel reported the highest percentage – 84.8% of 
outpatient treatment at the MTFs only.   The Air Force enlisted personnel 
constituted the highest percentage of 67.5% of outpatient admissions at the 
TRICARE civilian medical providers during the same study period. 
In contrast with the officer population, the enlisted population had a 
lesser tendency to visit TRICARE civilian providers for their PTSD related 
outpatient treatment.   For example, the percentages for outpatient visits to these 
providers were generally below 10% across the Services, with the exception of 
11.1% of the Air Force enlisted personnel given outpatient services at the civilian 
TRICARE facilities for PTSD related treatment.    This difference in the visit sites 
between the enlisted personnel and the officers could be due to the fact that 
enlisted personnel were much more likely to go to the places (MTFs) they were 
familiar with and were relatively cheaper for treatment as compared to utilizing 
civilian healthcare services which could be more expensive to start with. 
c. Average Treatment Costs  
The average outpatient treatment costs for PTSD (and related 
mental health illnesses) at the MTFs were between $235 to $370 per claim 
between FY2001 and FY2006.   This range of costs for enlisted personnel is 
slightly higher than for the officers and could be due to the fact that there were 
many more outpatient services rendered to affected enlisted personnel as 
compared to the officers. 
The Air Force enlisted personnel contributed to the highest average 
outpatient treatment costs of $370 at MTFs with 26,621 claims, while 141,273 
claims from the Army enlisted personnel received treatment at MTFs at lower 
average treatment costs of $235 per claim.  Similarly, for the average treatment 
costs at TRICARE civilian medical providers, the enlisted personnel from the Air 
Force incurred the highest costs of $330 for PTSD related treatment.    
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D. ANALYSIS OF PTSD COMORBIDITY DISTRIBUTION AND 
TREATMENT COSTS ACROSS SERVICES AT INDIVIDUAL LEVELS 
This section will concentrate on the analysis of the PTSD comorbidity 
distribution and average treatment costs for inpatient and outpatient claims 
(visits) of both officers and enlisted populations based on individual levels across 
the four branches of service between FY2001 and FY2006.    Analogous to the 
analysis at claims (visits) level, this analysis at the individual level is divided into 
the officer population and the enlisted population based on both inpatient and 
outpatient level records from the military as well as the civilian treatment facilities.   
The distinct difference between the analysis at the individual level (based on 
unique EDIPN) and at the claims level is that the latter focuses on each of the 
active duty service personnel whom has been treated at either MTFs of 
TRICARE civilian providers, i.e. regardless of how many times the individual 
submitted the claims (i.e. regardless on the numbers of times of visits to any 
treatment facilities) during the study period.   To obtain the necessary results for 
analysis at the individual level across the services, the four clinical data sets 
(SIDR, SADR, TEDI and TEDN) are separately collapsed into streamlined files 
via unique EDIPNs.   
1.1 Officers and Warrant Officers PTSD Population – Inpatient 
Visits (Refer to Table 7.4) 
Based on Table 7.4, at an individual level, the Army had the most officers 
(total of 67) who had incidences of admissions to either MTFs or TRICARE 
civilian medical providers during the span of the study period, while the Air Force 
had 23 officers who had been admitted for PTSD related treatment.   
a. Mental Health Illness Indicators 
Similar to the analysis at the claims level, depression remained the 
dominant comorbidity associated with PTSD across the services and highest 
incidences of inpatient treatment/admissions besides PTSD.    The results at the 
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individual level were generally at the same threshold as at the claims level; for 
instance, 71.4% of the officers from Marine Corps’ PTSD population were also 
treated for depression and were admitted, while nearly 60% of the Army officers 
also suffered from depression besides being diagnosed with PTSD.    
Besides depression being the predominant comorbidity associated 
with PTSD, substance abuse (alcohol and drugs) and other mental health 
illnesses were also comorbidities that had a certain extent of impact on the 
officers’ PTSD population (as depicted in Table 7.4) just as in the outcomes for 
the claims level.   In fact, at the individual level, the officers from Air Force and 
Marine Corps had higher percentages (21% and 43% respectively) of being 
admitted into treatment facilities/hospitals for substance abuse in conjunction 
with PTSD treatment than at the claims level.   At the individual level, the 
proportion of active duty service personnel who were admitted for acute illness 
was generally high (i.e. more than 45%) across the services with the exception of 
the Marine Corps (only 14.3%).   For instance, the Navy officers showed 66.7% 
of the population being admitted for acute illness while 47.8% of the Air Force 
officers and 46.3% of the Army officers were admitted for acute illness. 
b. Frequency of Site Visits 
At the individual level, the Marine Corps officers had the highest 
percentage (71.4%) of the population being admitted only at the MTFs, while 
both the officers from the Army and Air Force constituted 52% of the admissions 
for PTSD related illnesses at the MTFs.   For the inpatient admission at the 
civilian providers from TRICARE, the Air Force officers had the highest 
percentage of 43.5% admissions at individual level as compared to the rest of the 
services. 
c. Average Treatment Costs and Length of Stay 
From the individual perspective, the average treatment costs for 
PTSD (and related illnesses) for both the MTFs and the civilian providers were 
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relatively higher than that of the claims level since the individual data files would 
have a much smaller base to spread the total costs for treatment during all visits 
to the facilities.   For instance, the average treatment costs for an Army officer 
between FY2001 and FY2006 was at $12,954 for being admitted and receiving 
treatment at MTFs.   This cost is calculated based on the number of Army 
officers, i.e. 67 personnel were diagnosed with PTSD and received treatment at 
MTFs.  Similarly for the average treatment costs at the TRICARE civilian medical 
providers, the officers from the Marine Corps incurred the highest costs of 
$51,929 per person for PTSD related treatment during hospital admissions.  This 
inflated amount could be attributed to the small officer sample size from the 
Marine Corps (i.e. there were only 6 officers in the data).   The amount of the 
average treatment costs could be further explained by the average length of stay 
at the treatment facilities (military and civilian) in view of the fact that the longer a 
period of stay at the treatment facility, the higher the treatment costs.   For 
instance, the average length of stay for Air Force Officers at the treatment 
facilities was the longest among the services (17.3 days) while both the Army 
and Marine Corps officers reached an average of nearly 15 days for hospital 
admissions for PTSD treatment. 
1.2 Officers and Warrant Officers PTSD Population – Outpatient 
Visits (Refer to Table 7.4) 
On the whole, the trends for the outpatient visits at the individual level 
analysis were very much like the claims level, with the only difference being the 
magnitude of the various categories of comparison.    The number of officers who 
received outpatient treatment for PTSD related illnesses was highest for the 
Army, i.e. 1,202 among the four services between FY2001 and FY2006.   The 
Marine Corps officers appeared to have the lowest number of individuals – 126, 
seeking outpatient treatment at both the military and civilian treatment facilities.    
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a. Mental Health Illness Indicators 
Similar to the analysis at the claims level, depression remained the 
dominant comorbidity associated with PTSD across the services and had the 
highest incidence of inpatient treatment/admissions besides PTSD.    The results 
at the individual level were generally at the same threshold as at the claims level; 
for instance, the Marine Corps officers had the highest percentage of 23% 
seeking outpatient treatment for depression. 
Besides depression being the predominant comorbidity associated 
with PTSD, at the individual level, there were more officers being treated under 
the outpatient setting for other PTSD related mental health illnesses than for 
substance abuse.   In fact, the officers from Air Force and Navy had significantly 
higher percentages (30% and 28% respectively) of receiving outpatient treatment 
from military and civilian treatment facilities for other mental health illnesses than 
the Army or Marine Corp officers.    
b. Frequency of Site Visits 
At the individual level, as high as 83.4% of the Navy officers sought 
outpatient treatment at the MTFs only; while 23.6% of the officers from the Air 
Force received outpatient treatment at TRICARE civilian providers.  Generally, 
MTFs remained the places most frequented by individuals who sought outpatient 
treatment for PTSD related illnesses. 
c. Average Treatment Costs  
From the individual perspective, the average outpatient treatment 
costs for PTSD (and related illnesses) for both the MTFs and the civilian 
providers were relatively higher than that at the claims level since the individual 
data files would have had a much smaller base over which to spread the total 
costs for treatment during all visits to the facilities.   For instance, the average 
outpatient treatment costs for an Army officer between FY2001 and FY2006 was 
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at $1,811 at MTFs and $1,693 at civilian medical providers.   The Air Force 
officers incurred the highest average costs of $3,513 per person for PTSD 
related treatment at MTFs only; and the Marine Corps officers incurred the 
highest average costs of $2,038 for outpatient treatment at the TRICARE civilian 
providers, as illustrated in Table 7.4. 
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Officers (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Depression  59.7 16.6 47.8 21.1 71.4 23.0 26.7 17.3 
Substance Abuse  17.9 4.2 21.7 3.8 42.9 6.4 13.3 6.1 
Other Psychosis  11.9 2.7 8.7 1.9 14.3 4.8 6.7 4.4 
Other Mental Health Illness  17.9 27.6 26.1 30.4 28.6 19.1 26.7 28.1 
Unspecified mental and behavioral problems 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
External causes of Injury  1.5 0.2 4.4 0.5 0.0 2.4 0.0 0.7 
Other V-code diagnoses (excluding V40) 29.9 19.1 34.8 22.0 28.6 20.6 40.0 18.6 
Acute illness (any numerical ICD 9 that is 
<290 and >319, exclude E and V codes)  46.3 22.6 47.8 19.5 14.3 8.7 66.7 12.9 
Count of Mental Health Illness 
Comorbidity   
0 11.9 57.9 17.4 54.7 0.0 60.3 33.3 56.6 
1 68.7 33.7 69.6 35.2 57.1 28.6 60.0 32.9 
2 19.4 7.6 8.7 8.4 28.6 8.7 6.7 8.8 
>2 0.0 0.7 4.4 1.6 14.3 2.4 0.0 1.7 
Count of Acute Illness Comorbidity   
0 38.8 65.5 30.4 65.9 57.1 73.0 13.3 73.2 
1 44.8 27.2 52.2 26.6 42.9 22.2 66.7 21.4 
2 16.4 7.2 17.4 7.3 0.0 4.8 20.0 5.4 
>2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 
Visit Site (%)                 
MTF 52.2 77.3 52.2 68.3 71.4 71.4 60.0 83.4 
TRICARE Providers 41.8 13.9 43.5 23.6 14.3 19.8 33.3 9.5 
Both 5.9 8.8 4.4 8.1 14.3 8.8 6.7 7.1 
Total Number of Individuals 67 1,202 23 369 7 126 15 295 
  
Average Treatment Costs($)   
MTF   
Total Cost 12,954.27 1,811.73 8,787.64 3,513.89 7,027.07 2,189.92 7,323.72 2,608.36
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Officers (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Total Pharmacy Cost  124.8518  238.96  197.049  181.05 
Number of Individuals 38 1033 13 282 6 99 10 263 
                  
TRICARE Providers   
Bill Charged 14,758.03 1,693.13 29,836.63 1,374.96 51,929.56 2,038.61 5,828.20 1,656.44
Bill Allowed 5,914.04 1,105.58 16,723.41 976.04 28,986.40 1,091.00 2,916.50 1,040.79
Number of Individuals 32 273 11 117 2 36 6 49 
  
Length of Stay(Average) 14.34  17.26  14.71  6.87   
Number of Individual Claims 67  23  7  15   
Table 7.4. Overall PTSD Comorbidity Distribution and Average Treatment Costs for Officers Population 

















Enlisted Personnel (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Depression  35.3 12.6 46.5 20.1 30,0 16.4 34.2 17.3 
Substance Abuse  30.2 10.7 23.1 8.1 39.0 15.2 25.7 12.3 
Other Psychosis  10.9 3.4 11.4 3.3 7.8 2.8 7.1 3.7 
Other Mental Health Illness  24.9 30.7 26.0 30.0 24.6 27.2 33.5 35.9 
Unspecified mental and behavioral problems 
(V40) 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 
External causes of Injury  3.7 0.5 0.8 0.3 5.4 5.4 4.0 1.5 
Other V-code diagnoses (excluding V40) 29.2 22.0 20.1 23.7 51.2 24.3 47.9 20.2 
Acute illness (any numerical ICD 9 that is <290 
and >319, exclude E and V codes)  46.4 19.3 43.3 15.8 38.8 14.4 41.5 12.8 
Count of Mental Health Illness Comorbidity   
0 16.6 54.2 10.5 50.8 15.0 51.6 13.4 44.7 
1 66.6 35.7 73.1 38.7 68.9 37.0 73.0 43.3 
2 15.5 8.3 15.2 8.7 15.8 9.5 13.4 10.1 
>2 1.2 1.7 1.2 1.7 0.3 1.8 0.2 1.9 
Count of Acute Illness Comorbidity   
0 40.5 65.6 47.9 67.3 31.0 64.7 33.5 71.4 
1 41.2 26.8 40.1 25.6 45.7 26.9 42.6 23.0 
2 16.7 7.3 11.7 7.1 20.2 7.9 20.7 5.4 
>2 1.6 0.2 0.3 0.1 3.1 0.5 3.1 0.2 
Visit Site (%)   
MTF 49.2 84.1 30.4 76.9 78.8 87.2 63.4 90.0 
TRICARE Civilian Providers 43.6 9.3 67.3 12.8 18.1 8.2 34.2 5.2 
Both 7.1 6.6 2.3 10.3 3.1 4.6 2.5 4.8 
Total Number of Individuals 1,806 19,444 342 3,567 387 4,244 448 4,896 
  
Average Treatment Costs($)   
MTF   
Total Cost 12,954.27 1,808.88 12,574.90 2,956.76 12,191.85 1,654.84 10,723.06 2,101.21 
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Enlisted Personnel (in percentage) Army Air Force Marine Corps Navy 
Mental Health Illness Indicators  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Total Pharmacy Cost   122.4138   176.87   138.0972   138.86 
Number of Individuals 996 17,525 112 3,104 317 3,859 295 4,612 
                  
TRICARE Civilian Providers   
Bill Charged 11,809.04 1,337.19 12,154.65 1,861.90 12,341.05 1,153.64 9,912.36 1,239.17 
Bill Allowed 6,185.78 873.40 5,305.99 1,129.57 6,503.80 684.24 4,628.15 753.35 
Number of Individuals 917 3,091 238 824 82 544 164 492 
  
Length of Stay(Average) 13.04  11.49  12.87  10.58  
Number of Individual Claims 1,806  342  387  448  
Table 7.5. Overall PTSD Comorbidity Distribution and Average Treatment Costs for Enlisted Population 
across Services (Individual level)
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2.1 Enlisted PTSD Population – Inpatient Visits (Table 7.5) 
Given the operational profiles and mission requirements of the different 
services, there were a higher number of enlisted personnel (as compared to the 
officer population) across the services who were admitted for PTSD related 
treatments at either the MTFs or the TRICARE civilian medical providers as 
shown in Table 7.5.   A total of 1,806 Army enlisted personnel had been admitted 
during the study period for PTSD related treatment and this was at least four 
times more than other services.   In contrast to evidence in existing literature, it 
was found that the Navy enlisted personnel (total of 448 of them and 15% more 
than the Marine Corps) accounted for the next largest group of personnel who 
had prior admissions for PTSD treatment between FY2001 and FY2006.   This 
would imply that despite different operational profiles between the Navy and the 
Marine Corps, the Navy enlisted personnel were just as susceptible to PTSD 
risks as the GWOT continued. 
a. Mental Health Illness Indicators 
As derived from the data, and shown in Table 7.5, it was found that 
depression remained the dominant comorbidity associated with PTSD among the 
enlisted personnel across the services and was the most frequent co-morbidity 
among inpatient admissions in addition to PTSD.    There was a significantly 
higher percentage of the PTSD enlisted population who also suffered from 
depression and had been previously admitted to hospitals across the different 
branches of services.   For instance, 46.5% of the Air Force enlisted PTSD 
population were the largest proportion who were previously admitted for 
treatment of depression; while nearly 35% of both the Army and Navy enlisted 
personnel were admitted for depression.    Substance abuse and other mental 
health illnesses were also PTSD comorbidities that had a certain extent of impact 
on the enlisted PTSD population (as depicted in Table 7.5).   The enlisted 
personnel from the Marine Corps PTSD population had the highest percentage 
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(39%) among the four services to also be admitted for substance abuse.  This 
finding is in line with the existing literature that enlisted personnel suffering from 
PTSD were susceptible to substance abuse as well.   While it was common for 
mental health related illness to dominate the PTSD comorbidity distribution 
pattern, acute illnesses (i.e. non mental health related illnesses) were also found 
to be one large category of comorbidity that was associated with PTSD, with 
nearly 40% of the enlisted population across the board being treated for acute 
illness under inpatient admissions during the study period. 
b. Frequency of Site Visits 
Similar to the findings for the officer population, it was clear that the 
majority of the enlisted PTSD population (especially the Army and Navy) were 
admitted to MTFs for PTSD related treatment between FY2001 and FY2006, with 
the Marine Corps enlisted personnel accounting for 78.8%, Navy enlisted 
personnel with 63.4% having prior admissions at MTFs and 49% of the Army 
enlisted personnel of being admitted into MTFs for PTSD related treatment.   Air 
Force enlisted personnel were reported as having the highest percentage - 
67.3% of inpatient admissions at civilian hospitals under TRICARE.   Overall, the 
Army enlisted personnel had the highest percentage (7.1%) of having had prior 
admissions to both the MTFs and civilian medical providers.  
c. Average Treatment Costs and Length of Stay 
At the individual level, the Army enlisted personnel incurred the 
highest average treatment costs of $12,954 for PTSD and related illness 
admissions at the MTFs among the enlisted population; the Air Force and Marine 
Corps enlisted personnel incurred average treatment costs of over $10,000 per 
person for being admitted and receiving treatment at MTFs during the same 
period.    The Marine Corps enlisted personnel incurred the highest costs for 
admissions to TRICARE civilian providers at $12,341.   The average treatment 
costs could be further explained by the average length of stay at the treatment 
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facilities (military and civilian) in view of the fact that the longer a period of stay at 
the treatment facility, the higher the treatment costs.   For instance, the average 
length of stay for enlisted personnel at the treatment facilities across the services 
was the longest for both the Army and the Marine Corps enlisted personnel at 13 
days.  
2.2 Enlisted PTSD Population – Outpatient Visits (Refer to Table 
7.5) 
In contrast to the inpatient records for the enlisted population, records 
showed many more personnel from the enlisted population seeking outpatient 
treatment for PTSD related illnesses during the study period as shown in Table 
7.5.   The Army enlisted population was at the top of the list with 19,444 persons 
who received outpatient treatment from either the MTFs or the TRICARE civilian 
providers, while the enlisted personnel from the Navy, totaled 4,896 personnel 
and ranked second in terms of numbers. 
a. Mental Health Illness Indicators 
In contrast with the inpatient records for enlisted personnel at the 
individual level, other mental health illness accounted for more than 30% of the 
respective enlisted personnel across the services as the dominant comorbidity 
associated with PTSD outpatient treatment at the military and civilian facilities 
(except for Marine Corps at 27.2%).   Enlisted personnel from the Navy ranked 
with the highest percentage of 35.9% being treated for other mental illness as 
compared with the rest of the services.  While it could be inferred that there were 
definitely more personnel responding to outpatient treatment (i.e. medication, 
rehabilitation and behavioral therapy) for PTSD related comorbidities given the 
rising trends of PTSD incidences among the active duty service personnel in the 
GWOT, it was also important to note the substantial numbers among the Navy 
enlisted personnel who required outpatient treatment for PTSD related 
comorbidities. 
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b. Frequency of Site Visits 
Based on Table 7.5, it was evident that the majority of the enlisted 
PTSD population, especially the Marine Corp and the Navy with 87.2% and 90% 
respectively, had visited only MTFs for PTSD related outpatient treatment 
between FY2001 and FY2006; while 84.1% of the Army enlisted personnel and 
76.9% of the Air Force enlisted personnel visited only MTFs for outpatient 
treatment.   In contrast with the officer population, the enlisted population showed 
lesser tendency to visit TRICARE civilian providers for their PTSD related 
outpatient treatment.   For example, the percentages for outpatient visits to these 
providers were generally below 10% across the services for PTSD related 
treatment. The enlisted personnel from the Air Force had the highest percentage 
of its population (10.3%) who were treated at both the MTFs and the TRICARE 
civilian medical providers for PTSD related outpatient treatment.  
c. Average Treatment Costs  
At the individual level, the Air Force enlisted personnel incurred the 
highest costs for outpatient treatment at MTFs at $2,956.   For the average 
treatment costs at the TRICARE civilian medical providers, the enlisted 
personnel from the Air Force again had the highest costs of $1,861 per person 
for PTSD related outpatient treatment.   It appeared that the Air Force enlisted 
personnel had higher rates of outpatient treatment/services rendered for PTSD 
related treatment as compared to other services.  As the outpatient 
services/treatment for PTSD included mostly rehabilitation and medication, it 
could be inferred that the severity of PTSD symptoms amongst the Air Force 
enlisted personnel may have been way below those of the Army or the Marine 
Corps. 
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E. ANALYSIS OF DEMOGRAPHICS AT INDIVIDUAL LEVEL – GENDER 
AND RACE ON THE PTSD COMORBIDITY  
This section further extends the discussion of the PTSD comorbidity 
distribution at the individual level via the demographics of gender (male and 
female) and race (white and non white).51    The purpose of this was to assess 
whether there were potential differences in the PTSD comorbidity distribution and 
treatment costs for different demographic groups.   In addition, only the mental 
illness comorbidity component between the officer and enlisted population across 
the services will be evaluated here.  This section will also describe the potential 
differences between the inpatient52 and outpatient treatment trends between 
male and female within the respective officer and enlisted populations across the 
different branches of services.    
1.1  Officers and Warrant Officers PTSD Population – Analysis by   
 Gender (Table 7.6) 
a. Inpatient Records 
As shown in Table 7.6, depression was the dominant PTSD 
comorbidity among the officer population, especially amongst the female officers 
across the services.    Compared to the male officers, 64.3% of the female Army 
officers had prior admissions which were for treatment of depression, and this 
was significantly higher than female officers of the other services.   This could be 
inferred to mean that female personnel were more likely to succumb to 
depression given both exogenous (i.e. deployment characteristics, location etc) 
and endogenous factors (personality, emotion driven).   In addition, the difference 
could also be due to the fact that despite the social stigma associated with 
                                            
51 Non white population refers to personnel whose race is Black, Hispanic, Asian or other 
minority races. 
52 Inpatient records denote the admission history to either the MTFs or the TRICARE civilian 
providers, while the outpatient records denote the outpatient treatment received at either the 
MTFs or the TRICARE civilian providers. 
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PTSD, females were more willing to seek treatment for PTSD related comorbidity 
as compared to males. 
Based on the data, it was found that female officers were more 
likely to have at least one comorbidity associated with PTSD.  The Air Force 
male officers had the highest percentage of 69% to have prior inpatient 
admissions at MTFs only for PTSD related treatment.   It was also found that Air 
Force female officers had the highest percentage (40%) of being admitted for 
substance abuse treatment.   Of the Air Force female officers, 50% too were 
previously admitted for other mental health illness as compared to the females 
from the other services.  It could be inferred that the MTFs remained the most 
frequented venue for PTSD related treatment (for both inpatient and outpatient 
services) across the different branches of service as shown in Table 7.6.    
b. Outpatient Records 
Under the outpatient treatment profiles, depression remained the 
most common PTSD related comorbidity among the officer population across the 
services, with the females at the highest numbers during the study period.   For 
instance, the female officers from the Marine Corp constituted the highest 
proportion of personnel who sought outpatient treatment for depression problems 
at either the military or civilian medical facilities as shown in Table 7.6.    In terms 
of substance abuse, the female officers from the Marine Corps, too, showed the 
highest percentage of 12.5%, who were rendered outpatient treatment. 
While both the inpatient and outpatient records showed that most of 
the PTSD related treatment was conducted at the MTFs, i.e. with over half of the 
officers population being treated at MTFs only, it was interesting to note that 60% 
of the female officers from the Air Force actually were admitted at TRICARE 
civilian providers and 25% of them had visited only the civilian facilities for 
outpatient treatment.    It could be inferred from Table 7.6 that females tend to 
have more PTSD comorbidities as compared to their male counterparts. 
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Officers (By Gender) Army Air Force Marine Corps Navy 
(in percentage) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Mental Health Illness Indicators (%) M F M F M F M F M F M F M F M F 
Depression  56.4 64.3 14 23.9 46 50 14.8 26.9 66.7 100 22 31.3 12.5 42.9 14.4 21.5 
Substance Abuse  18.0 17.9 4.5 3.4 7.7 40 3.9 3.6 50 0 5.5 12.5 12.5 14.3 5.75 6.6 
Other Psychosis  15.4 7.1 2.2 3.9 7.7 10 2.27 1.5 16.7 0 4.6 6.2 0 14.3 4.0 4.9 
Other Mental Health Illness  23.1 10.7 27 28.5 7.7 50 32.4 28.5 33.3 0 19 18.8 37.5 14.3 23 35.5 
Unspecified mental and behavioral 
problems (V40) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Count of Mental Health Illness 
Comorbidity   
0 10.3 14.3 61 50.6 31 0 58.5 51.3 50 0 62 50 50 14.3 63.8 46.3 
1 66.7 71.4 31 39.9 69 70 31.8 38.3 33.3 100 28 31.3 37.5 85.7 27 41.3 
2 23.1 14.3 7.3 8.5 0 20 7.9 8.8 16.7 0 7.3 18.8 12.5 0 7.5 10.7 
>2 0 0 0.6 0.92 0 10 1.7 1.5 0 0 2.7 0 0 0 1.7 1.6 
Number of Individuals 39 28 876 326 13 10 176 193 6 1 110 16 8 7 174 121 
Visit Site (%)                                 
MTF 56.4 46.4 77 78.2 69 30 71.6 65.3 66.6 100 72 68.8 62.5 57.1 82.2 85.1 
TRICARE Providers 38.5 46.4 14 13.8 31 60 21.6 25.4 16.7 0 20 18.7 37.5 28.6 10.3 8.3 
Both 5.1 7.2 9.1 8 0 10 6.8 9.3 16.7 0 8.2 12.5 0 14.3 7.5 6.6 
Total Number of Individuals 67 1,202 23 369 7 126 15 295 
Table 7.6. Overall PTSD Comorbidity Distribution for Officer Population across Services (Individual Level 
- Gender) 
* M= Male 
F=Female
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1.2  Enlisted PTSD Population - Analysis by Gender (Table 7.7) 
a. Inpatient Records 
Similar to the officer population, the female enlisted personnel 
across the different branches of services showed a higher proportion of being 
admitted for depression problems.   Nearly half of the female Air Force enlisted 
personnel were admitted during the study period for depression, while nearly 
39% of the Army female enlisted personnel and 36% of the Navy female enlisted 
personnel were admitted to either the MTFs or civilian medical providers as 
illustrated in Table 7.7.  In addition, the female enlisted personnel across the 
services had a higher incidence of being admitted for other mental illness 
treatment as well.   For instance, 37.9% of the Navy female enlisted personnel 
were admitted to hospitals for other mental health illness problems.   On the 
contrary, the male enlisted personnel across the services accounted for higher 
percentages than their female counterparts when it came to substance abuse.   
The Marine Corps enlisted personnel were at the top of the list with over 41% of 
the Marine Corp enlisted population having prior admissions for substance abuse 
treatment between FY2001 and FY2006.    
b. Outpatient Records 
Depression was found to be a major PTSD comorbidity among the 
outpatient data samples across the services as can be seen in Table 7.7.  The 
female enlisted personnel across the services registered higher percentages of 
seeking outpatient treatment for depression and other mental health illnesses.   
The Air Force female enlisted personnel topped the list with nearly 24% of them 
who sought outpatient treatment for depression at either the military or civilian 
medical facilities between FY2001 and FY2006.   Nearly 40% of the Navy female 
enlisted personnel actually sought outpatient treatment for other mental health 
illnesses, outranking the Army or the Marine Corps.    
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Analogous to the inpatient records for the officers, most of the 
enlisted personnel (more than 50%) across the services were admitted and 
sought outpatient treatment at the MTFs only.   One of the possible reasons for 
the MTFs to be the most frequented places by the enlisted personnel could be 
due to the fact that the treatment costs there may be more affordable compared 
to the TRICARE civilian providers and the enlisted personnel may feel more at 
ease seeking treatment at one of the military bases.   
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Enlisted Personnel (By Gender) Army Air Force Marine Corps Navy 
(in percentage) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Mental Health Illness Indicators (%) M F M F M F M F M F M F M F M F 
Depression  34.2 39 11.67 16.7 41 50.5 16.1 23.5 29 35 15.5 22.3 32.7 36 15.4 20.1 
Substance Abuse  33.8 17.9 12 5.36 24 22.2 9.0 7.3 41.4 27 15.9 10.4 30.2 20.2 14.2 9.6 
Other Psychosis  11.3 9.3 3.3 3.8 9.5 12.9 2.56 3.8 6.5 14 2.7 3.42 6.12 8.4 3.3 4.0 
Other Mental Health Illness  21.5 36.5 29.9 33.67 25 26.8 27.8 31.8 22.5 35 26.6 30.8 29.8 37.9 33.1 39.8 
Unspecified mental and behavioral problems 
(V40) 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 
Count of Mental Health Illness Comorbidity   
0 18.7 9.8 55.1 50.7 14 8.2 54.7 47.5 16.4 7.9 52.2 47.5 15.5 10.8 48.2 39.8 
1 63.2 78.4 34.6 40.2 73 73.2 36.6 40.6 67.9 75 36.6 39.6 70.2 76.4 39.8 48.2 
2 16.8 11 8.41 7.9 14 16.5 7.3 9.8 15.7 16 9.2 11.5 14.3 12.3 10.1 10.1 
>2 1.3 0.7 1.77 1.15 0.00 2.1 1.3 2.0 0 1.6 1.9 1.44 0 0.5 2 1.7 
Number of Individuals 1,398 408 15,711 3,733 148 194 1,643 1,924 324 63 3,688 556 245 203 2,853 2,043 
Visit Site (%)   
MTF 46.7 57.6 83.6 86.4 27 33 77.9 76.0 77.5 86.0 86.6 91.2 62 65 89.6 90.5 
TRICARE Providers  45.9 35.5 9.4 8.8 72 64 12.3 13.2 19.7 9.5 8.6 5.6 34.7 33.5 5.7 4.5 
Both 7.2 6.9 7 4.8 1.4 3.0 9.8 10.8 2.8 4.8 4.8 3.2 3.3 1.5 4.7 5 
Total Number of Individuals 1,806 19,444 342 3,567 387 4,244 448 4,896 
Table 7.7. Overall PTSD Comorbidity Distribution for Enlisted Population across Services (Individual 
level- Gender) 
 




2.1  Officers and Warrant Officers PTSD Population – Analysis by 
Race (Table 7.8) 
a. Inpatient Records 
As illustrated in Table 7.8, depression appeared to be the common 
PTSD comorbidity among the white officers population across the services, with 
the white officers from the Army and the Marine Corps53 having over 60% of their 
population being admitted to either military or civilian treatment facilities between 
FY2001 and FY2006.    Based on the clinical data, it was also observed that 52% 
of the white officers from the Air Force suffered from depression and had been 
admitted during the study period as well, while the Navy officers constituted 30%.   
This clinical information on the Air Force and Navy’s PTSD population would be 
useful in providing some insights into the overall PTSD situation in view of the 
few or no statistics on those two services’ PTSD portfolios.   In addition to this, 
substance abuse was the other PTSD comorbidity which saw many of the white 
officers being admitted for treatment.  For instance, 50% of the white Marine 
Corps officers and 23% of both the Army and Air Force officers had been 
admitted between FY2001 and FY2006 for substance abuse. 
Other mental health illness seemed to be the most common PTSD 
comorbidity among the non white officer population across the services, with 
40% of Navy non white officers being admitted for PTSD treatment as compared 
to their white counterparts.   The Army and Air Force non white officer population, 
who were also admitted for other mental health illness as PTSD comorbidity, only 
accounted for 36.8% and 33.3% respectively as shown in Table 7.8.  
As illustrated in Table 7.8, Air Force officers have the highest 
percentage (76.5%) of having one mental illness comorbidity among the white 
 
                                            
53 As there was only one non white officer within the Marine Corp PTSD population in the 
sample, the admission incidence for the depression comorbidity for this individual should be taken 
as an exception and not affect the analysis for the white officers. 
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officers population who were admitted for PTSD related treatment; while the 
Army non white officers had the highest percentage (73.7%) in the same 
category.    
There was a larger proportion of the non white officers from the 
Services who were admitted at only MTFs for PTSD related treatment.   The 
Navy had the highest percentage (80%) of its non white officers who had 
admissions only at the MTFs for their PTSD related treatment; while the white 
officers from the Marine Corps had the highest percentage (66.7%) of personnel 
who had prior MTF admissions during the study period. 
b. Outpatient Records 
In outpatient records, the trend seemed to be reversed as there 
were higher percentages of non white officers from the services (except Navy) 
being treated for depression as PTSD comorbidity compared to the white 
officers.   The Marine Corps non white officers had the highest percentage of 
27% of its PTSD population seeking outpatient treatment for depression either at 
the MTFs or the TRICARE civilian providers.  For the other mental health illness 
comorbidity, the white officers seemed to constitute higher percentages of those 
being rendered outpatient treatment with the Air Force officers comprising 30% 
and the Navy officers being 28.7%. 
As highlighted in Table 7.8, the majority of the officers (more than 
55% of respective populations regardless of race) who had undergone outpatient 
treatment had no mental illness comorbidity.   From the perspective of the visit 
sites, it could be seen that most of the non white population from the different 
branches of services had only visited the MTFs for PTSD related outpatient 
treatment.  Navy non white officers were at the top of the list with 83% of the 
white officers and 84.5% of the non white officers who consulted only the MTFs 
for treatment.  
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2.2  Enlisted PTSD Population – Analysis by Race (Table 7.9) 
a. Inpatient Records 
As indicated in Table 7.9, the enlisted population from the Air Force 
showed the highest proportion of both the white (44.7%) and the non white 
population (51%) with depression as the most common PTSD comorbidity under 
an inpatient setting.   On the other hand, the enlisted population from the Marine 
Corp demonstrated the highest percentage of personnel – white (41.1%) and 
non-white (34.2%), having substance abuse as a PTSD comorbidity and 
admitted into either the MTFs or the TRICARE civilian providers between 
FY2001 and FY2006. 
Consistent with the previous findings, the majority of the enlisted 
population across the services had one count of mental illness comorbidity and 
prior admissions during the study period.  Notably, 81% of the non white enlisted 
personnel from the Air Force were found to have one mental illness comorbidity 
during the study period, while 74% of the white enlisted personnel from the Navy 
formed the highest proportion of the whites to have one mental illness 
comorbidity. 
Similar to the officer population, the non white enlisted personnel 
from the different services accounted for relatively higher proportion to have only 
sought outpatient treatment at either MTFs or the TRICARE civilian providers as 
compared to their white counterparts.    Among them, 84.6% of the Marine Corps 
non white enlisted personnel went only to the MTF for outpatient treatment of the 
PTSD related comorbidity and Army non white enlisted personnel accounted for 
55.8%.    As depicted in Table 7.9, it was presented that enlisted personnel from 
the Air Force had higher incidences for both the white (67.9%) and non white 
(66%) for inpatient admissions into TRICARE civilian providers only as compared 
to the MTFs. 
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b. Outpatient Records 
As indicated in Table 7.9, it was found that other mental health 
illness was the most common PTSD comorbidity with more than one-third of the 
enlisted personnel from the different services seeking outpatient treatment at 
either the military or the civilian treatment facilities.   A result was that both the 
white and non white enlisted personnel from the Navy (36.5% and 35% 
respectively) contributed to the highest percentage of personnel who were also 
seeking outpatient treatment for other mental illness comorbidity; while the Army 
enlisted personnel came close to about 31% for both distinct groups. 
Similar to the inpatient records, the majority of the enlisted 
population across the services had one count of mental illness comorbidity for 
outpatient treatment during the study period.  Notably, the Navy enlisted 
personnel – both white and non white personnel – were 43% and 44% 
respectively.   
Similar to the officer population, the non white enlisted personnel 
from the different services accounted for a relatively higher proportion to have 
only sought outpatient treatment at either MTFs or the TRICARE civilian 
providers as compared to their white counterparts.    Among them, 91.4% of the 
Navy non white enlisted personnel went only to the MTF for outpatient treatment 
of the PTSD related comorbidity.   The Marine Corps non white enlisted 
personnel accounted for 89.1%.    As depicted in Table 7.9, the enlisted 
personnel from the Air Force had higher incidences for both the white (67.9%) 
and non white (66%) for inpatient admissions into TRICARE civilian providers 
only as compared to the MTFs. 
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Officers (By Race) Army Air Force Marine Corps Navy 
(in percentage) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Mental Health Illness Indicators (%) W NW W NW W NW W NW W NW W NW W NW W NW 
Depression  60.4 57.9 15.6 18.9 52.9 33 20 25 66.7 100 22.5 27 30 20 19 10.3 
Substance Abuse  22.9 5.26 4.75 2.65 23.5 17 3.8 3.7 50 0 6.31 6.7 10 20 5.91 6.9 
Other Psychosis  14.6 5.26 3.01 1.77 0 33 2.1 1.2 16.7 0 5.41 0 0 20 4.64 3.45 
Other Mental Health Illness  10.4 36.8 28.4 25.7 23.5 33 31 30 33.3 0 19.8 13 20 40 28.7 25.9 
Unspecified mental & behavioral 
problems (V40) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Count of Mental Health Illness 
Comorbidity   
0 12.5 10.5 57.6 59 11.8 33 55 53 0 0 59.5 67 40 20 55.7 60.3 
1 66.7 73.7 33.8 33.3 76.5 50 35 35 50 100 29.7 20 60 20 32.5 34.5 
2 20.8 15.8 7.76 7.37 11.8 0 7.3 12 33.3 0 8.11 13 0 20 10.1 3.45 
>2 0 0 0.81 0.29 0 17 2.1 0 16.7 0 2.7 0 0 0 1.69 1.72 
Number of Individuals 48 19 863 339 17 6 288 81 6 1 111 15 10 5 237 58 
Visit Site (%)   
MTF 50 57.9 75.4 82 47.1 67 66 75 66.7 100 71.2 73 50 80 83.1 84.5 
TRICARE Providers 43.7 36.8 15.2 10.6 47.1 33 26 16 16.7 0 19.8 20 40 20 10.1 6.9 
Both 6.3 5.3 9.4 7.4 5.8 0 8 8.6 16.6 0 9 6.7 10 0 6.8 8.6 
Total Number of Individuals 67 1,202 23 369 7 126 15 295 
Table 7.8. Overall PTSD Comorbidity Distribution for Officers Population across Services (Individual 
Level – Race) 
 
* W=White population 
NW= Non White population (includes Black, Hispanic, Asian or other races)
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Enlisted Personnel (By Race) Army Air Force Marine Corps Navy 
(in percentage) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Mental Health Illness Indicators (%) W NW W NW W NW W NW W NW W NW W NW W NW 
Depression  34.2 37.4 11.91 14.02 44.7 51 19.81 21 28.5 33.3 16.31 16.5 33 35 17.3 17.4 
Substance Abuse  31.6 27.5 11.73 8.8 25.2 18 8.59 6.7 41.1 34.2 15.81 13.6 26 25 12.5 12 
Other Psychosis  11.4 9.72 3.55 3.1 11.8 10 3.32 3.1 6.67 10.3 2.81 2.63 7.6 6.4 4 3.09 
Other Mental Health Illness  26 22.8 31.26 29.57 24.4 30 30.38 29 23 28.2 28.03 25.1 33 35 36.5 34.9 
Unspecified mental and behavioral 
problems (V40) 0.00 0 0.06 0.1 0.00 0 0 0.1 0 0 0.13 0 0 0 0.03 0.05 
Count of Mental Health Illness 
Comorbidity   
0 15.3 19.4 53.53 55.75 12.6 5.2 50.53 52 15.9 12.8 50.58 54.3 13 14 44.4 45.2 
1 67.2 65.5 36.35 34.58 69.9 81 38.7 39 68.9 69.2 37.74 35.3 74 72 42.8 44.2 
2 16.5 13.4 8.41 8.15 16.3 13 8.93 8.1 15.2 17.1 9.81 8.64 13 14 10.9 8.72 
>2 0.99 1.68 1.72 1.52 1.22 1 1.83 1.4 0 0.85 1.88 1.73 0 0.6 1.87 1.95 
Number of Individuals 1,209 597 12,741 6,703 246 96 2,620 947 270 117 3,029 1,215 275 173 3,050 1,846 
Visit Site (%)   
MTF 46 55.8 82.5 87.1 30.1 31 75.1 82 76.3 84.6 86.4 89.1 62 66 89.1 91.4 
TRICARE Providers 47.3 36.2 10.4 7.3 67.9 66 13.8 10 20 13.7 8.9 6.6 36 32 5.4 4.9 
Both 6.7 8 7.1 5.5 2 3.1 11.1 8.2 3.7 1.7 4.7 4.3 2.6 2.3 5.5 3.7 
Total Number of Individuals 1,806 19,444 342 3,567 387 4,244 448 4,896 
Table 7.9. Overall PTSD Comorbidity Distribution for Enlisted Population across Services (Individual 
Level – Race) 
 
* W=White population 
NW= Non White population (includes Black, Hispanic, Asian or other races) 
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F. ANALYSIS OF DEMOGRAPHICS AT INDIVIDUAL LEVEL – GENDER 
AND RACE ON THE TREATMENT COSTS AND LENGTH OF STAY 
This section will examine the treatment cost patterns and the average 
length of stay (inpatient admissions) at the individual level across the different 
branches of services via gender and race.   The purpose of this section is to 
present the extent of the costs incurred for PTSD related inpatient and outpatient 
treatment either at the MTFs or the TRICARE civilian providers, as well as to 
assess the pattern of demographics having any length of stay.   This analysis will 
be divided into officers and enlisted PTSD population across the different 
branches of services based on gender and race. 
Generally, it could be seen that the average PTSD treatment costs per 
person for inpatient admissions and treatment were much higher than those of 
outpatient treatment at both the MTFs as well as the TRICARE civilian providers, 
in view of the differences in the complexity of the medical procedures between 
the two types of treatment.    Under the TRICARE system, the personnel were 
eligible for medical claims based on the TRICARE option plans they were 
enrolled in as depicted by the “bill allow”  variable.   In this section, the study will 
concentrate only on the treatment costs for PTSD and related illnesses to identify 
possible trends between different demographic characteristics. 
1. Average Treatment Costs and Length of Stay for Officers and 
Warrant Officers PTSD Population – by Gender (Table 7.10) 
As illustrated in Table 7.10, the average treatment costs for inpatient 
PTSD admissions at the MTFs for male officers were higher than their female 
counterparts (with the exception of the Navy).  The average PTSD treatment 
costs for a typical admission to a MTF for an Army male officer amounted to 
$12,642 as compared to the female counterpart at $12,048; while a male officer 




Comparatively speaking, the female officer from the Army incurred the highest 
inpatient treatment costs at $12,048 when compared to the female officers from 
the other services. 
Taking into account the inpatient treatments at the TRICARE civilian 
providers, it was found that the average costs for inpatient admissions were 
generally more expensive as compared to the MTFs.   Female officers across the 
services incurred higher costs when admitted to these facilities (with the 
exception of the Marine Corp as there was only one female officer who was 
admitted to MTF for PTSD related treatment) when compared with their male 
counterparts.   For instance, compared with the other services, the female officer 
from the Air Force had the highest average treatment costs of $43,419 for 
inpatient admissions between FY2001 and FY2006, while the Army female 
officers incurred $15,740 on average for civilian admissions.    For the male 
officers, the Marine Corps officers showed the highest average costs at civilian 
admissions of $51,929 during the same period. 
Consistent with the expensive inpatient treatment costs, the average 
length of hospital stay would be positively related.   As illustrated in Table 7.10, 
the female officers from the Air Force had the longest average length of stay of 
30.8 days at either the MTF or civilian treatment facilities as compared with the 
officer population.    The male officers from the Marine Corps, on the other hand, 
showed the longest duration of inpatient stay – 17 days when compared with the 
male officer population from the different services.  
From the outpatient treatment costs at the MTFs, it could be seen that the 
female officers from the services incurred higher average costs than their male 
counterparts.  For instance, the female officers from the Air Force incurred the 
highest outpatient costs of $4,181; while the female officers from the Marine 
Corps had average costs of $3,054 during the same period.      At the TRICARE 
civilian providers, the female officers from the Army had the highest outpatient 
costs of $2,767; and the male officers from the Marine Corps the highest at 
$2,186. 
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Overall, the male and female officers from the Army incurred the highest 
amount of inpatient treatment costs at the MTFs; while the female officers from 
the Air Force incurred the highest amount for the inpatient treatment at the 
TRICARE civilian providers.   The male officers from the Marine Corps, too, 
incurred the highest amount of treatment costs regarding TRICARE civilian 
providers.  The female officers from the services (except for Marine Corps) 
showed the tendency to have longer a length of stay at the treatment facilities as 
compared to their male counterparts.   
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Officers Army Air Force Marine Corps Navy 
(By Gender) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Average Cost ($) Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female 
MTF                                 
Total Cost 12,642.9 12,048.6 1,744.7 1,991.1 9,058.7 8,177.7 2,817.4 4,181.4 8,160.4 1,360.3 2,059.2 3,054.8 6,107.9 8,539.6 2,368.1 2,942.6 
Total Pharmacy Cost     125.5 123.0     197.3 278.9     186.6 267.8     168.4 198.9 
Number of Individuals 24 14 752 281 9 4 138 144 5 1 86 13 5 5 153 110 
                                  
TRICARE Providers   
Bill Charged 13,891.5 15,740.1 1,315.4 2,767.9 6,066.9 43,419.4 1,391.2 1,362.9 51,929.6 0.0 2,186.8 1,119.8 3,901.2 7,755.2 1,254.7 2,348.3 
Bill Allowed 5,653.9 6,208.9 855.8 1,816.3 1,970.0 25,153.9 995.3 961.7 28,986.4 0.0 1,172.0 588.7 1,693.4 4,139.6 816.0 1,427.9 
Number of Individuals 17 15 202 71 4 7 50 67 2 0 31 5 3 3 31 18 
                                  
Length of Stay(Av.) 13.62 15.36     6.85 30.80     17.00 1.00     4.75 9.29     
Number of Claims 39 28     13 10     6 1     8 7     
Table 7.10. Average PTSD Treatment Costs among Officer Population across Services (Gender) 
 




2. Average Treatment Costs and Length of Stay for Enlisted 
PTSD Population – by Gender (Table 7.11) 
As indicated in Table 7.11, the male enlisted personnel from the Air Force 
had the highest inpatient treatment costs - $15,441 for PTSD related admissions 
at the MTFs while the Army male enlisted personnel incurred costs of $13,920 
during the study period.    In contrast, the female enlisted personnel from the 
Marine Corps and the Navy incurred higher inpatient admission costs at the 
MTFs as compared to their male counterparts, accounting for $13,436 and 
$11,682 respectively.     
Based on records from TRICARE civilian providers, the male enlisted 
personnel from the Marine Corps appeared to have the highest inpatient 
treatment costs of $12,901 as compared to the male officers from the other 
services, while the female enlisted personnel from the Air Force had the highest 
treatment costs from inpatient treatment at the TRICARE civilian providers at 
$11,671.   Proportionally, with the high inpatient treatment costs, both male and 
female enlisted personnel from the Marine Corps experienced the longest 
average length of stay at 12.56 and 14.46 days respectively as shown in Table 
7.11. 
The outpatient treatment costs at the MTFs for the male enlisted 
population showed the highest amount being incurred by the Air Force male 
enlisted personnel, with an average cost of $2,786, followed by the Navy male 
enlisted personnel at $2,168.    Similarly, for the female population, the Air Force 
female enlisted personnel had the highest amount of treatment costs of $3,101 
as compared to the rest of the services.   Also, for the outpatient treatment at the 
TRICARE civilian providers, the Air Force enlisted personnel incurred the highest 
amounts of $1,566 and $2,094 for the male and female enlisted personnel 
respectively. 
Overall, it was surprising to note that Air Force male enlisted personnel 
had the highest inpatient and outpatient treatment costs at the MTFs when 
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compared to the rest of the services, especially the Army.   In addition, a point 
worth noting was the fact that the female enlisted personnel from the Air Force, 
too, incurred the highest amount for outpatient treatment at the MTFs.  The male 
enlisted personnel from the Marine Corps incurred the highest costs for the 
outpatient treatment at the TRICARE civilian providers instead.   While on the 
whole, both the Army and the Marine Corps enlisted personnel incurred 
substantial amount for the treatment costs of PTSD related illnesses during the 
study period, it was important to also note the rising costs that were incurred by 
both the Air Force and the Navy personnel. 
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Enlisted Personnel Army Air Force Marine Corps Navy 
 (By Gender) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Average Cost ($) Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female 
MTF                                 
Total Cost 13,920.1 10,205.9 1,843.9 1,662.3 15,441.3 10,855.1 2,786.3 3,103.7 11,919.1 13,436.1 1,615.9 1,902.8 9,913.9 11,682.1 2,168.0 2,009.3 
Total Pharmacy Cost     128.9 95.4     170.4 182.5     135.2 156.7     153.5 118.7 
Number of Individuals 737 259 14,148 3,377 42 70 1,437 1,667 260 57 3,335 524 160 135 2,674 1,944 
                                  
TRICARE Providers   
Bill Charged 12,156.9 10,312.9 1,346.2 1,291.3 12,736.5 11,671.3 1,566.0 2,094.9 12,901.5 7,795.5 1,170.3 985.2 10,066.9 9,710.0 1,130.3 1,406.3 
Bill Allowed 6,430.3 5,134.3 873.4 873.4 5,396.7 5,230.6 970.4 1,254.9 6,842.1 3,759.9 686.8 658.1 5,078.5 4,038.2 684.0 859.9 
Number of Individuals 744 173 2,584 507 108 130 363 461 73 9 495 49 93 71 298 194 
                                  
Length of Stay(Av.) 11.46 11.46     12.04 11.06     12.56 14.46     9.88 11.42     
Number of Claims 1398 408     148 194     324 63     245 203     
Table 7.11. Average PTSD Treatment Costs among Enlisted Population across Services (Gender)  





3. Average Treatment Costs and Length of Stay for Officers and 
Warrant Officers PTSD Population – by Race (Table 7.12) 
As illustrated in Table 7.12, the Army officers incurred the highest costs for 
inpatient admissions at $11,313 for the white officers and $14,829 for the non 
white officers.   At the TRICARE civilian providers, the Air Force non white 
officers accounted for the highest inpatient treatment costs at $117,622 while the 
Army white officers incurred the highest amount across the white officers’ 
population from the services at $17,456 between FY2001 and FY2006.  
The average length of stay for the white officers from the Army was the 
longest at 16.15 days as compared to the other services while the male officers 
from the Marine Corps showed a length of 15.17 days.   The length of stay for the 
non white officers from the Air Force was the longest at 45.33 days on average.   
This could be due to the fact that there was only a small sample size from the 
non white officers from the Air Force, but nevertheless, the overall proportion was 
still worth attention. 
The outpatient treatment costs at the MTFs for both the white officers and 
the non white officers from the Air Force showed the highest amount of $3,869 
and $2,395 respectively.   At the TRICARE civilian providers’ level, the outpatient 
treatment costs for the white officers from the Marine Corps was the highest at 
$2,257; while the outpatient costs for the non white officers from the Army were 
the highest at $1,171.    
Overall, there was evident information that the white officers from the 
Army had incurred substantial amount of inpatient treatment costs at the MTFs 
while the non white officers from the Air Force chalked up the highest amount for 
the inpatient treatment at the TRICARE civilian providers.   This was further 
exemplified by the fact that the average length of stay for the two groups of 
personnel from the Army and Air Force was also the longest as compared to the 




Officers  Army Air Force Marine Corps Navy 
(Race) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Average Cost ($) White Non W White Non W White Non W White Non W White Non W White Non W White Non W White Non W 
MTF   
Total Cost 11,313.8 14,829.4 1,805.3 1,827.3 6,862.9 13,118.4 3,869.1 2,395.9 6,458.9 9,867.8 2,207.1 2,065.4 8,281.8 5,886.6 2,757.2 1,989.8 
Total Pharmacy Cost   126.3 121.3   269.6 142.4   200.7 170.2   185.9 162.0 
Number of claims 26 12 730 303 9 4 214 68 5 0 87 12 6 4 212 51 
Overall Total 38 1,033 13 282 5 99 10 263 
    
TRICARE Providers   
Bill Charged 17,456.8 6,661.9 1,843.2 1,171.4 10,328.7 117,622.5 1,438.9 1,064.8 51,929.6 0.0 2,257.2 290.0 6,633.9 1,799.6 1,818.9 934.5 
Bill Allowed 6,937.0 2,845.1 1,234.6 657.0 4,692.8 70,861.2 1,014.7 788.6 28,986.4 0.0 1,206.0 170.7 3,176.5 1,616.5 1,149.5 557.5 
Number of claims 24 8 212 61 9 2 97 20 2 1 32 4 5 1 40 9 
Overall Total 32 273 11 117 3 36 6 49 
  
Length of Stay(Average) 16.15 9.79   7.35 45.33   15.17 12   7.8 5     
Number of Claims 48 19     17 6     6 1     10 5     
Table 7.12. Average PTSD Treatment Costs among Officers Population across Services (Race) 
 
* W=White population 
NW= Non White population (includes Black, Hispanic, Asian or other races) 
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4. Average Treatment Costs and Length of Stay for Enlisted 
PTSD Population – by Race (Table 7.13) 
As illustrated in Table 7.13, the Army enlisted personnel (both the whites 
and the non whites) showed the highest average amount of inpatient treatment 
costs at the MTFs at $12,575 and $13,582 respectively; followed by the white 
enlisted personnel from the Air Force at $12,393 and the non white enlisted 
personnel from the Marine Corps at $13,570 during the same time frame of 
FY2001 to FY2006.    Both the Army and the Marine Corps enlisted personnel 
experienced the longest duration of stay for inpatient admissions for the white 
enlisted personnel at 12.64 days and 15.5 days for the non white enlisted 
personnel respectively. 
The white enlisted personnel from the Air Force incurred the highest costs 
for inpatient stay at the TRICARE civilian providers at $13,018; while the Army 
non white enlisted personnel had the highest treatment costs at $12,300.   On 
the whole there seemed to be a trend toward non white enlisted personnel 
having a longer duration of hospitalization as compared to the white enlisted 
personnel (except for the Air Force enlisted personnel who had a similar 11 days 
of stay on average).  This could be attributed to the fact that the enlisted 
personnel were usually the frontline troops during combat and were more likely to 
be exposed to PTSD risks as compared to the officers. 
In terms of outpatient treatment costs, both the white and non white 
enlisted personnel from the Air Force remained the highest users of medical 
services rendered at the MTFs and TRICARE civilian providers for PTSD and 
related illness.  At the MTFs, the white and non white enlisted personnel from the 
Air Force incurred $3,044 and $2,723 respectively; while at the civilian providers, 
the white and the non white enlisted personnel incurred costs of $1,900 and 
$1,715   respectively. 
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Enlisted Personnel Army Air Force Marine Corps Navy 
(Race) Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient 
Average Cost ($) White Non W White Non W White Non W White Non W White Non W White Non W White Non W White Non W 
MTF   
Total Cost 12,575.0 13,582.3 1,750.4 1,916.3 12,393.3 13,009.6 3,044.7 2,723.1 11,547.3 13,570.4 1,652.4 1,660.8 10,575.7 10,944.1 2,162.6 2,000.4 
Total Pharmacy Cost     121.4 124.3     185.2 154.8     141.3 130.4   144.3 129.9 
Number of Claims 621 375 11343 6182 79 33 2255 849 216 101 2736 1123 177 118 2870 1748 
Overall Total 996 17525 112 3104 317 3859 295 4618 
  
TRICARE Providers   
Bill Charged 11,610.5 12,300.1 1,342.1 1,324.4 13,018.0 9,904.6 1,900.5 1,715.4 12,664.7 11,190.2 1,118.2 1,264.4 8,906.1 11,703.2 1,309.1 1,092.7 
Bill Allowed 6,262.8 5,995.2 864.0 897.8 5,227.3 5,510.9 1,099.6 1,243.4 5,457.7 10,223.2 699.2 637.7 4,714.5 4,474.5 803.2 649.0 
Number of Claims 653 264 2,228 863 172 66 652 172 64 18 412 132 105 59 333 159 
Overall Total 917 3,091 238 824 82 544 164 492 
  
Length of Stay(Average) 12.6 13.8   11.7 11.0   11.7 15.5   10.1 11.3    
Number of Claims 1,209 597     246 96     270 117     275 173     
Table 7.13. Average PTSD Treatment Costs among Enlisted Population across Services (Race) 
 
* W=White population 




Depression and substance abuse remained the most common PTSD 
comorbidity amongst the PTSD population from the different branches of 
services.   As gathered from information in the TRICARE data files, it could be 
concluded that while at least half of the PTSD diagnosed population across the 
services had only PTSD (ICD-9 CM code 30981) to contend with, there remained 
at least a third of the population who had been diagnosed with at least one 
mental health illness comorbidity between FY2001 and FY2006. 
As depicted in the clinical data samples from TRICARE, it was evident 
there was a significantly large proportion of the enlisted personnel from the Air 
Force and the Navy who had been diagnosed with similar PTSD comorbidity (i.e. 
depression and other mental health illness) as their Army and Marine Corps 
counterparts.   This may imply that personnel from these two services could 
suffer from the same comorbidity associated with PTSD (depression) even 
though they could have distinctly different operational profiles as compared with 
the Army or the Marine Corps.    In addition, this could be attributable to the fact 
that the enlisted personnel were much more likely to develop severe PTSD 
symptoms as compared to the officers, given their close proximity to combat 
threats and line of fire during their missions. 
At the individual level analysis, it was found that female active duty 
personnel across the services tended to have more PTSD comorbidities and 
tended to be admitted for a longer period at the treatment facilities as compared 
to their male counterparts.   The male officers from the Army and Air Force 
incurred higher inpatient treatment costs at the MTFs as compared to the rest of 
the services; while the female enlisted personnel from the Marine Corps and the 
Navy incurred higher inpatient treatment costs at the MTFs.   The Air Force 
active duty personnel seemed to have the highest treatment costs at the 
TRICARE civilian providers.   
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Generally, while the findings in this section highlighted similar evidence on 
the PTSD characteristics for Army and Marine Corps personnel, they also 
provided useful perspectives on the little known statistics among the PTSD 
diagnosed population from the Air Force and the Navy.  Contrary to common 
expectations, the active duty personnel from the Air Force and Navy were equally 
susceptible to PTSD risks when they were deployed overseas, especially in the 
combat regions of Iraq and Afghanistan.    Given the substantial treatment costs 
incurred by all PTSD diagnosed active duty personnel during the study period, it 
is important for the military planners to note the budgetary implications as the 
numbers of PTSD cases most likely are on a rising trend in view of the 





Consistent with existing literature on PTSD prevalence among active duty 
service personnel of the U.S military, the officers and enlisted personnel from the 
Army and the Marine Corps remained as the largest group of personnel who 
were highly susceptible to PTSD risks in view of their combat missions and 
operational deployment profiles.  This thesis utilized the clinical and deployment 
information from both TRICARE and DMDC to conduct a comprehensive study 
on PTSD prevalence rates across the four services of the U.S. military as well as 
the potential deployment effects on the probability of being diagnosed with PTSD 
among active duty service personnel who were deployed overseas. In addition, 
this study also analyzed the PTSD comorbidity distribution and treatment cost 
patterns across the services between FY2001 and FY2006.  
As described in Chapter V, there was an increasing trend in the number of 
new PTSD cases across the services between FY2001 and FY2006 as the 
GWOT continued. The sustained duration of OIF and OEF seemed to have 
exacerbated the toll on the deployed soldiers of the U.S. military as the statistics 
for PTSD continued to climb. By analyzing the different study population based 
on TRICARE enrollments and deployment history, we found that the enlisted 
population from the Army and the Marine Corps remained highly susceptible to 
PTSD risks, in view of their combat deployments especially in Iraq and 
Afghanistan. In addition, there was clear evidence that the PTSD statistics for the 
Air Force and particularly the Navy were also rising even though their operational 
roles and combat deployments may be vastly different from those of the Army 
and the Marine Corps. This information clearly bridged the existing gap of the 
little to no information on PTSD trends amongst the active duty service personnel 
from the Air Force and the Navy. The analysis on the PTSD prevalence rate 
done via separation of the data samples into the officer and enlisted PTSD 
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population further provided insight into the potential differences in the 
characteristics of the two populations.  Consistent with existing literature, the 
enlisted personnel, especially from the Army and the Marine Corps, showed 
increased risk of PTSD if they were ever deployed to Iraq or Afghanistan.    
The multivariate analyses showed that deployment characteristics, i.e., 
deployment location, deployment duration and frequency of deployment, had 
substantial impacts on the probability of being diagnosed with PTSD among the 
active duty service personnel between FY2001 and FY2006. Overseas 
deployments, particularly deployments to Iraq, increased the probability of being 
diagnosed with PTSD. As their deployment duration and frequency of 
deployments increased, the probability of the personnel being diagnosed with 
PTSD also increased. Consistent with the trend analysis and existing literature, 
the adverse effect of overseas deployment on the probability of being diagnosed 
with PTSD was found to be more significant on the enlisted personnel, than on 
the officers. In addition, the multivariate analyses also revealed that enlisted 
sailors were equally, if not more, affected by the overseas deployments, than the 
enlisted soldiers in the Army and Marine Corps between FY2001 to FY2006.   
Depression and substance abuse remained the most common PTSD 
comorbidity amongst the PTSD population from the different services. As 
depicted in the clinical data samples from TRICARE, it was evident there was a 
significantly large proportion of the enlisted personnel from the Air Force and the 
Navy who had been diagnosed with similar PTSD comorbidity (i.e. depression 
and other mental health illness) as their Army and Marine Corps counterparts. 
This may imply that active duty service personnel from the Air Force and Navy 
were equally susceptible to PTSD risks when they were deployed overseas, 
especially in the combat regions of Iraq and Afghanistan. In addition, consistent 
with the prevailing PTSD literature, enlisted personnel were much more likely to 
develop severe PTSD symptoms as compared to officers, given their close 
proximity to the combat threats and line of fire during their missions. 
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At the individual level analysis, it was found that the female active duty 
personnel across the services tended to have more PTSD comorbidity and 
tended to be admitted for a longer period at treatment facilities as compared to 
their male counterparts. The male officers from the Army and Air Force incurred 
higher inpatient treatment costs at the MTFs as compared to the rest of the 
services, while female enlisted personnel from the Marine Corps and the Navy 
incurred higher inpatient treatment costs at the MTFs only. The Air Force active 
duty personnel were found to have incurred the highest treatment costs at the 
TRICARE civilian providers.  This could be due to either the Air Force personnel 
having complex PTSD related symptoms which required specialized professional 
medical advice, or that they preferred to seek treatment out of the military 
settings to minimize inadvertent reminders of combat trauma. Given the 
substantial treatment costs incurred by all PTSD diagnosed active duty personnel 
during the study period, it is important for the military planners to note the 
budgetary implications as the numbers of PTSD cases are on the rise in view of 
the continuation of GWOT. 
B. LIMITATIONS OF STUDY 
Several limitations of the study deserve comment.  First, there is a need to 
note the two data restrictions and their possible impact on this study. The 
omission of observations missing EDIPN from the DEERS data set used for the 
study may have affected the precision of the analysis given the large standard 
errors present in the frequency distribution of the data.  In addition, the restriction 
on the availability of the deployment data by DMDC, may have rendered a less 
precise outcome of the multivariate analyses on the impact of deployment 
characteristics on PTSD occurrences among the deployed troops.   
Besides data restrictions, the study was also limited by the fact that only 
the clinical information from TRICARE was used to provide details on the PTSD 
population, i.e. only those who had sought medical treatment were considered in 
the data samples for analysis. While having this data could have provided useful 
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information on PTSD comorbidity and treatment costs amongst the affected 
personnel across the services, it greatly reduced the sample size of the PTSD 
population for a holistic evaluation. The data used in this thesis would not have 
captured those personnel who did not seek treatment for their PTSD symptoms. 
A possible area for improvement may be the use of different regression 
methods to estimate the deployment effects on the probability of being diagnosed 
with PTSD amongst the active duty service personnel. Although the probit 
regression is a widely used tool for the analytical purposes of medical 
evaluations and its results can be easily interpreted, the probit model could have 
understated the deployment effects due to the small magnitudes of its coefficient 
estimates and the low baseline PTSD prevalence rate in our sample. A multi-
nomial logistic regression methodology may a better approach as the odds ratio 
terminology and the logit regression would have presented a much more realistic 
picture for the effects of deployment on PTSD risks. 
C. RECOMMENDATIONS 
This study has provided detailed PTSD information on the four armed 
services of the U.S. military between FY2001 and FY2006, especially for the Air 
Force and the Navy.   In view of the rising trends of PTSD across the services 
and the deployment effects on the probability of being diagnosed with PTSD 
amongst active duty service personnel, the military planners would do well to 
make use of the information to review and evaluate the deployment lengths, 
especially for those “high risk” combat zones. Educational programs should also 
be used to create awareness among active duty personnel to understand and 
identify the symptoms for PTSD. In addition, active duty personnel who are 
returning from their combat tours should be encouraged to seek treatment early 
for PTSD symptoms. It is important to keep in mind that all service members are 
involved in the GWOT. An early diagnosis and treatment of PTSD would help to 
maintain the combat readiness of the U.S. military, as well as reduce the 
budgetary and social cost of PTSD.  
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